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ABSTRACT
Peptides derived from food proteins after enzymatic treatment and/or processing, are 
known to be bioactive in both biological and food systems; for this reason fish muscle 
peptides were investigated for their antihypertensive and antioxidant activity. Atlantic 
mackerel muscle proteins were hydrolysed with pepsin and pancreatine and the resultant 
hydrolysate was sequentially fractionated on 2 kDa membrane ultrafilters and further by 
gel filtration, ion exchange and high performance liquid chromatography and the 
resultant peptide fraction contained the amino acids histidine, proline, tyrosine, 
methionine, leucine, tryptophan and lysine. For ACE inhibitory activity, the peptide 
fraction (MFPH-V-JPA) had an inhibitory concentration (IC50) of 0.15 mg/ml and 
showed competitive inhibition for ACE with an inhibition constant (K0 of 0.32 mg/ml. In 
terms of antioxidant activity, the HPLC isolated peptide fraction (LC1-Z) contained the 
amino acids serine, histidine, tyrosine, phenylalanine, tryptophan and lysine. It inhibited 
the formation of both peroxides and malonaldehyde in a linoleic acid model emulsion in a 
dose dependent manner with lipid oxidation inhibitory concentration (IC50) of 1.80 
mg/ml. At concentration of 8 mg/ml, the inhibition of linoleic acid oxidation was more 
than that of 0.01 % butylated hydroxytoluene (BHT) and trolox (p<0.001). The 
mechanism of antioxidant activity of the peptide (LC1-Z) was by carbon centered radical 
scavenging (5.34 %), hydroxyly radical scavenging (IC50 value of 1.60 mg/ml), metal 
chelating (5.72 %) and reducing ability. In caco-2 cells, 1 mg/ml of the peptide (LC1-Z) 
was not toxic to the cells seeded at 2 x 104 cells/well. Proxidant tBHP (2.5 mM) reduced 
cell viability significantly (79.3 %) but this increased to 94.7 % in the presence of the
peptide or trolox. The peptide (1 mg/ml) also reduced TBARS formation (33.18 jag/ml) in 
cells compared to cells treated with tBHP alone (38.18 jig/ml). The activity of caspases-3 
and -7, was higher in caco-2 cells treated with tBHP only (157.5 ± 7.99 %) compared 
with those treated with the peptide (25.7 ± 3.92 %). Morphological modification of the 
caco-2 cells treated with tBHP was evident as the cells appeared detached from the flask 
surface compared to those treated with the peptide (LC1-Z) which were healthy and 
attached to the flask surface. In Ea.hy 926 cells, reactive oxygen species were reduced by 
26 %  and 39 %  in the lucigenin-chemiluminscence and flourescence methods 
respectively in cells treated with the peptide. In a caco-2 cell monolayer, transepithelial 
transport of the peptide was observed in both directions with a basolateral to apical 
apparent permeability of 0.95 ± 0 .1 2  cm' 1 and apical to basolateral flux of 0.74 ± 0.20 
cm'1. HPLC chromatograms of the buffer solution taken from the apical and basolateral 
side showed the presence of the peptide in both sides i.e. 11.5% for apical to basolateral 
flux and 12.2 % for basolateral to apical. These results demonstrate that peptides with 
antihypertensive and antioxidant activity can be derived from Atlantic mackerel muscle 
proteins, with potential for neutraceutical applications.
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C H A P T E R  O N E
Fish are aquatic vertebrates that use gills to obtain oxygen from water and have fins with 
variable number of fin rays also called skeletal elements (Thurman and Webber, 1984). 
The Census of Marine Life (COML) research group indicates that there are over 20,000 
different species of fish in the world's seas and oceans, about a quarter of which are still 
to be discovered and classified (Mason, 2003).
The consumption of fish has been linked to a number of health benefits as a result of its 
unique content of proteins, oils, vitamins and minerals. Globally, fish provides more 
than 2.6 billion people with approximately 20 % of the average animal protein 
requirements (Sidhu, 2003, FAO, 2004). However, the projected increase in world 
population is likely to lead to shortages in fish consuming areas. In addition, a large part 
of the fish harvested is wasted. The FAO estimates that post-harvest losses, as discards 
at sea and losses due to deterioration, are as high as 27 million tonnes of the total catch 
(110 million tones) (Kelleher, 2004). Fish processing waste has been well documented 
as a rich source of under-utilized protein, with well over 75 percent (by weight) of round 
fillet being discarded during a filleting process. The protein content in cod (Gadus 
morhua) fillet and offals was found to be 14.3 % and 17.8 %, of wet weight, respectively 
(Shahidi, 1994). Therefore, reducing these substantial losses by utilizing and upgrading 
the discards from processing into valuable food products remains a challenge and a 
primary objective of fish processors.
1. GENERAL INTRODUCTION
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Traditionally, food ingredients including herbs have been used to treat diseases in 
addition to conventional medicines. Recently, however, there has been a drive to acquire 
a detailed knowledge of the composition and mechanisms of the active ingredients like 
polyphenols. Thus food and nutritional sciences can make a contribution to the reduction 
of this disease burden and a part of this science is the role played by proteins and 
peptides.
The nutritional and functional properties of food proteins have been investigated for 
many years. The nutritional quality of a protein depends on its amino acid content and 
on the physiological utilization of specific amino acids after digestion and absoiption 
(Friedman, 1996). In terms of their functional properties, proteins contribute to the 
physicochemical and sensory properties of various protein-rich foods. Scientific 
evidence has shown that proteins and in particular peptides exert specific biological 
activities besides the established nutritional function (Korhonen and Pihlanto, 2003). 
These peptides are specific protein fragments that have a positive effect on body 
function and state and therefore impact on the health of individuals. These peptides are 
classified as bioactive peptides (BAPs) and they are generally considered to be inactive 
in their sequence in the protein. Upon hydrolytic proteolysis, by gastrointestinal 
enzymes or during processing through enzyme-mediated proteolysis of the parent 
protein, bioactive peptides are released which when absorbed exert a biological function 
in the human body and impact on the health of the individual (Korhonen and Pihlanto, 
2003; Yoshikawa et al, 2000). BAPs are relatively resistant to hydrolysis and can either 
be transported across the intestinal mucosa due to their small size to exert biological
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activity or they can exert local effects in the gastrointestinal tract (Vermeirssen et al, 
2002).
In vivo, these peptides have been documented to exhibit a number of biological activities 
and this is heavily dependent on the nature and the sequence of amino acids in peptides. 
Activities exhibited include Angiotensin I converting enzyme (ACE) inhibition, 
antioxidant activity, antimicrobial activity, mineral binding, opioid and 
immunomodulatory activities. Bioactive peptides of food origin therefore have the 
potential to be utilized and delivered to consumers as active ingredients in functional 
foods, conventional foods and nutraceuticals (Meisel, 1997; Korhonen and Pihlanto, 
2003; Mine and Shahidi, 2006). This review seeks to highlight the biological activity in 
vivo and in vitro, of fish derived peptides in inhibiting the Angiotensin converting 
enzyme (ACE) and antioxidant activity.
1.2. Proteins and peptides
1.2.1. Protein structure
Each protein consists of one or more unique polypeptide chains. Most proteins do not 
remain as linear sequences of amino acids; rather, the polypeptide chain undergoes a 
folding process. The process of protein folding is driven by thermodynamic 
considerations. This means that each protein folds into a configuration that is the most 
stable for its particular chemical structure and its particular environment. The final shape 
will vary but the majority of proteins assume a globular or fibrous configuration. In
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order to maintain their function, proteins maintain this conformation (Belitz et al, 2009). 
Four levels of protein organization are described: primary, secondary, tertiary and 
quaternary (Figure 1.1).
1.2.1.1. Primary structure
The primary structure refers to the linear sequence of amino acids that make up the 
polypeptide chain. That bond between two amino acids is a peptide bond. This bond is 
formed by the removal of a H20  molecule from two different amino acids, forming a 
dipeptide. The sequence of amino acids determines the positioning of the different side 
chain R groups relative to each other. This positioning therefore determines the way that 
the protein folds and the final structure of the molecule (Belitz et al, 2009).
1.2.1.2. Secondary structure
The secondary structure of protein molecules refers to the formation of a regular pattern 
of twists or kinks of the polypeptide chain. The regularity is due to hydrogen bonds 
forming between the atoms of the amino acid backbone of the polypeptide chain. The 
two most common types of secondary structure are known as the a-helix and B-pleated 
sheet (Belitz et al, 2009).
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1.2.1.3. Tertiary structure
Tertiary structure refers to the three dimensional globular structure formed by folding of 
the linear polypeptide chain. The folding of the polypeptide chain is stabilized by 
multiple weak, non-covalent interactions including hydrogen bonds, electrostatic 
interactions and hydrophobic interactions. During folding of the polypeptide chain, 
amino acids with a polar (water soluble) side chain are often found on the surface of the 
molecule while amino acids with non-polar (water insoluble) side chains are buried in 
the interior. This means that the folded protein is soluble in water or aqueous solutions. 
Covalent bonds including disulphide bonds may also contribute to tertiary structure. The 
amino acid, cysteine, has a SH group as part of its R group and, therefore, the disulphide 
bond (S-S) can form with an adjacent cysteine (Belitz et al, 2004).
1.2.1.4. Quaternary structure
Quaternary structure refers to the association of several polypeptide chains giving an 
additional level of structural organization: Each polypeptide chain in the protein is called 
a subunit which may comprise the same 01* different polypeptide chains (Belitz et al, 
2004).
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Figure 1.1: The four levels of protein structure. Adapted from
http://www.genome.gov/page.cfm?pageID=10000552.
1.2.2. Fish proteins
The proteins of fish tissue can be divided into three groups namely structural, 
sarcoplasmic and connective tissue proteins.
I.2.2.I. Structural proteins
Structural proteins, that include actin, myosin, tropomyosin and actomyosin, constitute 
70-80 % of the total protein content and make up the contractile apparatus responsible
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for muscle movement. Myosin and actin are the predominant constituents in structural 
proteins and account for more than 70 %  of total protein (Pearson and Young, 1989). 
Myosin is a very large protein (about 500 kDa) consisting of two identical heavy chains 
(about 200 kDa each) and two pairs of light chains (about 20 kDa each). Each heavy 
chain consists of a globular head region and a long a-helical tail. The a-helical tails of 
two heavy chains twist around each other in a coiled-coil structure to form a dimer, and 
two light chains associate with the neck of each head region to form the complete 
myosin molecule. The amino acid composition of structural proteins is similar to 
mammalian muscle proteins; however the physical properties differ slightly (Spinelli et 
al, 1972). Myosin has 17 % basic amino acids, 18 % acidic amino acids and about 42 
thiol residues that contribute to its function. Actin represents about 15 % of meat 
proteins. It has 3 isoforms a, (3 and y and in its monomeric form it’s referred to as G- 
actin. Four hundred (400) G-actin molecules are joined to form the non covalent 
filament called F -actin and these form the backbone of the thin filaments in muscles 
(Offer et al, 1989).
I.2.2.2. Sarcoplasmic proteins
Sarcoplasmic proteins include albumins, globulins and enzymes; and constitute 25-30 % 
of the protein, the majority being enzymes participating in cell metabolism. They are 
soluble in water and dilute aqueous solutions (Belitz et al, 2009).
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Fish connective tissue proteins consist predominantly of fibrillar collagen, constituting 
approximately 3 -  10 % total proteins compared with 17 % in most mammals. Collagen 
contains large quantities of hydroxyproline, with the primary structure having a 
repeating sequence of glycine-proline-hydroxyproline-glyeine amino acids. In 
vertebrates, at least twelve different forms have been identified, each with a 
characteristic sequence of amino acids which allows the formation of a left-handed 
helical secondary structure. Three helices combine to form tropocollagen, a right handed 
super helix, which assemble and aggregate to form fibrils and consequently fibers 
(Lawrie, 1991).
The chemical and physical properties of collagen proteins differ depending on the 
tissues such as skin, swim bladder and the myocommata in muscle. Fish collagen fibrils 
form a delicate network structure with varying complexity in the different connective 
tissues. Compared to mammals, the hydroxyproline content is lower varying from 4.7 -  
10 % of total amino acids (Sato et al, 1989). However, different fish species contain 
varying amounts of collagen in the body tissues. This difference is believed to reflect the 
swimming behaviour and influences the textural characteristics of fish muscle 
(Yoshinaka et al, 1988; Montero and Borderias, 1989).
As with all other proteins, fish proteins have nutritional, functional and biological 
properties. In terms of nutrition, fish proteins are a source of energy and contain all the 
essential amino acids (with a high biological value) that are essential for growth and
I.2.2.3. Connective tissue proteins
maintenance. Fish proteins are also known to contribute to the physicochemical and 
sensory properties of various protein-rich and enriched foods (Belitz et al, 2009). 
Besides the nutritional and functional properties, fish proteins are reported to exhibit 
specific biological activities which make them potentially useful nutraceuticals and 
functional food components. These properties are attributed to physiologically active 
peptides encrypted in fish protein molecules which when liberated affect numerous 
physiological functions of the organism.
1.3. Protein and peptide separation
Proteins and peptides are typically characterized by their size (molecular weight) and 
shape, amino acid composition and sequence, isoelectric point (pi), hydrophobicity, and 
biological affinity. The chemical composition of the unique R groups is responsible for 
the important characteristics of amino acids, chemical reactivity, ionic charge and 
relative hydrophobicity. Therefore protein properties relate back to number and type of 
amino acids that make up the protein. The amino acid composition is the percentage of 
the constituent amino acids in a particular protein while the sequence is the order in 
which the amino acids are arranged. Differences in these properties can be used as the 
basis for separation methods in a purification strategy (Belitz et al, 2009).
1.3.1. Size
Protein size is usually measured as molecular weight (mass), although occasionally, the 
length or diameter of a protein is given in Angstroms. The molecular' weight of a protein
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is the mass of one mole of protein, usually measured in units called daltons; one dalton 
is the atomic mass of one proton or neutron. The molecular weight can be estimated by a 
number of different methods including electrophoresis, gel filtration, and more recently 
by mass spectrometry. Separation methods that are based on size and shape include gel 
filtration chromatography (size exclusion chromatography) and polyacrylamide gel 
electrophoresis (Belitz et al, 2009).
1.3.2. Charge
Each protein has an amino group at one end and a carboxyl group at the other end as 
well as numerous amino acid side chains, some of which are charged. Therefore each 
protein and peptide carries a net charge. The net protein/peptide charge is strongly 
influenced by the pH of the solution. Different proteins have different number of each of 
the amino acid side chains and therefore have different isoelectric points. So, in a buffer 
solution at a particular pH, some proteins will be positively charged, some proteins will 
be negatively charged and some will have no charge. Separation techniques that are 
based on charge include ion exchange chromatography, isoelectric focusing and 
chromatofocusing (Belitz et al, 2009).
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1.3.3. Hydrophobicity
In aqueous solutions, proteins and peptides tend to fold so that areas of the protein with 
hydrophobic regions are located in internal surfaces next to each other and away from 
the polar water molecules of the solution. Polar groups on the amino acid are called 
hydrophilic (water loving) because they will form hydrogen bonds with water 
molecules. The number, type and distribution of nonpolar amino acid residues within the 
protein determine its hydrophobic character. A separation method that is based on the 
hydrophobic character of proteins and peptides is hydrophobic interaction in most solid - 
liquid chromatography (Belitz et al, 2009).
1.3.4. Solubility
The 3-D structure of a protein affects its solubility properties. Cytoplasmic proteins and 
peptides have mostly hydrophilic (polar) amino acids on their surface and are therefore 
water soluble, with more hydrophobic groups located on the interior of the protein, 
sheltered from the aqueous environment. On the other hand, proteins and peptides that 
reside in the lipid environment of the cell membrane have mostly hydrophobic amino 
acids (non-polar) on their exterior surface and are not readily soluble in aqueous 
solutions.
Each protein has a distinct and characteristic solubility in a defined environment and any 
changes to those conditions (buffer or solvent type, pH, ionic strength, temperature, etc.)
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can cause proteins and peptides to lose solubility and precipitate out of solution. The 
environment can be manipulated to bring about a separation of proteins e.g. the ionic 
strength of the solution can be increased or decreased, which will change the solubility 
of some proteins (Belitz et al, 2009).
1.3.5. Biological affinity
Proteins and peptides often interact with other molecules in vivo in a specific way. They 
have a biological affinity for particular molecules and these molecular' counterparts are 
called ligands. These specific interactions are often exploited in protein purification 
procedures. Affinity chromatography is a common method for purifying recombinant 
proteins (e.g. proteins produced by genetic engineering). Several histidine residues can 
be engineered at the end of a polypeptide chain. Since repeated histidines have an 
affinity for metals, a column (250p.m i.d) of the metal can be used as a bait to “catch” 
the recombinant protein (Belitz et al, 2004).
1.4. Angiotensin I converting enzyme (ACE) and blood pressure
Blood pressure (BP) within the body is controlled by several physiological processes, 
which either increase or decrease it. The major physiological pathways involved in the 
regulation of BP are the renin-angiotensin system (RAS), the kinin-nitric oxide system 
(KNOS), the renin-chymase system (RCS), and neutral endopeptidase system (NEPS). 
The RAS is perhaps the most important of various humoral vasoconstrictor and 
vasodilator mechanisms implicated in blood pressure regulation. RAS regulates BP,
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electrolyte balance; and renal, neuronal and endocrine functions associated with 
cardiovascular control in the body. RAS plays a vital role in regulating blood volume 
and systemic vascular resistance; these two functions together control cardiac output and 
arterial pressure. The RAS has three important components namely, renin, angiotensin 
and aldosterone (Meisel et al, 2006).
In the RAS, through the action of kallikrein, renin is released from the precursor 
compound prorenin (Beldent et al, 1993; Ondetti and Cushman, 1982). Renin cleaves 
angiotensinogen to release angiotensin I (Ang-I) a decapeptide, Asp-Arg-Val-Tyr-Ile- 
His-Pro-Phe-His-Leu. The Angiotensin Converting Enzyme (ACE) hydrolyzes Ang-I by 
removing the C-terminal dipeptide His-Leu to give an octapeptide angiotensin II (Ang- 
II) Asp-Arg-Val-Tyr-Ile-His-Pro-Phe, a potent vasoconstrictor (Figure 1.2).
Ang II is known to interact with at least two distinct Ang II receptor subtypes, 
designated ATi and AT2. Angiotensin II acts directly on a G-coupled receptor known as 
the ATi causing a negative effect. When the Ang II binds to the complementary 
receptor, it stimulates vascular smooth muscle contraction and release of noradrenaline 
thus constricting arteries and increasing the heart rate. It also stimulates the adrenal 
cortex, releasing the hormone aldosterone. Once aldosterone is released, the electrolyte 
balance of sodium and water is lost, resulting in retention of sodium and water 
(Laurence et al, 1997).
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Figure 1.2. Angiotensin II formation via ACE.
The three-dimensional structure reveals that ACE is composed of a-helices for the most 
part, and incorporates a zinc ion and two chloride ions (Figure 1.3). The active site 
consists of a deep, narrow channel that divides the molecule into two subdomains. On 
top of the molecule is an amino-terminal 'lid', which seems to allow only small peptide
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substrates (2530 amino acids) access to the active site cleft. This accounts for the 
inability of ACE to hydrolyse large, folded substrates (Natesh et al, 2003).
Figure 1.3. Three-dimensional structure of angiotensin converting enzyme (ACE) 
(Natesh et al, 2003).
Three different forms of ACE are identified namely somatic ACE, testicular ACE and 
ACE homologue (ACEH). The somatic and testicular forms of ACE consist of two 
homologous domains, N- and C-domain (Inagami, 1992). Both domains contain active 
sites which are responsible for the catalytic hydrolysis of angiotensin I (Wei et al, 1992). 
The C-domain appears to be responsible for controlling blood pressure, signifying that 
the C-domain is the principal angiotensin-converting site (Natesh et al, 2003).
ACE is one of a number of biologically important ectoproteins existing in both 
membrane-bound and soluble forms. Localized on the surface of various cells, ACE is 
inserted at the cell membrane via its carboxyl terminus. Human plasma ACE originates 
from endothelial cells while other body fluids may contain ACE that originates from
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epithelial, endothelial or germinal cells. The two isoforms of ACE, the two-domain 
somatic form and the single domain germinal form, convert angiotensin I to angiotensin 
II, and metabolize kinins and many other biologically active peptides, including 
substance P, chemotactic peptide and opioid peptides. The broad spectrum of substrates 
for ACE and its wide distribution throughout the body indicates that this enzyme, in 
addition to an important role in cardiovascular homeostasis, may be involved in 
additional physiological processes such as neovascularization, fertilization, 
atherosclerosis, kidney and lung fibrosis, myocardial hypertrophy, inflammation and 
wound healing (Igic and Behnia, 2003)
Thus, ACE is a key enzyme in the regulation of BP and has been targeted in the control 
of hypertension. ACE inhibition prevents the formation of the vasoconstrictory 
(hypertensive) agent angiotensin II and enhances the vasodilatory (hypotensive) 
properties of bradykinin, leading to a concerted lowering of the blood pressure. As a 
result of Ang II production, several physiological processes are elicited that include 
systematic vasoconstriction, cardiac and vascular hypertrophy, increased blood volume 
and renal sodium and fluid retention (Figure 1.4). This process consequently leads to the 
lowering of blood pressure and forms the basis for the use of the inhibitors of ACE in 
the treatment of hypertension, heart failure, myocardial infarction and diabetic 
nephropathy (Mine and Shahidi, 2006).
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Figure 1.4. Physiological effects of Angiotensin II production.
1.4.1. ACE inhibitors
The first naturally occurring Angiotensin-I-Converting Enzyme Inhibitors (ACEI) of 
peptide nature were isolated from snake venom (Ferreira et al, 1970, Ondetti et al, 
1971). Ferreira et al (1970) isolated nine biologically active peptides from Bothrops 
jararaca containing 5 to 13 amino acid residues. Ondetti et al (1971) also isolated from 
venom of Bothrops jararaca and reported other strong ACE inhibitors having an 
antihypertensive effect in vivo from the venom. However, since it was not orally active, 
a synthetic inhibitor had to be designed. In the 1970s, Ondetti et al (1977) developed
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inhibitors of ACE by rational drug design, where they constructed the active site of 
ACE, using computer assisted studies.
Varying terminal amino acid sequences of peptides may serve as inhibitors of ACE. The 
shortest peptides that serve as inhibitors of ACE are tripeptides. It is suggested that the 
C-terminal tripeptide residue of peptide inhibitors, as well as the nonpeptide inhibitors 
such as captopril, interact with an "obligatory binding site" on ACE, which is necessary 
for effective binding. Peptide inhibitors, on the other hand, bind not only to the 
obligatory binding site of the enzyme but also interact with regions of the enzyme 
adjacent to the obligatory binding site (Antonaccio, 1982) (Figure 1.5).
Si Si Sg
Figure 1.5. Hypothetical model of ACE and suggested binding of peptides to the 
active site of the enzyme.
18
Many prototypes of ACE inhibitors were developed, which eventually led to the 
development of the first synthetic ACE inhibitor, Captopril (Laurence et al, 1997). 
However, due to many reported zinc deficient adverse reactions (Golik et al, 1998), 
subsequent ACE inhibitors were designed that includes Enalapril, Lisinopril and 
Ramipril (Figure 1.6).
Enalapril
CH3
Captopril
LisinoprilRamilpril
Figure 1.6. Synthetic ACE inhibitors.
Despite these positive developments in synthetic ACEI, their use is questioned due to 
side effects such as skin rash, headache, dry cough and loss of taste perception. As a
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result, another dimension to current research is now directed to naturally occurring 
inhibitors from natural sources. Until now, several ACE inhibitory (ACEI) peptides have 
been isolated from various food proteins such as milk, animal (non- milk), plant, insect 
and different protein sources and these are reviewed in the literature (Meisel et al, 2006; 
Mine and Shahidi, 2006). ACE inhibitory peptides have been isolated and characterized 
from a number of fish sources, from the muscle proteins themselves as well as from 
waste and discards from fish processing plants. ACE inhibitory peptides have been 
isolated and characterized from several fish species that include salmon, sardine, bonito, 
tuna, Alaska pollack, sea bream, pelagic thresher, fish sauce, blue whiting and yellowfin 
sole (Table 1.1).
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Table 1.1. ACE inhibitory peptides derived from fish proteins: source, amino acid 
sequence, parent protein, enzyme used for hydrolysis, and ICso-value.
Source Parent
Protein
Enzyme
treatment
Amino IC50
Acid (pM)
Sequence_______
Reference
Sardine
Tuna
Bonito
Sardine
Bonito
bowels
Sardine
Meat
Muscle
A.oryzae
protease
Acid PTHIKWG
D
3.97 Suetsuna and Osajima 
mg/1 1986
N/A ICohama et al, 1988
Muscle Acid IF 70.0 ICohama etal, 1988
Muscle Acid VWIG 110.0 Kohamaeta/, 1988
Muscle Acid LTF 330.0 Kohama et al, 1988
Muscle Acid IFG >100
0
0.32
Kohama etal, 1988
Muscle Thermolysin LKP Fugita and Yoshikawa 
1999
Actin Thermolysin IY 2.31 Yokoyama etal, 1992, 
Fugita and Yoshikawa 
1999
Actin Thermolysin IVGRPRH
QG
2.4 Yokoyama et al, 1992
Muscle Thermolysin LKPNM 2.4 Yokoyama et al, 1992 
Fugita and Yoshikawa 
1999
Actin Thermolysin IWH 3.5 Fugita and Yoshikawa 
1999
Actin Thermolysin IWHHT 5.8 Yokoyama et al, 1992 
Fugita and Yoshikawa 
1999
Muscle Thermolysin IKP 6.9 Fugita and Yoshikawa 
1999
Actin Thermolysin ALPHA 10 Yokoyama et al, 1992
Actin Thermolysin FQP 12 Yokoyama et al, 1992
Muscle Thermolysin IKPLNY 43 Yokoyama et al, 1992
Muscle Thermolysin DYGLYP 62 Yokoyama et al, 1992
Muscle B.licheniformis 
alkaline protease
NSIR* 0.015
mg/
ml
Matsuietn/, 1993
Autolysate LRP 1.0 Matsumura et al, 1993
Autolysate IRP 1.8 Matsumura et al, 1993
Autolysate VRP 2.2 Matsumura etal, 1993
Autolysate IKP 2.5 Matsumura et al, 1993
Autolysate YRPY 320 Matsumura etal, 1993
Autolysate GHF 1100 Matsumura et al, 1993
Muscle Alkaline protease ICY 1.63 Matsufuji et al, 1994
Muscle Alkaline protease AICK 3.13 Matsufuji etal, 1994
Muscle Alkaline protease GWAP 3.86 Matsufuji et al, 1994
Muscle Alkaline protease VY 10 Matsufuji etal, 1994
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Muscle Alkaline protease IY 10.5 Matsufuji et al, 1994
Muscle Alkaline protease GRP 20 Matsufuji et al, 1994
Muscle Alkaline protease LY 38.5 Matsufuji et al, 1994
Muscle Alkaline protease VF 43.7 Matsufuji et al, 1994
Muscle Alkaline protease MF 44.7 Matsufuji et al, 1994
Muscle Alkaline protease RY 51 Matsufuji et al, 1994
Muscle Alkaline protease YL 82 Matsufuji et al, 1994
Muscle Alkaline protease MY 193 Matsufuji et al, 1994
Muscle Alkaline protease RVY 205.6 Matsufuji et al, 1994
Muscle Alkaline protease RFH 330 Matsufuji et al, 1994
Sardine NSIR* NSIR* LKVGVKQ
v
11.0 Ariyoshi 1993
NSIR* NSIR*
I
KVLAGM 30.0 Ariyoshi 1993
NSIR* NSIR* HQAAGW 60.0 Ariyoshi 1993
NSIR* NSIR* VKAGF 83.0 Ariyoshi 1993
NSIR* NSIR* LKL 188.0 Ariyoshi 1993
Tuna
(Skipjack)
Flesh Trypsin, 
chymotrypsin, 
pronase E + pepsin
CWLPVY 22.20 Astawan et al, 1995
Flesh Trypsin, 
chymotrypsin, 
pronase E + pepsin
VAWKL 31.97 Astawan et al, 1995
Flesh Trypsin, 
chymotrypsin, 
pronase E + pepsin
SKVPP 74.22 Astawan et al, 1995
Flesh Trypsin, 
chymotrypsin, 
pronase E + pepsin
YSKVL 156.3 Astawan et al, 1995
Salmon Sauce Fermentation NSIR* 1.69
mg/
mi
Okamoto etal, 1995
Sardine Sauce Fermentation NSIR* 1.43
mg/
ml
Okamoto et al, 1995
Sardine Sauce Fermentation NSIR* 3.15
mg/
ml
Okamoto et al, 1995
Dried
bonito
Sauce Fermentation NSIR* 0.24
mg/
ml
Squid Autolysate
Autolysate
YALPHA
GYALPHA
9.8
27.3
Wako et al, 1996 
Wako et al, 1996
Bonito Thermolysin
Thermolysin
Thermolysin
Thermolysin
IKP
IY
LKPNM
IWHHT
1.6
2.1
2,4
5.8
Fugita et al, 2000 
Fugita et al, 2000 
Fugita et al, 2000 
Fugita et al, 2000
2 2
Thermolysin IVGRPRH 2.4 Fugita et al, 2000
QG mg/
ml
Alaska skin Alcalase, GPL 2.60 Byun and Kim 2001
Pollack pronase+
collagenase
skin Alcalase, GPM 17.13 Byun and Kim 2001
pronase+
collagenase
Frame Pepsin FGASTRG 14.7 Je et al, 2004
protein A
Pelagic Muscle Thermolysin IKW 0.54 Nomura et al, 2002
thresher +
viscera
extracts
Thermolysin vw 1.68 Nomura et al, 2002
Thermolysin MW 3.76 Nomura et al, 2002
Thermolysin FRVFTPN 9.59 Nomura et al, 2002
Thermolysin LWA 12.7 Nomura et al, 2002
Thermolysin VSW 23.2 Nomura et al, 2002
Thermolysin VTR 135.9 Nomura et al, 2002
Salmon Muscle Thermolysin VW 2.5 Ono et al, 2003
Muscle Thermolysin IW 4.7 Ono et al, 2003
Muscle Thermolysin MW 9.9 Ono et al, 2003
Muscle Thermolysin LW 17.4 Ono et al, 2003
Muscle Thermolysin WM 96.6 Ono et al, 2003
Muscle Thermolysin WA 277.3 Ono et al, 2003
Sea Scales Alkaline VIY 7.5 Fahmi et al, 2004
breams (gelatin
\
protease
J
Scales Alkaline VY 16 Fahmi et al, 2004
(gelatin
\
protease
Scales Alkaline GY 265 Fahmi et al, 2004
(gelatin protease
/
Scales Alkaline GF 708 Fahmi et al, 2004
(gelatin
\
protease
Salmon
/
Muscle Thermolysin AW 6.4 Ono et al, 2006
Muscle Thermolysin FL 13.6 Ono et al, 2006
Muscle Thermolysin WL 34.1 Ono et al, 2006
Muscle Thermolysin LF 383.2 Ono et al, 2006
Muscle Thermolysin WV 500.5 Ono et al, 2006
23
Yellowfin Frame Chymotrypsin MIFPGAG 28.7 Jung et al, 2006
sole protein GPEL fig/
ml
Salmon Muscle Papain IW 1.2 Enari et al, 2008
Atlantic muscle Pancreatic digest Hydrolysate 5.0 Nalcajima et al, 2009
salmon mg/
ml
Coho muscle Pancreatic digest Hydrolysate 3.7 Nakajima et al, 2009
salmon mg/
ml
Alaska muscle Pancreatic digest Hydrolysate 2.9 Nalcajima et al, 2009
pollack mg/
ml
Blue muscle Pancreatic digest Hydrolysate 3.69 Nakajima et al, 2009
whiting mg/
ml
Atlantic muscle Thermolysin Hydrolysate 0.078 Nakajima et al, 2009
salmon mg/
ml
Coho muscle Thermolysin Hydrolysate 0.138 Nakajima et al, 2009
salmon mg/
ml
NSIR*, Not specified in reference
The spontaneous hypertensive rat (SHR), a strain of Rattus norvegicus with elevated 
blood pressure, is extensively used as a model for studying hypertension in experimental 
animal models. SHR have been used to investigate the efficacy of ACEI peptides to 
regulate blood pressure. When orally or intravenously administrated to SHR, various 
animal and plant peptides have demonstrated antihypertensive effects through the 
reduction in blood pressure (Meisel et al, 2006). Peptides derived from fish proteins with 
ACE inhibitory activity are reported in literature and some show hypotensive activity in 
SHR (Table 1.2).
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Table 1.2. Hypotensive effects of fish derived peptides in Spontaneously 
Hypertensive Rats (SHR).
Origin of 
peptide
M ain peptides Dose Study
design
Results References
Sardine VY 20 mg/kg SHR, 12 wk SBP - 7.2 mmHg & Matsufuji et
muscle IC50: 7.1 pM BW old, Japan, DBP -  28.8 mmHg al, 1995
(alkaline i.v.
protease) 50 mg/kg SHR, 12 wk SBP - 18 mmHg and
BW old, Japan, BP- 35 mmHg
Dried bonito LKPNM, IC50: 8 mg/kg
1*V
SHR, 16-25 SBP - 23 mmHg at 4 Fugita and
(Thermolysin) 2.4 pM BW wk old, h Yoshikawa
Japan, SOD 1999
LKP 2.25 SHR, 16-25 SBP - 18 mmHg at 2
IC50: 0.32 pM mg/kg wk old, h
BW Japan, SOD
LKPNM 100 SHR, 16-25 SBP - 30 mmHg
mg/kg wk old,
BW Japan, i.v.
LKP 30 mg/kg SHR, 16-25 SBP - 50 mmHg
BW wk old,
Japan, i.v.
Bonito muscle IY, 10 mg/kg SHR, Japan, SBP - 45.0 mmHg Fugita et al,
(Thermolysin) ICso:2.1 pM BW by i.v. and (i.v.), 2000
i.v and SOD SBP -19.0 mmHg
60 mg/kg (SOD+ 2 h)
BW for
SOD
IW SBP - 55.0 mmHg
IC50: 5.1 pM (i.v.),
SBP - 22.0 mmHg
(SOD+ 2 h)
IKP, SBP - 70.0 mmHg
IC50: 1.6 pM (i.v.),
SBP - 20.0 mmHg
(SOD+ 6 h)
IWH, SBP - 70.0 mmHg
IC50: 3.5 pM (i.v.),
SBP - 30.0 mmHg
(SOD+ 4 h)
IVGRPR, IC50: SBP - 25.0 mmHg
300 pM (i.v.),
SBP -17.0 mmHg
(SOD+ 6 h)
LKPNM SBP - 80.0 mmHg
IC50: 2.4 pM (i.v.),
SBP - 23.0 mmHg
(SOD+ 6 h)
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IWHHT 
IC50: 5.8 |-iM
IVGRPRHQG 
IC50: 2.4 pM
SBP - 60.0 mmHg 
(i.v.),
SBP - 26.0 mmHg 
(SOD+ 6 h) 
SBP 0.00 mmHg 
(i.v.),
SBP - 14.0 mmHg 
(SOD+ 8 h)
Yellowsole MIFPGAGGPEL 
IC50: 28.7 pg/ml
lOmg/kg
BW
SHR lOwk 
SOD
SBP -  22mmHg +3h Jung et al, 
2006
Mackerel Hydrolysate 
IC50: 0.1 mg/ml
lOmg/kg
BW
SHR SOD SBP Decreased + 2- 
4h
Itou and 
Akahane 
2004
Tuna Hydrolysate 
IC50: 0.63 mg/ml
- SHR SOD SBP Decreased. Astawan et 
al, 1995
Sea breams Hydrolysate 
IC50: 0.57mg/ml
300
mg/kg
BW
SHR SOD SBP -  20mmHg +3h Fahmi et al, 
2004
Salmon Hydrolysate 
IC50: 27 pg/ml
500-2000
mg/kg
BW
SHR SOD SBP -28 to 
38mmHg + 4h
BW, body weight; SOD, single oral dose; SBP, systolic blood pressure; DBP, disystolic 
blood pressure.
1.4.2. Method for ACE inhibition activity
Angiotensin-converting enzyme (ACE) is a dipeptidyl carboxypeptidase that catalyzes 
the conversion of Angiotensin I to Angiotensin II. Therefore, the formation of the 
Angiotensin II is a measure of the enzyme activity, and the inhibition of the enzyme by 
certain compounds consequently indicates the potential and ability of these compounds 
to inhibit the activity of the ACE enzyme. Several methods for the measurement of ACE 
activity are reported and among them are included those based on spectrophotometry 
(Cushman and Cheung, 1971; Hayakari et al, 1978; Neels et al, 1983, Holmquist et al, 
1979), fluorimetry (Friedland and Silverstein, 1976; Friedland and Silverstein, 1977; 
Persson and Wilson, 1977), high-performance liquid chromatography (HPLC) (Neels et
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al, 1982, Doig and Smiley, 1993; Meng et al, 1995; Hyun and Shin, 2000; Wu et al, 
2002), and internally quenched fluorogenic methods (Araujo et al, 1999). However, 
spectrophotometry methods are widely used in food and pharmaceutical industries. The 
Cushman and Cheung (1971) protocol is the most widely used method and is based on 
the hydrolysis of a synthetic substrate hippuryl- histidyl-leucine (HHL) by ACE to give 
hippuric acid (HA) and histidyl-leucine as products. ACE-inhibitory activity is 
quantified through the formed HA. Among the HPLC methods, the method of Wu et al, 
(2002), has recently been developed to improve on the Cushman and Cheung method. It 
utilises C l8 reversed phase HPLC columns and a gradient acetonitrile-water- 
trifluoroacetic acid (TFA) mobile phase system.
1.5. Lipid oxidation inhibition and peptides
1.5.1. Lipids and ROS in biological systems
Lipids are a large and diverse group of naturally occurring organic, biological molecules 
that are related by their solubility in non-polar organic solvents and insolubility in 
aqueous solutions. Lipids are generally defined as fatty acids and their derivatives, and 
substances related biosynthetically or functionally to them, and include fatty acids, 
triacylglycerols, steroids, phospholipids, sphingolipids, plasmalogens, eicosanoids, 
waxes and terpenes. Lipids occur in both plants and animals serving a number of 
physiological functions including as structural components of biological membranes, 
energy reserves, precursors in vitamins and hormone synthesis and aiding lipid 
solubilization (Belitz et al, 2009).
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Fatty acids contain an even numbers of carbon atoms in straight chains and may be 
saturated or unsaturated (with or without double bonds) and can have a range of 
substituent groups, and possess a carboxylic acid moiety at one end. Fatty acids have 
two major roles in the body, as constituents of more complex membrane lipids and as 
major components of stored fat in the form of triglycerides/triacylglycerols. These 
triglycerides constitute fats and oils that are found in both plants and animals, forming a 
major food group in human diets. Unsaturated lipids are unstable and oxidize easily 
leading to a loss of functionality and consequently changes in structural arrangement of 
biological membranes and food systems (Belitz et al, 2009).
The human body and other aerobic organisms have reactive oxygen species (ROS) that 
can induce in vivo lipid oxidation; they comprise singlet oxygen *0 2 , hydroperoxyl 
radical HO2’, superoxide radical anion C>2*~, hydroxyl radical *OH, hydrogen 
hydroperoxide H2O2, hydroperoxide ROOH, peroxyl radical ROO*, alkoxyl radical RO\ 
and hypochlorous acid HOC1. ROS participate in a number of in vivo biological 
processes, are products of enzymatic reactions of oxidases such as xanthine oxidase and 
NAD (P) H oxidase, and may be produced by various cells. In the body, oxidative 
metabolism is indispensable for the survival of cells and the consequence of this 
dependence is the formation of ROS that can cause oxidative changes. These ROS, 
when formed in excess, overpower the protective enzymes like superoxide dismutase, 
catalase and peroxidase and cause destructive and lethal cellular effects (e.g. apoptosis) 
in membrane lipids, cellular proteins, DNA and enzymes, impairing cellular respiration. 
Due to these effects, lipid oxidation is a risk factor for diseases such as cardiovascular
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diseases, cancers, diabetes, neurological diseases, immune diseases and eye diseases 
(Wilcox et al, 2004). Several studies have shown increased oxidative damage to all the 
main classes of biomolecules in the brains of Alzheimer’s patients (Halliwell, 2001). 
Atherosclerosis, diabetes and rheumatoid arthritis are also associated with free radical 
mediated injury (Halliwell, 2000; Halliwell and Whiteman, 2004). Some types of cancer 
are possibly a consequence of oxidative DNA-damage (Collins, 2005). Exposure to 
ultraviolet radiation, air pollution and cigarette smoke can also generate free radicals. 
Nitrogen dioxide, one of the major oxidants in smog, is also found in cigarette smoke. 
Two free radicals are found in cigarette smoke, one in the tar portion and the other in the 
gaseous phase. The NO’ is found in the tar portion and is able to reduce oxygen to the 
superoxide radical. Highly reactive oxygen and carbon-centered radicals are found in the 
gas phase (Chow, 1993).
In food systems, lipid oxidation causes deterioration in food quality producing rancid 
flavours, unacceptable taste, toxic compounds and shortening of shelf life. However, 
physiological processes and food processing techniques are employed to mitigate the 
negative effects of lipid oxidation through the use of antioxidants. In food processing, 
major natural antioxidants include tocopherols, ascorbic acid and phenolic compounds, 
and synthetic ones such as butylated hydroxytoulene (BHT), butylated hydroyanisole 
(BHA), propyl gallate and ethoxyquin. Synthetic antioxidants are cheap and potent and 
therefore popular in food processing. However, current research has shown that they 
interfere with DNA, proteins and lipids and may cause diseases. Thus there is a shift to
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using naturally occurring antioxidants including peptides and amino acids from animal 
and plant proteins.
1.5.2. Lipid oxidation
Lipids, and in particular fatty acids that are unsaturated, can be oxidized under 
appropriate conditions. The mechanisms by which lipid oxidation is induced are 
multifaceted but are similar for many lipids. Three different mechanisms are postulated, 
namely autoxidation, photooxidation and enzymatic oxidation (Kolakowska, 2002).
1.5.2.1, Autooxidation
Autooxidation of lipids is a radical-chain process involving free radicals, defined as any 
species capable of independent existence and that contains one or more unpaired 
electrons. Free radicals are, therefore, highly reactive species due to the presence of 
these unpaired electrons as they need another electron to fill the orbital to assume 
stability. Oxidation is initiated by radicals present in living organisms (e.g., 
hydroperoxide HO2*, hydroxide ’OH, peroxide ROO*, allcoxyl RO*, alkyl R’) or by 
thermal or photochemical homolytic cleavage of an R-H bond. The classical 
autooxidation route involves three stages: initiation, propagation, and termination 
(Kolakowska, 2002).
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Initiation; In the presence of an initiator (In), unsaturated lipids (RH) lose hydrogen to 
form a lipid radical (R*):
R H  +In —> R* + InH
Propagation; The alkyl radical lipid (R*) reacts with molecular oxygen to form peroxyl 
radical (ROO*)
R + O 2 —> R O O
Peroxyl radicals abstract hydrogen from another molecule of unsaturated lipid (RH) to 
form hydroxyperoxides (ROOH) and a new lipid radical (R*)
ROO* + R H  —» R O O H  + R
Termination: The peroxyl radicals react with each other to form non-radical products:
ROO* + ROO* -» R O O R  + 0 2
1.5.2.2. Photooxidation
Photooxidation involves the highly electrophilic singlet oxygen ([0 2) that can react with 
unsaturated fatty acids, but by a different mechanism to free radical autoxidation. In the 
presence of photosensitizers (e.g. chlorophyll, porphyrins, myoglobin), a double bond in 
the unsaturated fatty acid interacts with singlet oxygen produced from 0 2 by light.
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Ultraviolet (UV) light, may be involved in initiation of the classical free radical 
oxidation of lipids and catalyse other stages of the process (Kolalcowska, 2002).
1.5.2.3. Enzymatic oxidation
Enzymatic oxidation processes are driven by the lipoxygenase enzyme (LOX) system. 
L O X  catalyzes reactions between oxygen and unsaturated fatty acids to form 
hydroperoxides which can be transformed into hydroxy products. LOX-catalyzed lipid 
oxidation is different from the free radical reactions as the formation of hydroperoxides 
is at a certain position of the chain of usually a free fatty acid (Kolalcowska, 2002).
1.5.3. Secondary oxidation products
In lipid oxidation, free radicals and hydroperoxides are regarded as primary oxidation 
products, and the products derived from them are thus termed secondary oxidation 
products. These formed products vary in composition and differ both quantitatively and 
qualitatively as they depend on the types of lipids, the presence of pro- and anti oxidants 
and conditions of oxidation. Hydroperoxides are transformed into ketones, aldehydes 
and hydroxides with a functional group situated at different positions, depending on the 
unsaturated FA, epoxides, dimers, and oligomers (Frankel, 1998). Volatile compounds 
that include aldehydes, alcohols, and hydrocarbons are formed as a result of homolytic
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P-scission of fatty acids hydroperoxides. Unsaturated aldehydes and ketones undergo 
autoxidation and supply further volatile compounds (Kolakowska, 2002).
Oxidation of a single pure fatty acid gives rise to several tens of volatile compounds. 
Propanal and hepta-2s4-dienal are characteristic of the oxidative decomposition of n-3 
polyunsaturated fatty acids, while hexanal and pentane are typical for oxidative 
decomposition of n- 6  polyunsaturated fatty acids (Frankel, 1998). The rancid lipid odour 
profile is made up of a mixture of several volatile compounds. Among them, the trans, 
cis -alkadienals, and vinyl ketones have the lowest flavor threshold in oils, while the 
threshold of hydrocarbons (alkanes and alkenes) is the highest (Min, 1998). The sensory 
effects depend on the composition of the participating compounds and on the 
composition of the food matrix. The rancid off-odors and off-flavors of foods emanate 
from the interactions between lipids and other components, especially proteins 
(Kolakowska, 2002).
1.5.4. Mechanisms of antioxidant action
Based on their mode of action, antioxidants are classified as free radical terminators, 
chelators of metal ions, or oxygen scavengers. For this reason, primary antioxidants 
react with high-energy lipid radicals to convert them to thermodynamically more stable 
products. On the other hand, secondary antioxidants, also known as preventive 
antioxidants, function by retarding the rate of chain initiation by breaking down 
hydroperoxides (Kolakowska, 2002).
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1.5.4.1, Free radical terminators
In free radical termination, free radical scavengers (FRS) or chain-breaking antioxidants 
such as phenolic compounds (AH) impede lipid oxidation by rapidly donating a 
hydrogen atom to lipid radicals such ROO*, RO*.
ROO* + A H  — ► R O O H  + A* (1)
RO* + A H  —> R O H  + A* (2)
ROO* + A* — > R O O A  (3)
RO* + A* -+ R O A  (4)
RO* + R H  —*■ R O O H  + R* (5)
The resulting phenoxy radical (A*) does not start a new free radical reaction or, is not 
subjected to rapid oxidation by a chain reaction. This property makes phenolic 
antioxidants excellent hydrogen or electron donors. Besides this activity, the radical 
intermediates of phenolic antioxidants are relatively stable due to resonance 
delocalization and lack of suitable sites for attack by molecular oxygen (Belitz et al, 
2009).
The reactions of FRS with peroxyl radicals are favoured due to a number of reasons. 
The propagation reaction is a slow step in lipid oxidation and accordingly, peroxyl 
radicals are often found in the greatest concentration of all radicals in the systems. The 
interaction between FRS and peroxyl radicals is favourable because peroxyl radicals
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have lower energies than radicals such as alkoxyl radicals, and also react more readily 
with the low energy hydrogens of FRS than with polyunsaturated fatty acids. As FRS are 
generally found at low concentrations, they do not compete effectively with initiating 
radicals. Therefore, FRS generally inhibits lipid oxidation by more effectively 
competing with other compounds (especially unsaturated fatty acids) for peroxyl 
radicals (Kolakowslca, 2002; Belitz et al, 2009).
With phenolic antioxidants, the stability of the phenoxy radical is increased by bulky 
groups at the ortho positions as seen in butylated hydroxyanisole (BHA) (Hall, 2001). 
These groups increase the steric hindrance in the region of the radicals. They 
additionally reduce the rate of possible propagation reactions that may involve 
antioxidant free radicals (Gordon, 1990):
A* + O 2 — > A O O
A O O  + R H  —* A O O H  + R-
A« + R H  — »A H  + R*
The introduction of a second hydroxyl group at the ortho or para position of the 
hydroxyl group of a phenol also increases antioxidant activity of phenolic antioxidants. 
The antioxidant efficiency of a 1,2-dihydroxybenzene derivative is amplified by the 
stabilization of the phenoxy radical through an intramolecular hydrogen bond. This
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property makes catechol and hydroquinone more effective in their peroxynitrite 
scavenging activity than phenol (Hall, 2001).
Multiple hydroxyl groups also confer significant antioxidant, chelating, and, in some 
cases, pro-oxidant activity to the molecule. These methoxyl groups introduce 
unfavorable steric effects but the presence of a double bond and carbonyl functionality 
in the C ring increases the activity by affording a more stable flavonoid radical through 
conjugation and electron delocalization (Heim et al, 2002).
In some instances, the antioxidant activity of phenolic antioxidants is influenced by pH 
e.g. hydroxyflavones. The antioxidant potential of hydroxyflavones increases upon 
deprotonation of the hydroxyl group. This shows that the mechanism of action of 
flavonoids is variable and electron (not hydrogen) atom donation is involved in the 
deprotonated species although abstraction of the hydrogen atom is involved for 
underprotonated species (Lemanska et al, 2001). Furthermore, the hydroxyl radical 
scavenging activity of phenolics involves multiple mechanisms, including hydroxyl 
bond strength, electron donating ability, enthalpy of single electron transfer and spin 
distribution of the phenoxy radical after hydrogen abstraction (Cheng et al, 2003).
The effect of antioxidant concentration on autoxidation rates depends on many factors, 
including the structure of the antioxidant, oxidation conditions, and nature of the sample 
oxidized. In certain cases, phenolic antioxidants lose their activity at high concentrations 
and behave as pro-oxidants by getting involved in initiation reactions (Gordon, 1990).
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In food systems, phenolic antioxidants are more effective in extending the induction 
period when added to foods that have not deteriorated to any great extent. Phenolic 
antioxidants are generally ineffective in delaying decomposition of already deteriorated 
lipids. Therefore, antioxidants should be added to foodstuffs as early as possible to 
realize utmost protection against oxidation (Coppen, 1983).
I.5.4.2. Metal chelators
Metal chelating agents inhibit lipid oxidation by blocking the pro-oxidant metal ions, 
and as a consequence limit the formation of chain initiators by preventing metal-assisted 
homolysis of hydroperoxides.
R O O H  + M n + -> RO* + 'OH + M (ll+I)+
R O O H  + M (n+,)+ -» ROO* + H + + M n+
Ascorbic, phosphoric, citric, tartaric and malic acids possess pronounced chelating 
activities and are effective in improving the oxidative stability of aqueous food emulsion 
systems (Franlcel, 1998). The salts of phytic acid, phospholipids, and oxalates especially 
from plant materials are also common representatives of this group.
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Amino acids and peptides in their antioxidant behavior have been shown to be metal 
chelating agents (Fujimoto et al, 1984; Pokorny, 1987). In peptides, the characteristic 
amino acid sequences are important for them to show lipid oxidation inhibitory effects 
(Chen et al. 1995). In peptides containing the amino acid histidine, their antioxidant 
behavior is related to their metal chelating ability and to lipid-radical trapping potential 
of the imidazole ring (Uchida and Kawakishi, 1992; Murase et al, 1993). Dipeptides 
carnosine and anserine that contain histidine involve not only singlet oxygen and free 
radical scavenging, but also metal chelation (Egorov et al, 1992). Phenolics, such as 
flavonoids also exhibit metal chelating characteristics in their antioxidant activities 
(Afanasev et al, 1989; Morel et al, 1993; Nardini et al, 1995; Chen and Ahn, 1998).
1.5.4.3. Oxygen scavengers
Foote and Denny (1968) first demonstrated that carotenoids, such as (3-carotene, 
lycopene, zeaxanthin, lutein and canthaxanthin, can quench the singlet oxygen 'o2. This 
discovery was an important advance in understanding how effectively carotenoid 
pigments prevent the damage of photobiological systems. The quenching mechanism is 
understood to proceed by two routes. In the first route, a carotenoid is thought to 
undergo no ultimate chemical change (physical quenching) whilst the second route 
involves a chemical reaction that results in new products (Young and Brewer, 1978).
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The deactivation of l0 2 by carotenoids results primarily from a physical quenching 
process involving transfer of excited energy from * 0 2  to the carotenoids. This results in 
the formation of ground state oxygen 30 2 and triplet excited carotenoid 3Car* (Stahl and 
Sies, 1993). The energy is dissipated through rotational and vibrational interactions 
between3Car* and the solvent to recover the ground state of the carotenoid.
10 2 + Car -> 30 2 + 3Car*
3Car* —> Car + thermal energy
One molecule of (3-carotene is estimated to quench up to 1000 molecules of singlet 
oxygen (Foote and Denny, 1968).
In the other mechanism, where there is no hydrogen abstraction, carotenoids are 
postulated to scavenge peroxyl radicals through addition of the radical to the conjugated 
system. As such, the resulting radical, which is carbon-centered, is stabilized by 
resonance (Burton and Ingold, 1984). Once oxygen concentrations are low, a second 
peroxyl radical is added to the carbon-centred radical to produce a non-radical product 
(Erickson, 1998). However, at high oxygen pressures, carotenoids work as pro-oxidants 
(Jorgensen and Sldbsted , 1993).
In photosensitised oxidation, the inhibition of oxidation by carotenoids is rather complex 
as they are very prone to autoxidation themselves. They are rapidly destroyed during the
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free-radical oxidation process and therefore need to be protected by antioxidants when 
used in unsaturated lipids exposed to light irradiation (Warner and Frankel, 1987; Haila 
and Heinonen, 1994; Haila et al, 1996). Without antioxidant protection, carotenoids 
present in oil exhibit pro-oxidant behavior as observed in pure triacylglycerols of 
rapeseed (Haila et al, 1994, Haila et al, 1996). Tocopherols and fiavonoids also act as 
oxygen scavengers in photosensitised oxidation (Kamal-Eldin and Appelqvist, 1996; 
Fukuzawa et al, 1998; Criado et al, 1995).
1.6. Antioxidation defense systems
1.6.1. Endogenous antioxidants
Living organisms possess a network of defense systems consisting of intracellular and 
extracellular antioxidants that include molecules and enzyme systems with diverse roles 
within each area of defense. The levels and locations of these antioxidants are highly 
regulated for cell survival. The enzymatic system that controls the levels of oxygen 
reactive species is comprised of three major enzyme systems: superoxide dismutase 
(SOD), catalase, and glutathione peroxidase (GPx). They work within the cells to 
suppress radical formation, removing most superoxides and peroxides before they react 
with metal ions to form more reactive free radicals.
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I.6.I.I. Superoxide dismutases (SOD)
Superoxide dismutases are enzymes that are found universally in oxygen-metabolising 
organisms. SODs are generally classified according to the metal species which acts as 
the redox-active centre to catalyse the dismutation reaction. Four different SOD are 
classified namely, copper- and zinc-containing SOD (with copper as the catalytic active 
metal), manganese-containing SOD, iron-containing SOD, and nickel containing SOD 
(Miller, 2004). Plant prokaryotes contain two types of SOD, M n S O D  and FeSOD 
whilst mammals contain three types of SOD CuZnSOD in the cytoplasm, M n S O D  in 
the mitochondria and extracellular SOD (Kolakowska, 2003).
The substrate of superoxide dismutases (SODs) is the superoxide radical anion (0/-)
which is generated by the transfer of one electron to molecular oxygen which is 
responsible both for direct damage of biological macromolecules (such as proteins and 
D N A  for example) and for generating other reactive oxygen species. SOD catalyses the 
dismutation of two molecules of O / - to yield one molecule of molecular oxygen and
one molecule of peroxide via the following reaction:
2  O  *“ + 2H+ -+ H 2 0 2 + 0 2
SODs keep the concentration of superoxide radicals in low limits and therefore play an 
important role in the defense against oxidative stress.
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I.6.I.2. Catalases
Catalase is a heme containing redox enzyme found in virtually all organisms, in cells 
called peroxisomes. Through a scavenging reaction, catalase catalyses the conversion 
of hydrogen peroxide, a powerful and potentially harmful oxidizing agent, to water and 
molecular oxygen. It also utilizes hydrogen peroxide to oxidise toxins that include 
phenols, formic acid, formaldehyde and alcohols.
2 H 20 2 -* 2 H 20  + 0 2
I.6.I.3. Glutathione peroxidase (GPx)
Glutathione peroxidase is a selenium-containing tetrameric glycoprotein, that is, a 
molecule with four selenocysteine amino acid residues bestowing the catalytic activity. 
Glutathione scavenges hydrogen peroxide and organic hydroperoxides including 
peroxides of fatty acids to form water, alcohols and oxidized glutathione (GSSG), thus 
stopping the oxidation reaction.
2 GSH + H 20 2 -+ GSSG + 2 H 2 0.
2 G S H  + R O O H  -> GSSG + H 20  + R O H
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GSSG is harmful to cells as it can interact with proteins or oxidized thiol groups to form 
disulphides, thus forming disulphide bonds in proteins. A  subsequent reaction follows 
that reduces the GSSG back to GSH by enzyme glutathione reductase (Wilcox et al, 
2004).
GSSG + N A D  (P) H  + H + -> 2 GSH + N A D P +
1.7. Dietary antioxidants
1.7.1. Synthetic antioxidants
The most common synthetic antioxidants utilized in food systems possess phenolic 
group(s) and include butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), 
butyl hydroquinone (BHQ) and propyl gallate (PG) (Figure 1.7). The antioxidant 
mechanisms they exhibit involve the formation of resonance-stabilized phenolic 
radicals. The formed radical neither catalyzes the oxidation of other molecules nor reacts 
with oxygen to form antioxidant peroxides that autooxidize. Synthetic phenolic radicals 
react with each other in a way similar to that of tocopherols. The phenolic radicals also 
react with other peroxyl radicals in termination reactions resulting in phenolic-peroxyl 
species. In addition, oxidized synthetic phenolics undergo numerous degradation 
reactions resulting in degradation products with active hydroxyl groups. These products 
may retain antioxidant activity because of the presence of the phenolic group. Therefore, 
the net antioxidant activity of synthetic phenolics in food systems represents the activity
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of the original phenolic in addition to some of its degradation products. This property 
makes synthetic phenolics effective antioxidants that are widely used in food. However, 
their application in the food industry has recently declined due to consumer safety 
concerns and demand for all-natural products (Yanishlieva-Maslarova, 2001).
1.7.2. Natural antioxidants
Diet plays a vital role in the production of the exogenous antioxidants defense system by 
providing essential nutrient antioxidants supplied by plants and food additives. 
Vegetables, fruits, herbs, spices, teas, oilseeds, nuts, cereals, legumes are rich sources of 
natural antioxidants (Yanishlieva-Maslarova, 2001). These dietary antioxidants include 
vitamins (vitamin E, C, and /2-carotene), plant phenols (flavanoids, other phenolic 
compounds) and essential minerals (selenium, zinc, manganese and copper) that form 
important antioxidant enzymes (Figure 1.5). Diet also provides a significant function in 
the oxidative process by affecting the substrates that are subject to oxidation. In the 
oxidation of lipids, polyunsaturated fatty acids (PUFA) having two or more double 
bonds are more susceptible to free radical attack. Therefore, antioxidants available at the 
site of radical attack break the chain of oxidation by being preferentially oxidized by the 
attacking radical, thereby preventing oxidation of the adjacent fatty acid (Wilcox et al, 
2004).
Phenolic and polyphenolic compounds are the most active dietary antioxidants contained 
in plants and utilized in both body and food systems. The most important compounds,
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along with tocopherols and tocotrienols (tocols), are flavonoids. Flavonoids that include 
flavones, flavonols, isoflavones, and chalcones, with over 8000 compounds among 
them, remain the most abundant group of natural antioxidants. Antioxidants inhibit lipid 
oxidation reactions by various mechanisms, including radical (ROO*, RO*, HO*, 10 2) 
scavenging, protein (enzymes and their metal binding sites) complexing, and synergistic 
effects by reducing oxidized antioxidants and metal chelation (Frankel, 1999).
HO.
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Butylated hydroxy toluene Butylated hydroxyanisole
(BHT) (BHA) Propyl gall ate (PA)
Figure 1.7. Structure of some natural and synthetic antioxidants.
1.7.3. Antioxidant peptides from food sources
Various plant- and animal-derived proteins, individual peptides and amino acids, and 
protein hydrolysates possess significant antioxidant activity against the peroxidation of 
lipids and fatty acids. Proteins, peptides and amino acids have been utilized both in vitro 
and in vivo systems to inhibit lipid oxidation. These include, for example, hydrolyzed 
milk proteins (Pihlanto, 2006), fish proteins (Je et al, 2005; W u  et al, 2003), egg 
proteins (Davalos et al, 2004; Sakanaka et al, 2004) and pork protein (Carlsen et al, 
2003; Saiga et al, 2003). Plant sources with proteins, peptides and amino acids 
possessing antioxidant activity include oilseed proteins (Rhee et al, 1979), wheat gliadin 
(Iwami et al, 1987), maize zein (Kong and Xiong 2006), soy bean protein (Chen et al, 
1995).
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Peptides and amino acids from fish proteins are emerging as potential sources of 
anti oxidants. The diversity of fish species and their valuable contribution to protein and 
lipid content of diets has precipitated large scale production and processing. This has led 
to increased fish consumption and, as a result of processing, an increase in by products 
and waste. Both the fish muscle and waste products from filleting and processing are 
potential sources of bioactive peptides that may be used as antioxidants. Peptides 
derived from enzymatic digestion of various fish proteins are reported to possess 
antioxidant activity based on the nature, size and composition of the different peptide 
fractions and the protease specificity (Table 1.3).
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Table 1.3. Antioxidant peptides derived from fish proteins
Fish type Source
of
Peptide
Hydrolytic
Enzyme
Peptide sequence Scavenging
Activity
Reference
Capelin Protein NSIR* Hydrolysates NSIR* Amarowiz 
and Shahidi 
1996
Mackerel Protein Protease N Hydrolysates N
Lipoxygenase
(LOX)
Chuang et al, 
2000
Alaska
pollack
Skin
gelatin
Alcalase, 
pronase E, 
collagenase
repeating motif - GPP- NSIR* Kim et al, 
2001a
Tuna Cooking
juice
Protease XXIII 4-8 amino acid 
residues
Carbon
centered
Jao and Ko 
2002
Herring Protein NSIR* hydrolysate Sathivel et al, 
2003
Mackerel Protease N NSIR* Scavenging 
and Reducing 
ability
Wu et al,, 
2003
Yellowfin
sole
Protein Pepsin and 
MICE*
RPDFDLEPPY Jun et al, 
2004
Alaska
pollack
Protein MICE* LPHSGY Hydroxyl
radical
Je et al, 2005
Hooky Skin
gelatin
Commercial
enzymes
HGPLGPL Superoxide,
carbon-
centered
Je et al, 
2005 ; 
Mendis et al, 
2005
Giant Muscle Pepsin, trypsin NADFGLNGLEGLA Radicals Rajapalcse et
squid chymotrypsin NGLEGLK carbon- 
centered, 
hydroxyl and 
superoxide
al, 2005
Chum
salmon
Cartilage 
and skin
NSIR* NSIR* Superoxide,
hydroxyl,
carbon
centered
Nagai et al, 
2006
Jumbo Skin Properase, M w  < 2 kDa Superoxide Lin and Li
flying
squid
gelatin pepsin and hydroxyl 2006
Shell fish Muscle
protein
Gastrointestinal
enzymes
LV GDEQAVP A V C VP Hydroxyl, 
super-oxide 
and carbon- 
centered
Jung et al, 
2007
Yellow
stripe
trevally
Meat Alcalase 2.4L Hydrolysates Radical-
scavenging,
reducing,
metal
Klompong et 
al, 2007
48
chelating
Walleye GI proteases, Hydrolysates Superoxide Nagai et al,
pollack pronase,
thermolysin
and hydroxyl 
radicals
2007
Tuna Back
bone
protein
Pepsin VKAGFAWTANQQLS Radical
scavenging,
superoxide
Je et al, 2007
Round Muscle Alcalase Hydrolysates Radical Thiansilakull
scad scavenging, 
reducing 
power, and 
Fe2+ chelating
et al, 2007
Grass Muscle Alcalase 2.4L PSKYEPFV Hydroxyl Ren et al,
carp 2008
Smooth Muscle GI proteases M w  < 3.5kDa Radical Bougatef et
hound scavenging al, 2009
(shark)
Sole Skin
gelatin
Alcalase M w  < 6.5kDa Metal
chelating,
Fe3+
reducing,
radical
scavenging
Gimenze et 
al, 2009
* MICE, Mackerel intestine crude enzyme; NSIR* ,Not specified in reference
1.7.4. Methods for the determination of lipid oxidation
1.7.4.1. Peroxide value (PV).
Determination of peroxide value (PV) is the oldest method of lipid oxidation evaluation 
and is based on the quantification of primary oxidation products. It is carried out using 
the iodometric technique. The result depends on the amount of oxygen, availability of 
light, and the number of double bonds in the substrate. To improve the sensitivity of the 
method, several iodine spectrophotometric and potentiometric techniques have been 
developed (Oishi et al., 1992; Lovaas, 1992). The ferric thiocyanate (FTC) technique of
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peroxide determination involves Fe2+ —* Fe3+ oxidation. The red Fe3+ complexes 
formed is determined spectrophotometrically at 470 nm. The FTC is ten times more 
sensitive than the iodometric technique (Wolff, 1994).
I.7.4.2. Carbonyl Compounds
Carbonyl compounds in lipid oxidation comprise the secondary products of lipid 
oxidation. The determination of carbonyl compounds mostly involves the formation of 
colour products that result from the reaction of the carbonyl group with the amine group 
of a cyclic leuco-compound. The most popular old method involves determination of 
carbonyl compounds by reaction with 2,4-dinitrophenylhydrazine (carbonyl value). The 
most popular method used currently involves 2-thiobarbituric acid (TBA). In this 
method, 2 molecules of 2-thiobarbituric acid are condensed with Malondialdehyde 
(Figure 1.8). The developed chromogen, the two tautomeric structures of the red TBA- 
Malondialdehyde adduct, is determined at 532 nm, and also often at 450 nm, to analyse 
for alkenals and alkanals, respectively (Ohlcawa et al, 1979).
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Thiobarbituric acid (TBA) Malondialdehyde (MDA) Pink chromagen (TBARS-MDA)
Figure 1.8. T B A  reaction with Malondialdehyde.
1.8. Peptide sequencing
1.8.1. Edman degradation
Edman degradation is one of the methods of sequencing amino acids in a peptide or 
protein. In this method, the amino-terminal residue is labeled and cleaved from the 
peptide without disrupting the peptide bond between other amino acid residues. 
Phenylisothiocynate is commonly used to label the N-terminal amino residue. The 
phenylisothiocynate reacts with an uncharged terminal amino group, forming a cyclical 
phenylthiocarbamoyl derivative. This derivative of the terminal amino acid under acidic 
conditions is cleaved as a thiazolinone derivative that is selectively extracted into an 
organic solvent and treated with an acid to form the more stable phenylthiohydantoin 
(PTH) - amino acid derivative that can be identified by chromatography or 
electrophoresis. This is repeated again to identify the next amino acid. The Edman 
degradation can accurately sequence up to 30 amino acids. The advantage of the Edman 
degradation is that it can be used at levels of 10 - 100 picomoles of peptides (Belitz et 
al, 2004).
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1.8.2. Liquid Chromatography-Mass spectroscopy (LC-MS).
Liquid Chromatography-Mass spectroscopy (LC-MS) is a powerful and useful analytical 
technique providing information about the structure and composition of a compound. 
LC-MS has been applied to many fields. LC combined with ESI-MS has become a 
standard approach for the separation and identification of many macromolecules like 
peptides and proteins (Careri and Mangia, 2003). Electrospray ionization has facilitated 
the direct analysis of peptides as they elute from a liquid chromatograph (LC) in the 
LC/MS experiment (D’agostino et al, 1997).
LC-MS is based on the separation of compounds by LC chromatography followed by 
MS. The ions produced by M S  are subsequently filtered according to their mass-to- 
charge (mfz) ratio and then detected (Van der Greef and Niessen, 1992). To achieve 
this target, two ionization modes have been used in current commercial instruments 
which are electrospray ionization and atmospheric pressure chemical ionization. In an 
electrospray interface, the eluent from LC is passed through a capillary held at a high 
voltage, generating an aerosol of charged droplets. Nitrogen gas flow is usually used to 
desolvate the droplets leading to increase in the charge density at the droplet surface. 
The ions overcome the liquid’s surface tension and attain the gas phase in a process 
commonly referred to as ion evaporation. Therefore, the ions which are highly charged 
can be directly sampled into the mass spectrometer for mass and peptide sequencing 
through appropriate programs.
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1.9. Cytotoxicity effects of ROS in epithelial and endothelial cells
Apoptosis and necrosis are two types of cell death. Apoptosis is programmed cell death 
process and is common in cell development in living cells (Banerjee et al, 2005). In 
apoptotic cell death, the cell shrinks, forms blebs and detaches from its neighboring 
cells; the mitochondria undergo modifications including release of cytochrome c into the 
cytosol, reduction in the membrane potential and deterioration of membrane 
permeability with opening of specialized pores and diffusion of diverse pro-apopototic 
proteins; in the nucleus, the chromatin condenses at the nuclear membrane. Finally the 
cell splits into apoptotic bodies and caspases are activated (Green and Kroemer, 1998). 
Stimulated apoptosis together with defective D N A  repair mechanisms and cell cycle 
alteration contribute to several disorders such as cancer, AIDS, autoimmune diseases, 
degenerative disorders, ageing, liver and heart diseases (Ducasse et al, 2005). Apoptosis 
is controlled by a network of positive and negative signal pathways via the intrinsic or 
extrinsic pathways (Figurel.9). In the intrinsic pathway, cysteine proteases activating 
proteins are released into the cytosol from the mitochondria and this triggers apoptosis. 
This family of intracellular cysteine proteases is also known as caspases; with at least 14 
members identified. Among them, caspase-3 is responsible for many of the nuclear 
changes associated with apoptosis, including D N A  fragmentation (Leung et al, 2005). 
The extrinsic pathway is regulated by proteins such as Fas and the tumour-necrosis 
factor receptor (TNF-R) inducing apoptosis at the cell surface. Necrosis is considered as 
a disordered cellular death or non-programmed death. It is characterized by cell 
swelling, lysis and inflammatory response (Girotti, 2001).
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Oxidant
Apoptosis
Figure 1.9. Mechanisms of oxidant induced apoptosis through caspases.
1.10. Protein hydrolysis and digestion
Food proteins are currently one of the sources of a range of bioactive peptides, encrypted 
within the primary structure of their individual proteins. Proteolysis releases the 
bioactive peptides from their precursors during gastrointestinal transit or during food 
processing. Three strategies are generally utilized to identify and characterize
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biologically active peptides: isolation from in vitro enzymatic digests of precursor 
proteins, isolation from in vivo gastrointestinal digests of precursor proteins; and 
chemical synthesis based on combinatorial library designs of peptides that have a 
structure identical to that of those known to be bioactive (Mine and Shahidi, 2004).
The digestion of proteins begins in the acidic environment of the stomach by pepsin. The 
resultant polypeptides are additionally cleaved by the pancreatic proteases namely 
trypsin, a-chymotrypsin, elastase and carboxypeptidase A  and B at alkaline pH in the 
small intestine. The action of these enzymatic actions results in a concoction of free 
amino acids and predominantly oligopeptides. Free amino acids absorption into the 
enterocytes takes place across the brush border membrane via distinctive amino acid 
transport systems. On the other hand, the oligopeptides go through additional hydrolysis 
by the action of an array of peptidases present at the brush border.
The aminopeptidase activity present at the intestinal brush border membrane provides 
functional complementation to the carboxypeptidases present in the pancreatic juice. 
Peptides of different amino acid sequences and chain length in vivo studies have been 
documented, exhibiting resistance to digestive enzymes. Tripeptides with the C-terminal 
proline-proline resist degradation by proline-specific peptidases. Proline- and 
hydroxyproline-containing peptides are also, in general, resistant to hydrolysis by 
digestive enzymes (Vanhoof et al. 1995; FitzGerald and Meisel, 2000). Several 
researchers have shown that dietary peptides exert biological activity in vivo after 
release during gastrointestinal digestion and absorption into the blood. Bioactive
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peptides have been isolated from the stomach, small intestine and blood of adult human 
subjects fed with milk or yoghurt. Peptides derived from asl-, p - or K-caseins were 
detected in the stomach, and smaller peptides derived from casein and lactoferrin from 
the small intestine. Two long peptides, casein glycomacropeptide, k-casein f(106-l 17) 
and the N-terminal peptide f(l -23) of asi-casein, were believed to be absorbed and 
hence detected in plasma (Chabance et al. 1998).
1.11. Peptide intestinal absorption
Small peptides (primarily di- and tripeptides) and amino acids are both absorbed from 
the small intestine against a concentration gradient. The energy-dependent transport of 
amino acids is linked with the co-transport of Na+; for peptides, energy-dependent 
transport is linked with the co-transport of protons. Peptides are absorbed more rapidly 
than amino acids (Webb, 1990; Webb et al, 1992). Yang et al (1999) postulated that 
peptides consisting of two or three amino acids are absorbed intact across the brush 
border membrane by a specific peptide transport system. The peptide transporter PepTl, 
with a broad substrate specificity, uses a transmembrane electrochemical proton gradient 
as the driving force. When they enter the enterocyte, the peptides are generally 
hydrolysed to free amino acids in the cytoplasm by various intracellular peptidases. 
Besides the peptide transporter path, peptides are considered to be absorbed whole 
across the intestinal mucosa through other mechanisms - paracellular, passive diffusion, 
endocytosis and carrier mediated transport (Gardner, 1998). Literature evidence exists
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supporting both paracellular and transcellular routes for passage of intact peptides, 
however, there are still questions as to the relative significance of these. Paracellularly, 
large water-soluble peptides pass via the tight junctions between cells, whilst the more 
lipid-soluble peptides appear to be able to diffuse via the transcellular pathway. Peptides 
are also thought to enter the enterocytes by means of endocytosis, which entails that 
there is membrane binding and vesiculisation of the material (Ziv and Bendayan, 2000).
The intestinal basolateral membrane also has a peptide transporter, which facilitates the 
exit of hydrolysis-resistant small peptides from the enterocyte into the portal circulation 
(Gardner, 1984). Peptides brought about through the diet can be absorbed whole through 
the intestine and bring about particular biological effects at the tissue level. 
Nevertheless, chain length appears to be a factor in the absorption mechanism as the 
potency of the peptides to be absorbed decreases as the chain-length increases (Roberts 
etal. 1999).
The caco-2 cell monolayer model is widely used in intestinal transport studies of drugs 
and food compounds (Augustijns et al. 1998; Boisset et al. 2000, Rubio &  Seiquer, 
2002). This confluent cell monolayer caco-2 cell line, which is derived from a human 
colon carcinoma, has characteristics that closely resemble intestinal epithelial cells and 
displays several properties typical of differentiated intestinal epithelial cells (Wilson et 
al. 1990). Caco-2 cell monolayers are thought to be tighter than mammalian intestinal 
tissues (Boisset et al. 2000). The brush border membrane-associated enzyme activities 
are generally thought to be lower (Bolte et al. 1998).
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1.12. Summary and aims
In recent times, consumers have started to look for foods that are capable of improving 
their health and reducing their risk of developing chronic diseases as they become more 
aware of the direct link between diet and health. Drug-based approaches are currently 
available to cushion the development of chronic diseases but their use is increasingly 
being questioned because of their side effects. This has led to innovative research to 
derive natural compounds from natural sources such as foods.
One research thrust is the isolation of bioactive peptides (BAPs) and proteins from 
several sources to impart positively on diseases such as cardiovascular diseases and 
cancers. These BAPs have been reported to possess antihypertensive and antioxidant 
activities. Marine organisms represent a valuable source for BAPs and nutraceuticals. 
The biodiversity of the marine environment in its fish species amount to a practically 
unlimited resource of new active substances in the field of the development of functional 
foods. In particular Atlantic mackerel, a fatty fish, is readily available and highly 
consumed especially in countries of the Atlantic Ocean in the north. Its muscle protein 
remains a potential source of BAPs after hydrolysis with enzymes or processing.
Therefore, the aim of this study is to investigate the antihypertensive and antioxidant 
activity of peptides derived from Atlantic mackerel with gastrointestinal enzymes, and in 
particular:
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■ To isolate and characterize peptides from Atlantic mackerel (Scomber scombrus) 
muscle protein with A C E  inhibitory activity and study the mechanism of ACE 
inhibition.
■ To isolate and characterize peptides from Atlantic mackerel (Scomber scombrus) 
muscle protein with antioxidant activity and its mechanisms of lipid oxidation 
inhibition.
■ To study the antioxidant behavior of peptides derived from Atlantic mackerel in 
caco- 2  cells exposed to a proxidant.
■ To examine the ROS scavenging activity of peptides derived from Atlantic 
mackerel in endothelial Ea.hy 926 cells and
■ To investigate the absorption of peptide in a caco-2 cell monolayer model.
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C H A P T E R  T W O
2. ISOLATION O F  ANGIOTENSIN C O N V E R T I N G  E N Z Y M E  (ACE) 
INHIBITORY PEPTIDE F R O M  ATLANTIC M A C K E R E L  (SCOMBER  
SCOMBRUS) FISH PROTEIN
2.1. I N T R O D U C T I O N
Angiotensin I-converting enzyme (ACE, dipeptidyl carboxypeptidase, EC 3.4.15.1) 
plays an important role in the regulation of blood pressure. A C E  hydrolyzes Ang-I (Asp- 
Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) by removing the C-terminal dipeptide His-Leu to 
give an ocatapeptide angiotensin II (Ang-II) Asp-Arg-Val-Tyr-Ile-His-Pro-Phe, a potent 
vasoconstrictor (Manger and Page, 1982). ACE is a key enzyme in the regulation of BP 
and has been targeted in the control of hypertension. Ang II production leads to several 
physiological processes that include systematic vasoconstriction, cardiac and vascular 
hypertrophy, increased blood volume and renal sodium and fluid retention. This cascade 
of events leads to the elevation of blood pressure and forms the basis for hypertension, 
heart failure, myocardial infarction and diabetic nephropathy (Mine and Shahidi, 2006). 
Thus, inhibition of AC E  results in a decrease in blood pressure. Hypertension is a 
worldwide problem of epidemic proportions mostly in adults. It is the most common 
serious chronic health problem because it carries with it a high risk of cardiovascular 
complication. About 70% of over 65 year olds show > Systolic Blood Pressure (SBP) 
140 and/or Diastolic Blood Pressure (DBP) 90 m m H g  or are on antihypertensive 
medication in the U K  (Spronston and Primatesta, 2003).
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Several potent synthetic A C E  inhibitors such as captopril, benazepril, enalapril, 
fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril, and trandolapril are 
widely used in the clinical treatment of hypertension in humans (Sica, 2003). However, 
these synthetic A C E  inhibitors can have side effects such as skin rash, headache, dry 
cough and loss of taste perception (Fotherby and Panayiotou, 1999). As a result, there is 
an increasing interest in nutraceuticals and diet-related preventive measures for 
hypertension. Peptides from food proteins with A C E  inhibitory activity are potential 
candidates for such products. As they are not known to have any side effects, peptides 
from food proteins may represent an alternative or an additional treatment to 
antihypertensive drugs and may be applied in the prevention of high blood pressure 
(Fitzgerald and Meisel, 2000).
The three-dimensional structure reveals that AC E  is composed mainly of a-helices, and 
incorporates a zinc ion and two chloride ions. The active site consists of a deep, narrow 
channel that divides the molecule into two subdomains. On top of the molecule is an 
amino-terminal 'lid', which seems to allow only small peptide substrates access to the 
active site cleft (Natesh et a l 2003). Although the N-domain and C-domain are highly 
similar in protein sequence and share many enzymatic properties, they can be 
differentiated by substrate and inhibitor preferences and by the extent to which they are 
activated by Cl- (Bingham et al, 2006).
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AC E  inhibitory peptides have been isolated from enzymatic hydrolysates or 
fermentation of different food proteins (Mine and Shahidi, 2004) that include fish 
proteins (Kasase and Howell, 2009). However, a combination of pepsin and pancreatin 
is rarely used to investigate if A C E  inhibitory peptides can be produced in an in vitro 
digestion model system with enzymes similar to those in the gastrointestinal digestive 
system of humans.
Atlantic mackerel (Scomber scombrus) is a pelagic species that varies between 180 to 
210 cm in length and 325 to 360 g in body weight. Atlantic mackerel has a large 
proportion of dark muscle. The main chemical composition of muscle includes water ( 6 6  
- 84 %), proteins (15 - 25 %), lipids (0.1 - 22 %), carbohydrate (0.3 %), minerals (0.8 - 
2 %) and vitamins (Kolalcowska, 2002).
In this study, the objective was to hydrolyse Atlantic mackerel (Scomber scombrus) 
muscle protein using digestive enzymes pepsin and pancreatin; to isolate and 
characterize peptides with respect to AC E  inhibitory activity and to investigate the 
mechanism of A C E  inhibition.
2.2. M A T E R I A L S  A N D  M E T H O D S
2.2.1. Materials
Atlantic mackerel (Scomber scombrus) fillets were supplied by M  &  J Seafood, 
Farnham, U K  and delivered in ice to the laboratory. Pancreatine, pepsin, Sephadex G-
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25, Sephadex C-25, captopril, phenyl isothiocyanate (PITC), triethylamine (TEA), 
hippuric acid (HA), histidyl hippuryl leucine (HHL), sodium borate, sodium acetate, 
sodium chloride, acetonitrile and Trifluoroacetic acid (TFA) were obtained from Sigma- 
Aldrich (Dorset, UK). Vivaspin membrane ultrafiltration cartridges were obtained from 
Sartorius (Epsom Surrey, UK). All other reagents were of analytical grade and were 
obtained commercially.
2.2.2. Methods
2.2.2.I. Preparation of Atlantic mackerel Fish Protein Hydrolysates (FPH)
Fish fillets were skinned and the muscle part only was washed in distilled water, and a 
portion was mixed with distilled water in the ratio (1:2.5 w/w) and homogenised in a 
blender (Omni mixer homogeniser, USA) for about 2 min. The mixture was adjusted to 
pH 2.0 with 1.0 M  HC1. Pepsin (1:25 w/w enzyme to substrate) was added and the 
mixture was incubated for 1 h at 37 °C with shaking. After 1 h, the pH of the mixture 
was adjusted to 5.3 with 0.9 M  NaHC0 3 and then to pH 7.5 with 1.0 M  NaOH. 
Pancreatine (1:35 w/w enzyme to substrate) was added and incubated for 2 h at 37 °C 
with shaking. After 2 h, the mixture in the beaker was immersed in boiling water for 10 
min and centrifuged at 12000 x g for 15 min. The resultant hydrolysate was freeze dried.
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2.2.2.2. Membrane ultrafiltration
The freeze-dried protein hydrolysate from the enzymatic hydrolysis was dissolved in a 
minimum amount of milli-Q water and ultrafiltered using a 2, 5 and 10 kDa molecular 
weight cut off (MWCO) Vivaspin membrane ultrafilter (Sartorious, UK). Fractionation 
was effected by centrifuging at 3,500 xgona centrifuge (Beckman, UK) for 30 minutes. 
The collected fractions were quantified and freeze-dried.
2.2.2.3. Gel filtration chromatography
The 2 kDa fraction was dissolved in 5 ml distilled water and loaded onto a gel filtration 
column (2.5 x 90 cm) filled with Sephadex G-25 previously equilibrated with 50 m M  
sodium phosphate buffer (pH 7.0). The column was eluted with 50 m M  sodium 
phosphate buffer (pH 7.0) at 1 ml/min for 10 h. Fractions were collected in 5 ml portions 
and the absorbance of the collected fractions was monitored at 250 nm. The fractions 
showing A C E  activity were collected, pooled and freeze dried.
2.2.2.3. Ion exchange chromatography
The freeze-dried fraction with the highest A C E  activity from gel filtration was dissolved 
in 5 ml of 20 m M  sodium phosphate buffer (pH 4.0) and loaded onto an ion-exchange 
column (3.0 X 40 cm) packed with SP-Sephadex C-25 previously equilibrated with 20
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m M  sodium phosphate buffer (pH 4.0). The components were eluted with 20 m M  
sodium phosphate buffer (pH 4.0) and a linear gradient of 0 to 2.0 M  NaCl at 1 ml/min. 
Fractions were collected in 5 ml portions and the absorbance of the collected fractions 
monitored at 250 nm. The fractions showing A C E  activity were collected, pooled and 
freeze dried.
2.2.2.4. High performance chromatography
The fraction exhibiting the highest A C E  inhibitory activity was further purified using a 
reversed-phase high-performance liquid chromatography (RP-HPLC) on a Partisil 10 
ODS-1 (9.5 m m  x 500 mm) column (Whatman pic, UK) with a linear gradient of 
acetonitrile (0-70 %  in 50 min) containing 0.1 %  trifluoroacetic acid (TFA) at a flow rate 
of 1 ml/min. The elution peaks were detected at 215 and 250 nm and fractions were 
collected in 2 ml portions. The fraction from this HPLC separation with highest ACE 
inhibitory activity was re-chromatographed on a Phenomenex Cl 8  (10 m m  x 250 mm) 
column and fractions were collected. RP-HPLC analysis was performed on the HPLC 
system comprising a pump (Thermoseparation Products), autosampler (Spectra Physics 
AS 1000, detector (Thermoseparation Products UV6000LP) and intergration software 
(Chromquest, 2004). The fractions showing A C E  activity were collected, pooled and 
freeze dried.
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The A C E  inhibitory activity assay was performed according to the method of W u  et al 
(2002) with some modifications. In this method, the total reaction volume was 70 pL, 
made up of 50 pL of 2.17 m M  hippuryl histidyl leucine (HHL), 10 pL of 2 m U  of ACE 
and 10 pL of different of peptide fractions obtained after 2, 5, 10 kDa, gel filtration, ion 
exchange and HPLC (all prepared with 100 m M  borate buffer, containing 300 m M  
NaCl, pH 8.3). The H H L  and peptide fractions were combined and maintained at 37 °C 
for 10 min in 2 ml polyethylene microcentrifuge tubes. A C E  was also maintained at 
37 °C for 10 min before the two solutions were combined and incubated at 37 °C with 
agitation. The reaction was terminated after 30 min by adding 85 pL of 1.0 M  HC1 and 
the mixture kept for HPLC analysis. A  positive control of H H L  and enzyme; and blank 
of H H L  and buffer were also prepared in the same manner.
Samples (10 pL) were analyzed on a Cl 8 column (3.0x150 mm, 5 pm, Phenomenex); 
and H A  and H H L  were detected at 228 nm .The column was eluted (1 ml/ min) with a 
two solvent system: (A) 0.05 %  TFA in water and (B) 0.05 % TFA in acetonitrile, with a 
5-60 %  acetonitrile gradient for the first 1 0  min, maintained for 2  min at 60 %  
acetonitrile, then returned to 5 %  acetonitrile for 1 min. This was followed by isocratic 
elution for 4 min at the constant flow-rate of 1 ml/min. RP-HPLC analysis was 
performed on the HPLC system comprising a pump (Thermoseparation Products), 
autosampler (Spectra Physics AS 1000, detector (Thermoseparation Products 
UV6000LP) and intergration software (Chromquest, 2004).
2.2.2.5. ACE inhibitory activity
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(i) A C E  activity (%)
= (PeakAreasampie - PeakAreabiank)/ (PeakAreacontroi - PeakAreabiank) x 100
(ii) A C E  inhibitory activity (%) = 100 - A C E  activity (%).
The IC5 0 of fractions from each purification stage exhibiting highest A C E  inhibitory 
activity was determined. The IC5 0 value was defined as the concentration of inhibitor 
required to inhibit 50 %  of the AC E  activity under the assayed conditions and 
determined by regression analysis of A C E  inhibition (%) versus inhibitor concentration 
(mg/ml).
2.2.2.6. A C E  inhibition mechanism
Two different concentrations of A C E  inhibitory peptide were added to each reaction 
mixture (0.1 and 1.4 mg/mL). The enzyme activity was measured with different 
concentrations of the substrate (0 - 0.05 p M  HHL). The resultant mixtures were 
analysed for hippuric acid peaks by HPLC as described above in section 2.2.2.5. The 
kinetics of A C E  in the presence of the inhibitor was determined by the Lineweaver-Burk 
plots. Standard comprising captopril and negative controls were also included in the 
analysis. A  standard curve of hippuric acid was determined with a concentration range 
of 0.02 to 0.1 pM.
The ACE inhibitory activity was calculated as
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2.2.3.1. Preparation of samples and standards in determination of amino acids
Ten milligrams of each sample were placed in screw-cap tubes (16 m m  x 125 mm) and 
hydrochloric acid ( 6  M, 10 ml) was added. The tubes were then closed under nitrogen, 
and placed in an oven at 110 °C for 24 h. After hydrolysis, tube contents were vacuum- 
filtered to remove solids.
2.2.3.2. Derivatization with PITC
The derivatization procedure was a modification of the method used by (Gonza'lez- 
Castro et al, 1997). Amino acid standard solution and hydrolysed sample (20 pi) were 
placed in a vial and dried under vacuum for 20 min at room temperature. After this, 20 
pi drying agent (200 pi methanol + 200 pi 1 M  sodium acetate + 100 pi triethylamine) 
were added to the residue and the resulting solution was vacuum-dried for a further 1 0  
min. Next, 20 pi of the derivatizing reagent (140 pi methanol + 20 pi water + 20 pi + 
20 pi PITC) were added, and the vials were vortex-mixed for 30 s and left to stand at 
room temperature for 20 min. Finally, the resulting solution was vacuum-dried for 20 
min and reconstituted in eluent A  (0.22 M  sodium acetate buffer containing 0.05 % (v/v) 
TEA (pH adjusted to 6.2 with glacial acetic acid).
2.2.3. Amino acid composition determination
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RP-HPLC analysis was performed on the HPLC system comprising a pump 
(Thermoseparation Products), autosampler (Spectra Physics AS 1000, detector 
(Thermoseparation Products UV6000LP) and intergration software (Chromquest, 2004).
Compounds were separated 0 1 1 a 3.9 x 150 mm, 5 p m  particle size, C18 reversed-phase 
column (Nova-Pak, Waters separations, Elstree, UK). The mobile phase was a gradient 
prepared from two solutions, A  and B. Solution A  was 0.22 M  sodium acetate buffer 
containing 0.05 % (v/v) TEA (pH adjusted to 6.2 with glacial acetic acid). Solution B 
was 60:40 acetonitrile:water. The gradient profile was as shown in Table 2.1. The flow 
rate was 1 ml min/ml and the detection wavelength 254 nm.
2.2.3.3. HPLC equipment and conditions
Table 2.1. Gradient profile for chromatographic run
Time
(min)
Flow rate 
(ml/min)
%
Solution A
%
Solution B
0 1 . 0 1 0 0 0
1 0 . 0 1 . 0 54.0 46.0
10.5 1 . 0 0 . 0 1 0 0 . 0
11.5 1 . 0 0 . 0 1 0 0 . 0
1 2 . 0 1.5 0 . 0 1 0 0 . 0
12.5 1.5 1 0 0 . 0 0 . 0
2 0 . 0 1.5 1 0 0 . 0 0 . 0
20.5 1 . 0 1 0 0 . 0 0 . 0
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2.2.4. Statistical analysis
Statistical analyses were performed with Minitab statistical software (13.1). 
Comparisons were made by one-way analysis of variance. P< 0.05 was considered 
statistically significant.
2.3. RESULTS A N D  DISCUSSION
2.3.1. Purification and amino acid sequencing of A C E  inhibitory peptide
Atlantic mackerel fish muscle protein was successfully hydrolysed with pepsin and 
pancreatine (trypsin and chymotrypsin) to yield a protein hydrolysate (MFPH) that was 
fractionated using 2, 5 and 10 kDa molecular weight cutoff (MWCO) ultrafiltration 
membrane cartridges.
The AC E  inhibitory activity of the fractionated ultramembrane fractions < 2 kDa 
(MFPH-V), 3-5 kDa (MFPH-III), 5-10 kDa (MFPH-II) and crude enzymatic hydrolysate 
(MFPH-I) is shown in figure 2.1. MFPH-V having a molecular mass (MW) below 2 kDa 
showed the highest A C E  inhibitory activity of 95.0 %. Consequently, MFPH-V fraction 
was chosen for further chromatographic purification and A C E  inhibitory activities.
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MFPH-V MFPH-III MFPH-II MFPH-I
Figure 2.1. AC E  inhibitory activity (%) of mackerel fish protein crude enzyme 
hydrolysate and 2,5 and 10 kDa fractions obtained by membrane ultrafiltration.
The MFPH-V fraction was loaded onto the column packed with Sephadex G25 and was 
eluted with 50 m M  sodium phosphate buffer (pH 7.0). Five milliliter (5 ml) portions 
were collected in test tubes and the absorbance of the resultant peptide fractions was 
monitored at 215 nm.
The 2kDa fraction (MFPH-V fraction), after separation on a Sephadex G-25 gel 
filtration column (2.5 x 90 cm) previously equilibrated with 50 m M  sodium phosphate 
buffer (pH 7.0), showed 19 peptide fractions (A - T) as shown by the chromatogram in 
figure 2.2A. These gel filtration peptide fractions were freeze-dried and analysed for 
their ACE inhibitory activity by the HPLC method according to W u  et al (2002). 
Fraction J (MFPH-V-J) showed the highest ACE inhibitory activity of 36.09 % (figure 
2.2B). This fraction (MFPH-V-J) was subjected to ion exchange chromatography on a
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SP-Sephadex C-25 column and elution with a 0 - 2.0 M  sodium chloride gradient. 
Sixteen fractions denoted by letters were identified as shown in the chromatogram in 
figure 2.3A and their corresponding A C E  inhibitory activities were measured. The 
fraction labelled P showed the highest ACE inhibitory activity of 86.1 % (figure 2.3B); 
this fraction (MFPH-V-JP) was freeze-dried and stored at -20 °C for liquid 
chromatography purification. When fractionated on a Cl 8  (9.8 x 50 cm) reversed phase 
column, MFPH-V-JP gave 5 fractions that showed A C E  inhibitory activity (figure 
2.4A). The fraction with highest A C E  inhibition activity of 34.9 %  was tube A  (MFPH- 
V-JPA) (figure 2.4B).
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Figure 2.2. (A) Gel filtration chromatography of the 2kDa mackerel muscle protein 
hydrolysate (MFPH-V) separated on Sephadex G-25 column and detected at 215 
nm. (B) AC E  inhibitory activity of the 2 kDa mackerel fish peptides from gel 
filtration. Separation was performed at a flow rate of 1 ml/min and 5 ml fractions 
were collected. Aliquots, drawn from each fraction, were used to measure ACE  
inhibitory activity. The fractions showing peptides are designated with letters.
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Figure 2.3. (A) Ion Exchange chromatography of MFPH-V-J fraction on the SP- 
Sephadex C-25 column and detected at 215nm. (B) A C E  inhibitory activity of the 
fractions from ion exchange chromatography. Separation was performed at a flow 
rate of 1 ml/min and 5 ml fraction collected. Aliquots, drawn from each fraction, 
were used to measure A C E  inhibitory activity. The fractions showing peptides are 
designated with letters.
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Figure 2.4. (A) High performance liquid chromatography of MFPH-V-JP on 
Partisil 10 ODS-1 (9.5 m m  x 500 mm) column and detected at 215 nm. (B) ACE 
inhibitory activity of the fractions on Partisil 10 ODS-1 (9.5 m m  x 500 mm) column. 
Separation was performed at a flow rate of 1 mL/min and 2 m L  fraction collected. 
Aliquots, drawn from each fraction, were used to measure A C E  inhibitory activity. 
The fractions showing peptides are designated with letters.
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Fraction MFPH-V-JPA was rechromatographed on the C18 9.8 x 250 m m  reversed 
phase column as shown in chromatogram in figure 2.5. One identifiable peak was 
evident in the chromatogram (figure 2.5), showing the presence of peptide(s). This 
fraction was collected and freeze dried. The amino acid composition of the peptide 
fraction was determined and contained the amino acids - Histidine, proline, tyrosine, 
methionine, leucine, tryptophan and lysine (Figure 2.6 and Table 2.2).
Minutes
Figure 2.5. Chromatogram of MFPH-V-JPA rechromatographed on Partisil 10 
ODS-1 (9.5 m m  x 250 mm) column and detected at 215 nm.
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Figure 2.6. (A) Chromatogram of amino acid standards and (B) amino acids from 
MFPH-V-JPA2.
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Table 2.2. Amino acid composition of standard and peptide fraction (MFPH-V- 
JPA2)
Amino acid Standards
Retention Amount 
time (pg) 
(min)
Peptide Fraction 
(MFPH-V-JPA2) 
Retention Amount 
time (pg/mg) 
(min)
Asp 3.5 1.33 - -
Glu 3.8 1.47 - -
Ser 5.7 1.05 - -
Gly 6.0 0.75 - -
His 6.2 1.55 6.2 0.16
Tin* 6.7 1.19 - -
Ala 6.8 0.89 - -
Pro 7.0 1.15 6.8 0.05
Try 8.1 1.81 8.0 0.59
Val 9.0 1.17 - -
Met 9.3 1.49 9.2 0.15
Cys 9.8 1.21 - -
He 10.5 1.31 - -
Leu 10.7 1.31 11.0 0.56
Phe 11.5 1.65 - -
Tip 11.9 2.04 11.9 0.53
Lys 12.2 0.73 12.3 0.12
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2.3.2. ACE inhibitory activity
The purification and AC E  inhibitory activity of peptides derived from Atlantic mackerel 
muscle hydrolysed with gastrointestinal enzymes is the first to be reported in this study. 
The inhibitory potential was quantified through the inhibitory concentration (IC5 0) that is 
the concentration required to inhibit 50 %  of the enzyme. The IC5 0 of 2 kDa, gel 
filtration, liquid chromatography 1 fractions and sequenced peptide from Atlantic 
mackerel fish were determined with the validated HPLC method (Table 2.3). The (IC5 0) 
values of MFPH-V, MFPH-V-J, MFPH-V-JPA and MFPH-V-JPA2 were significantly 
different (p<0.0001) and were found to be 2.76, 0.43, 0.36 and 0.15 mg/ml respectively.
Table 2.3. Inhibitory concentration (IC5 0) mg/ml of the different fractions (2 kDa, 
gel filtration fraction, liquid chromatographyl and liquid chromatography 2) of 
Atlantic mackerel fish protein peptides.
Fraction Inhibitory concentration (IC5 0)
mg/ml
MFPH-V (2kDa Fraction) 2.76
MFPH-V-J (Gel Filtration Fraction) 0.43
MFPH-V-JPA (HPLC Fraction) 0.36
MFPH-V-JPA2 (HPLC 2 Fraction) 0.15
Research on bioactive peptides derived from Atlantic mackerel with gastrointestinal 
enzymes has not been reported previously. In the present study, an A C E  inhibitory 
peptide fraction was purified with an IC5 0 value of 0.15 mg/ml. This IC5 0 activity value 
was higher or similar to those of peptides derived from protein sources hydrolysed with
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one or two of the gastrointestinal enzymes. In peptides (5-6 amino acid sequence) 
derived from tuna fish with trypsin, chymotrypsin, pronase and pepsin hydrolysis, IC5 0  
values obtained ranged from 0.019 to 0.106 mg/ml (22.2 to 156.3 pM). Among these, 2 
peptides C W L P V Y  and SKVPP with a characteristic proline on the C-terminal tripeptide 
had IC5 0 values 0.019 and 0.106 mg/ml (22.2 and 74.22 pM) respectively (Astawan et 
al, 1995); these values are comparable to the IC5 0 value 0.15 mg/ml of the isolated 
peptide in this study. Itou and AJkahane (2004) obtained a hydrolysate obtained by 
fermentation from mackerel with an IC5 0 value of 0 . 1  mg/ml; this is comparable to the 
HPLC fraction isolated in this study of 0.15 mg/ml.
The release of bioactive peptides from their immediate precursor sequence is a 
requirement for any functional role they will play in biological systems. Bioactive 
peptides can be released by enzymatic proteolysis of food proteins, so gastrointestinal 
enzymes, pepsin and pancreatine (chymotrypsin and trypsin) in combination or alone 
have been used to derive bioactive peptides from proteins. Among these gastrointestinal 
digestive enzymes, pepsin is known to cleave peptide bonds with phenylalanine and 
tyrosine whilst trypsin is specific for lysine and arginine. In contrast, a-chymotrypsin is 
specific for peptide bonds involving amino acids with bulky side chains and non-polar 
amino acids (Jung et al, 2004). Therefore, natural peptides derived by gastrointestinal 
hydrolysis can have varied C-terminus amino acids. The peptide isolated in this study 
shows that the peptide bonds present in the peptide can survive the intestinal peptic and 
pancreatine enzyme hydrolysis and be available for absorption in the lumen and exert 
the A C E  inhibitory activity. As most food derived A C E  peptides are derived from non-
80
gastrointestinal enzymes, their potential to be used as nutraceuticals is limited as they 
may be prone to peptic and pancreatic hydrolysis with consequential loss of bioactivity. 
The use of gastrointestinal enzymes in this study eliminates this hurdle and strengthens 
the nutraceutical potential of the isolated peptide in this study.
The somatic form of the A C E  comprises two homologous domains, generally known as 
the N-domain and C-domain, arranged in tandem and joined by a short connecting 
peptide sequence. A C E  inhibitors may preferentially act on either A C E  domain. 
However, the C-domain seems to be necessary for controlling blood pressure (Ondetti 
and Cushman, 1982) suggesting that this domain is the dominant angiotensin-converting 
site. It is expected that the peptide conformation, that is, the structure adopted in a 
specific environment of the binding site, should contribute to A C E  inhibitor potency 
(Natesh et al, 2005). Therefore the peptide isolated in this study, comprising 7 kinds of 
amino acid can access the active site of A C E  and may enhance to lower blood pressure. 
This is in agreement with the results which have been shown from crystallography 
studies that the active site of A C E  cannot accommodate large peptide molecules 
comprising more than 2530 amino acids (Natesh et al, 2005).
It is thought that AC E  inhibition is strongly influenced by the C-terminal tripeptide 
sequence of the peptide in question. It is proposed that peptides with hydrophobic amino 
acids at these positions are potent inhibitors. Furthermore, the presence of a positive 
charge as in the guanidine group of the C-terminal also contributes to the ACE 
inhibitory potency of several peptides (Wu et al, 2006a, W u  et al, 2006b). In this study,
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the observed IC5 0 value of the purified peptide can be attributed to its C -terminal 
tripeptide. The presence of a hydrophobic amino acid in the C-terminal tripeptide may 
explain the observed A C E  inhibitory bioactivity. Several peptides derived from fish with 
gastrointestinal enzymes with hydrophobic amino acids such as proline, histidine, 
tyrosine and phenylalanine in the tripeptide position in the C-terminal show a range of 
IC5 0 values; for example C W L P V Y  0.019 mg/ml, V A W K L  0.021 mg/ml, SKVPP 0.044 
mg/ml, Y S K V L  0.106 mg/ml (Astawan et al, 1995); MIFPGAGGP 0.029 mg/ml (Jung 
et al, 2006). In particular, pancreatic digests of salmon and and Pollack had IC5 0 ranging 
between 3.69 to 5.0 mg/ml (Nakajima et al, 2009). It appears that the position of a 
hydrophobic amino acid may be a factor for the AC E  inhibitory activity of the peptide. 
The ultimate goal for A C E  inhibition is the reduction of blood pressure and 
gastrointestinal enzymatic hydrolysates of mackerel (IC5 0 0.1 mg/ml), yellowfin sole 
(IC5 0 0.028 mg/ml) and Tuna (IC5 0 0.63 mg/ml) have been shown to reduce systolic 
blood pressure (SBP) in spontaneously hypertensive rats (SHR) (Itou and akahane, 
2004; Jung et al, 2006; Astawan et al, 1995).
2.3.3. Competitive or non-competitive binding of the peptides to A C E
Derivation of peptides with A C E  inhibitory activity and the determination of the amino 
acid sequence and composition can help to further understand the mechanisms by which 
the specific sequenced peptides effect the bioactivity. Peptides inhibit the AC E  either by 
binding to the active site (competitive inhibition) or to another site on the enzyme (non­
competitive inhibition). In this study, the mechanism of AC E  inhibition by the isolated
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peptide was characterised through Lineweaver-Burk plots. The Lineweaver-Burker 
plots of A C E  with or without the peptide (at 2 different concentrations of 0.1 and 1.42 
mg/ml) are shown in figure 2.7. The calculated V max for control (without 
inhibitor/peptide), 0.1 and 1.42 mg/ml was 0.18, 0.21 and 0.23 respectively (Table 4.1). 
The values are not significantly different (p < 0.01) and therefore have the same kind of 
ACE inhibition mechanism. These results indicate that the peptide acted as a competitive 
inhibitor with respect to H H L  as substrate, implying that the peptide competed with the 
substrate for the active site of ACE. The competitive mechanism exhibited is similar to 
that exhibited by captoprii (IC5 0, 0.022 pM), the most potent synthetic A C E  inhibitor as 
the Vmax values for the peptide, control and captoprii are not significantly different
(p<0.01).
The calculated K m value of A C E  was 0.50 m M  for H H L  in the absence of the peptide. In 
the presence of the peptide at concentrations of 0.1 and 1.42 mg/ml, the calculated K m 
value of A C E  was 0.79 and 1.97 m M  respectively (Table 2.4). Therefore, in the presence 
of the peptide (inhibitor), the IQ value was 0.32 mg/ml. This inhibition constant 
represents the dissociation for the enzyme - inhibitor complex; therefore the lower the 
value, the greater the affinity of the inhibitor for the enzyme. The IQ obtained in this 
study shows considerable affinity of the peptide for AC E  and will consequently infer 
considerable inhibition as observed in the IC5 0 value obtained.
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Figure 2.7. Lineweaver-Burk plots of A C E  inhibition in the presence of the peptide, 
control (without inhibitor/peptide), 0.1 and 1.4mg/mL of peptide and captopril.
This type of inhibition shows that the peptide competitively binds to the active site of 
ACE and consequently impairs the production of Angiotensin II. Therefore, in the RAS 
system, the peptide will compete with angiotensin I for the active site of ACE. As a 
result limited or no angiotensin II will be produced. In this way, the vasoconstriction 
reaction cascade is impaired and blood pressure consequently lowered in a hypertensive 
condition.
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Table 2.4. Vmax and Kmax values for the isolated peptide and captopril
Fraction V max
(mM/min)
K m
(mM)
R 2
Control 0.18 0.50 0.997
Peptide 1.42 mg/ml 0.23 1.97 0.884
Peptide 0.1 mg/ml 0.21 0.79 0.992
Captopril 0.19 0.41 0.975
Peptides are known to exhibit both competitive and non-competitive inhibition of ACE. 
A C E  appears to prefer substrates or competitive inhibitors containing hydrophobic 
(aromatic or branched side chains) amino acid residues at each of the three C-terminal 
positions (Cheung et al, 1980) and many naturally occurring peptidic inhibitors contain 
proline at the C-terminus (Ondetti et al, 1977). Peptides with Tip as the C-terminal 
residue, Ala-Trp, Val-Trp, Met-Trp, Ile-Trp, Leu-Trp showed non-competitive 
inhibition. But when the sequence is reversed with Tip at the N-terminal they exhibit 
competitive inhibition, except Trp-Leu. (Ono et al, 2006). Peptides, Phe-Gly-Ala-Ser- 
Thr-Arg-Gly-Ala, isolated from Alaska Pollack (Je et al, 2004) and Met-Ile-Phe-Pro- 
Gly-Ala-Gly-Gly-Pro-Glu-Leu, from yellowfin sole (Jung et al, 2006) were found to be 
non-competitive. These results show that the sequence of amino acids in peptides can 
affect both inhibitory potency and the type of inhibition mechanisms.
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The isolated peptide in this study has hydrophobic amino acids and when positioned in 
the C-terminal tripeptide may possibly explain the observed inhibitory mechanism. For 
example, peptides with proline in the C-terminal tripeptide are known to be competitive 
inhibitors. AC E  inhibitors with a competitive inhibition are preferred as the peptidic 
fractions resulting from their hydrolysis by A C E  are docile or inert and do not have any 
negative physiological effects. In some instances, the resulting peptidic fragments may 
also exhibit some A C E  inhibitory effects (Yokoyama et al, 1992, Fugita and Yoshikawa, 
1999).
2.4. CONCLU S I O N S
The results from this study show that in vitro digestion of Atlantic mackerel (Scomber 
scombrus) fish protein with pepsin and pancreatine produced peptides with ACE 
inhibitory activity. The inhibitory mackerel fish peptides with the highest inhibitory 
activity, produced after 3 h of in vitro sequential digestion with pepsin and pancreatin, 
were all smaller than 2 kDa and after further purification by gel filtration, ion exchange 
and liquid chromatography, resulted in a peptide with amino acids histidine, proline, 
tyrosine, methionine, leucine, tryptophan and lysine; and a significant A C E  inhibitory 
activity. The binding of the peptide to A C E  was found to be competitive. This finding 
suggests the potential production of A C E  inhibitory mackerel fish peptides upon 
consumption and digestion of Atlantic mackerel, since the pepsin and pancreatin 
enzymes used in this study are similar to enzymes in a gastrointestinal digestive system.
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C H A P T E R  T H R E E
3 ANTIOXIDANT PROPERTIES O F  PEPTIDES D ERIVED F R O M  ATLANTIC 
M A C K E R E L  (SCOMBER SCOMBRUS) PROTEIN
3.1 I N T R O D U C T I O N
Oxidation of proteins and lipids in biological systems is harmful and is reported to be 
linked to several diseases such as atherosclerosis, inflammation, and cancer (Frlich and 
Riederer, 1995). In food, lipid oxidation produces rancid flavours and toxic undesirable 
compounds, leading to quality deterioration and shortened shelf life. Oxidation of lipids 
and proteins can be retarded by antioxidants both in vivo and in vitro. An antioxidant is 
defined as any substance that significantly delays or inhibits oxidation of a substance 
when present at low concentrations compared to that of an oxidisable substrate (Belitz et 
al, 2009).
Many synthetic antioxidants, such as butylated hydroxyanisole and butylated 
hydroxytoluene, are used as food additives to prevent food deterioration. Despite these 
synthetic antioxidants showing stronger antioxidant activity than that of natural 
antioxidants such as a-tocopherol and ascorbic acid, there is concern about their safety 
with regard to human health (Ito et al., 1986; Becker, 1993). Therefore, current research 
focuses on identifying antioxidants from natural sources that includes plant polyphenols 
as well as novel peptides from dietary proteins such as zein, fish, egg and milk (Kong 
and Xiong, 2006; Mendis et al, 2001; Yamamoto, et al, 1996). Marine products and by­
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products have been shown to be good sources of antioxidant peptides, such as jumbo 
squid skin (Mendis et a l, 2005), hoki frame protein (Kim et al, 2007), yellowfin sole 
frame protein (Jun et al, 2004), yellow stripe trevally (Klompong et al, 2007), round 
scad (Thiansilakul et al, 2007), Pacific hake (Samaranayaka and Li, 2008), Alaska 
pollack skin (Kim et al., 2001) among many.
Antioxidant peptides have been characterized from enzymatic hydrolysates of different 
food proteins, produced by fermentation or enzymatic hydrolysis of food proteins 
(Kasase and Howell, 2009). Peptides obtained from a combination of gastrointestinal 
proteases (pepsin and pancreatin) have rarely been used to investigate if antioxidant 
peptides can be produced in an in vitro digestion model system. The digestion of 
Atlantic mackerel muscle with gastrointestinal enzymes is a potential strategy that can 
be employed to produce antioxidant peptides. This offers an advantage in that the 
formed peptides will resist physiological digestion after oral intake when targeted as 
nutraceuticals.
Atlantic mackerel (Scomber scombrus) is a pelagic or fatty species found on both sides 
of the northern hemisphere of the Atlantic Ocean. It varies in size between 180 to 210 
cm in length and 325 to 360 g in body weight. Its proximate composition include 15-25 
%  proteins, 0.1-22% lipids, 0.8-2% minerals, 0.3% carbohydrates and 66% and 84% 
water (Kolokowska, 2003).
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Therefore, the aim of this study is to investigate the antioxidant activity of enzymatically 
prepared peptides from Atlantic mackerel fish protein. The antioxidative activity of the 
peptide against lipid peroxidation was tested in a linoleic acid model system. It is hoped 
that understanding of the antioxidative properties of Atlantic mackerel fish peptides may 
lead to their potential use as potent natural anti oxidants.
3.2. M A T E R I A L S  A N D  M E T H O D S
3.2.1 Materials
Atlantic mackerel (Scomber scombrus) fillets were supplied by M  &  J Seafood, 
Farnham, U K  and delivered in ice to the laboratory. Sodium phosphate, hydrochloric 
acid, sodium hydrogen carbonate, sodium hydroxide and ethanol, were obtained from 
Fisher Scientific, UK. Vivaspin Membrane ultrafilters (Sartorius (Epsom Surrey, UK). 
Pancreatine, pepsin, a-tocopherol, trolox, ammonium thiocyanate, ferrous chloride, 
Sephadex G-25 and Sephadex C-25 were obtained from Sigma-Aldrich, Dorset, UK.
3.2.2. Methods
3.2.2.I. Enzymatic hydrolysis of Atlantic mackerel fish protein
See section 2.2.2.1
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3.2.2.2. Membrane ultrafiltration
See section 2.2.2.2
3.2.2.3. Gel filtration
See section 2.2.2.3
3.2.2.4. Measurement of lipid peroxidation in linoleic acid model system.
Linoleic acid was oxidized in a linoleic acid model system to measure the antioxidative 
activity following the method of Osawa et al (2001) with some modifications.
3.2.2.4.I. Preparation of reaction mixture
Each freeze-dried hydrolysate or peptide sample (60 mg) was mixed with 4.87 m L  
distilled water, 0.13 m L  linoleic acid, 10 m L  ethanol, and 10 m L  50 m M  phosphate 
buffer (pH 7.0) in glass flasks. The flasks were sealed tightly with silicone rubber caps 
and kept at 40 °C in the dark. The analyses were performed in triplicate with a positive 
control (a-tocopherol and trolox) and a negative control (without the peptide).
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3.2.2.4.2. Ferric thiocyanate method for peroxide formation
At 24 h intervals, 100 fiL aliquots of the emulsion were withdrawn with a microsyringe 
into test tubes to which 4.7 ml of 75 % ethanol (v/v), 100 jiL 30 % ammonium 
thiocyanate (w/v) and 100 pL 20 mM ferrous chloride solution was added. Precisely 
after 3 minutes after the addition of ferrous chloride solution, the absorbance was 
measured at 500 nm on a spectrophotometer (UV Mini 1240, Shimadzu Europa, Milton 
Keynes, UK).
3.2.2.4.3. Thiobarbituric acid reactive species (TEARS) method
The TBARS were measured using a modified version of the method of Ohkawa et al 
(1979). At 24 h intervals, 50 p,L aliquots of the emulsion were withdrawn with a 
microsyringe into test tubes to which 0.8 ml distilled water, 0.2 ml 8.1 % sodium 
dodecyl sulfate (w/v), 1.5 ml of 20 % acetic acid (v/v), and 1.5 ml of 0.8 % TBA (w/v) 
solution were added. The mixture was then heated at 100 °C for 1 h in the dark. After 
cooling, the tubes were centrifuged and the supernatant was measured for TBARS on a 
spectrophotometer by reading the absorbance at 532 nm.
3.2.2.4.3. Lipid oxidation inhibitory concentration
Different concentration of peptide, 0.4, 0.8, 4, 6 and 8 mg/ml were prepared in a linoleic 
acid emulsion system. After 3 days, the peroxide values through the FTC method were
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determined. A standard of 0.01 % BHT and 0.01 % trolox were also prepared and 
treated in the same way.
3.2.3. Amino acid composition of isolated peptide determination
Amino acids composition was determined according to section 2.2.3.
3.2.4. Statistical analysis
Statistical analyses were performed with Minitab statistical software (13.1). 
Comparisons were made by one-way analysis of variance. P< 0.05 was considered 
statistically significant.
3.3. RESULTS AND DISCUSSION
3.3.1. Isolation and purification of antioxidative peptides
The functional properties of bioactive peptides are highly influenced by the molecular 
structure, molecular mass, as well as conditions of processing. Enzymatic hydrolysis has 
become the most important tool for modifying the functionality of dietary proteins to 
identify different bioactivities (Korhonen et al, 1998). Therefore, Atlantic mackerel
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protein was hydrolyzed with pepsin and then with pancreatine, the enzymes that are 
involved in the gastrointestinal digestive system in humans.
To purify the antioxidant peptides from the mackerel protein hydrolysate, membrane 
ultrafiltration (2 kDa MWCO), gel filtration chromatographic and HPLC techniques 
were utilized. The lipid oxidation inhibition (%) by the ferric thiocyanate method was 
used as the selection criteria for choosing the peptide fractions for further purification. 
Figure 3.1, 3.2 and 3.3 show the chromatographic profiles obtained during the 
purification steps of a < 2 lcDa Atlantic mackerel fish hydrolysate peptide as well as their 
lipid oxidation inhibition (%).
In the lipid peroxidation inhibition activity assay, peroxyl (RO O ) and allcoxyl (RO*) 
radicals, derived from the pre-existing lipid peroxide, were employed directly to initiate 
lipid peroxidation in the emulsified linoleic acid system (Cheng et al, 2003). Previous 
studies with soya protein isolates (SPI) hydrolysed with pepsin and pancreatine and 
fractionated into >2 kDa, 2-5 kDa, 5-10 kDa, and the crude hydrolysate, shows >2 kDa 
fraction exhibits the highest lipid oxidation inhibition (Kasase and Howell, 2008). 
Therefore, in this study, the Atlantic mackerel fraction was first purified on a 2 kDa 
MWCO ultrafiltration membrane and then purified by gel filtration on Sephadex G 25, 
collecting 5 ml fractions. When the freeze dried fractions where determined for their 
lipid oxidation inhibition, fraction G (in figure 3.1) gave the highest lipid oxidation 
inhibition of 47.0 %. Consequently, this fraction was pooled, freeze dried and purified 
on a C18 (9.8 x 500 mm) column by HPLC (Figure 3.2). Of the four fractions collected,
93
the fraction denoted by the letter Z gave the highest lipid oxidation inhibition of 19.05 % 
(Figure 3.3). Fraction Z was then rechromatographed by HPLC on a C18 (9.8 x 250 
mm) column, collected, pooled and freeze dried. The amino acid composition of the 
peptide fraction was determined and found to contain 7 amino acids - serine, histidine, 
tyrosine, phenylalanine, tryptophan and lysine (figure 3.4 and Table 3.1).
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Figure 3.1(A). Gel filtration chromatography of the 2kDa Atlantic mackerel fish 
peptides on the Sephadex G-25 column and detected at 215 nm and (B) the 
corresponding lipid oxidation inhibition. Separation was performed at a flow rate 
of 1 ml/min and collected at a fraction volume of 5 ml.
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Figure 3.2. (A) HPLC of fraction G from gel filtration detected at 215nm and (B). 
The corresponding % lipid oxidation inhibition. Separation was performed on a 
Cl8 (9.8 x 500 mm) column at a flow rate of 1 ml/min and 2 ml fraction collected.
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Figure 3.3. HPLC of fraction Z from HPLC rechromatographed C18 (9.8 x 250 
mm) column and detected at 215 nm.
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Figure 3.4. (A) Chromatogram of amino acid standards and (B) amino acids from 
LC1-Z.
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Table 3.1. Amino acid composition of standard and peptide fraction (LC1-Z).
Amino acid Standards Peptide Fraction (LC1-Z)
Retention time Amount Retention time Amount 
 _______  (min)__________ (gg)__________ (min)________ (pg/mg)
Asp 3.5 1.33 - -
Glu 3.8 1.47 - -
Ser 5.7 1.05 5.5 0.31
Gly 6.0 0.75 - -
His 6.2 1.55 6.2 0.31
Thr 6.7 1.19 - -
Ala 6.8 0.89 - -
Pro 7.0 1.15 - -
Try 8.1 1.81 8.0 0.63
Val 9.0 1.17 - -
Met 9.3 1.49 - -
Cys 9.8 1.21 - -
lie 10.5 1.31 - -
Leu 10.7 1.31 - -
Phe 11.5 1.65 11.2 0.31
Tip 11.9 2.04 11.4 0.16
Lys 12.2 0.73 12.0 0.08
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3.3.2. Inhibitory effects of isolated peptide on lipid peroxidation
To assess the inhibitory effects of the isolated peptide (LC1-Z) on lipid peroxidation, 
linoleic acid was oxidized in an emulsified model system. The mixture was incubated in 
the dark at 40 °C and primary (peroxides) and secondary oxidation products (TBARS as 
Malondialdehyde) of linoleic acid determined for 7 days. In lipid oxidation process, 
there is a sequential formation of peroxides and hydroperoxides as primary products 
which are then transformed into carbonyl secondary products also referred to as 
thiobarbituric acid reactive substances (TBARS) and include Malondialdehyde (MDA). 
Peroxides/hydroperoxides and TBARS are considered as biomarkers of lipid 
peroxidation (Liu et al, 1997). In this study, the inhibition of linoleic acid oxidation by 
the isolated peptide was followed by monitoring peroxides through the feme thiocyanate 
method and MDA through the thiobarbituric acid method. Figure 3.5 and 3.6, shows that 
the oxidation of linoleic acid results in both peroxides and MDA (control) being formed 
and that the formation of both primary and secondary products is markedly and 
effectively inhibited in the presence of the isolated peptide (LC1-Z). The trend in the 
inhibition of linoleic acid oxidation is similar to that of the standards, butylated 
hydroxytoluene (BHT) and trolox. The trend in the formation of MDA in the presence of 
the peptide (LC1-Z) and standards (BHT and trolox) correlated well as it appears to 
follow the same pattern (Figure 3.6).
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♦ LC1 -Z —■— Trolox BHT x Control
Figure 3.5 Antioxidant activity of LC1-Z. LC1-Z was incubated in a linoleic acid 
oxidation system for 6 days and the degree of linoleic acid oxidation was assessed 
by measuring peroxides equivalents (mg/ml FeCh) at every 24-h interval. Butylated 
hydroxytoluene (BHT) and trolox were used as positive controls.
Time (Days)
■ ♦ LC 1 -Z —»— Trolox BHT ■ x Control
Figure 3.6 Antioxidant activity of LC1-Z. LC1-Z was incubated in a linoleic acid 
oxidation system for 6 days and the degree of linoleic acid oxidation was assessed 
by measuring malondialdehyde (pg/ml) at every 24-h interval. Butylated 
hydroxytoluene (BHT) and trolox were used as positive controls.
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A dose dependent inhibition of linoleic acid oxidation by the peptide was observed 
through the formed peroxides by the ferric thiocyanate method (figure 3.7). An increase 
in the peptide concentration had a corresponding increase in linoleic acid oxidation 
inhibition. This dose dependent phenomenon in figure 3.7 gives an inhibitory 
concentration (IC50) of the peptide of 1.80 mg/ml assay volume (y = 8.254x + 35.239, R2 
= 0.85). However, at peptide concentration of 8 mg/ml, the inhibition of linoleic acid 
oxidation inhibition is markedly more than (p<0.001) BHT and trolox (0.01 % in each) 
at concentrations normally used in food systems (figure 3.8)
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Figure 3.7. Dose dependent lipid oxidation inhibition of LC1-Z. LC1-Z was 
incubated in a linoleic acid oxidation system and lipid oxidation inhibition assessed 
by measuring peroxides equivalents (mg/ml FeCh) after 72 h.
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Figure 3.8. Lipid oxidation inhibition of L C 1-Z . L C 1-Z  was incubated in a linoleic 
acid oxidation system and lipid oxidation inhibition was assessed by measuring 
peroxides equivalents (mg/ml FeC l2) after 72 h. Butylated hydroxytoluene (BHT) 
(0.01%) and trolox (0.01%) were used as positive controls.
Peptides exhibiting antioxidant activity have been isolated from a number of fish 
species. The antioxidant activity of these peptides is generally attributed to the size of 
the peptide, sequence of amino acids and most importantly the composition of the amino 
acids. Amino acids, as individual compounds, do not show marked antioxidant activity 
(Elias et al, 2008). The observed activity is due to their increased free radical scavenging 
activity, metal chelation and aldehyde adduction activity (Chan et al, 1994; Zhou and 
Decker, 1999a and b). In free radical scavenging, peptides impart their protective actions 
in lipid peroxidation by scavenging the lipid-derived (R*, RO* or ROO*) radicals through
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the donation of hydrogen thereby inhibiting the propagation cycle of lipid peroxidation. 
Some peptides are reported to exhibit higher antioxidative activities against lipid 
peroxidation in the presence of specific hydrophobic amino acids such as Gly, Leu, Phe, 
and Pro (Saiga et al, 2003).
In peptides containing histidine, the antioxidant activity is attributed to hydrogen 
donating ability, lipid peroxyradical trapping, and/or the metal ion-chelating ability of 
the imidazole group (Chan and Decker, 1994). The anti-oxidative activities of histidine- 
containing peptides exceed that of histidine itself. This trend is partly due to the 
increased hydrophobicity of the peptides, that increases the interaction between the 
peptides and fatty acids (Jun et al, 2004; Yee et al, 1980). The observed antioxidative 
activity of the peptide in this study can therefore be attributed to the presence of 
histidine hydrophobicity, which may lead to a higher interaction between the peptide and 
linoleic acid, and hydrogen donating ability and peroxy radical trapping.
The environment surrounding the imidazole group of histidine in a peptide affects the 
antioxidant activity of the individual peptides. A'-(longchain-acyl) histidine-containing 
compounds restrain the oxidation of phosphatidylcholine liposomes and methyl linoleate 
as the hydrophobicity of the compounds is important for the accessibility to the 
hydrophobic targets (Murase et al, 1993). In the lipid oxidation inhibition with Asp-Arg- 
Val-Tyr-Ile-His-Pro-Phe mediated by copper (II)/ascorbate, the N-terminal Asp-Arg- 
Val-Tyr sequence adds extensively to the reactivity of the histidine residue, which is 
converted to the 2-imidazolone derivative upon oxidation. The histidine residue in Ile-
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His-Pro-Phe shows no activity against lipid oxidation inhibition without the N-terminal 
segment (Uchida and Kawakishi, 1992). Also, a potent antioxidative peptide Ala-His- 
Lys from the egg white albumen hydrolysate, in which neither His-Lys nor a constituent 
amino acid mixture has activity, but Ala-His is as potent as the parent peptide (Tsuge et 
al, 1991. Therefore, the amino acids in the environment of the hydrophobic amino acid 
in the peptide are contributing to the overall observed antioxidant activity.
In addition to hydrophobicity, the specific positioning of amino acid residues in the 
peptide sequence plays an important role in the antioxidative activity observed. In 
residue-activity relationship studies of synthetic antioxidative peptide mimics, in linoleic 
acid peroxidation system, a loss of the antioxidative activities was observed after 
deletion of the terminal histidine residue (Chen et al, 1996; Chen et al, 1998). A peptide 
from yellow fin sole fish with 10 amino acid residues, RPDFDLEPPY contained a 
tyrosine residue, which is a potent hydrogen donor and considered to be responsible for 
the antioxidant activity (Jun et al, 2004). Another peptide, LPHSGY, from Alaska 
Pollack fish has histidine and tyrosine (Je et al, 2005). Histidine was reported to be 
responsible for the chelating and lipid radical-trapping ability due to the imidazole ring 
while the tyrosine residue was thought to be responsible for the hydrogen donating 
ability (Je et al, 2005). Besides peroxy radical scavenging, some histidine-containing 
peptides can act as a metal-ion chelator, singlet oxygen quencher and/or hydroxy radical 
scavenger (Chen et al, 1998). Similar antioxidative properties have been reported for 
carnosine, a unique histidine-containing dipeptide in which the antioxidant activity is 
attributed to the donation ability of the histidine imidazole group (Chen et al, 1998;
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Decker et al, 1992). The presence of histidine contributes to the overall antioxidant 
activity. Therefore, we can speculate that the particular size, amino acid composition and 
sequence, and hydrophobicity in the terminal positions of the peptide contributes to the 
overall observed antioxidant activity of LC1-Z peptide.
3.4. C O N C L U SIO N S
Enzymatic digestion of Atlantic mackerel protein with gastrointestinal enzymes (pepsin 
and pancreatine) and subsequent purification of hydrolysate with membrane 
ultrafiltration, gel filtration and HPLC yielded a peptide with lipid oxidation inhibition 
activity. The antioxidant activity was dose-dependent and peptide concentrations of 4 - 8 
mg/ml were comparable to 0.01 % BHT and 0.01 % trolox. These results suggest that 
antioxidant peptide fractions from Atlantic mackerel protein may have useful 
applications in the food and pharmaceutical industries when specifically targeting the 
inhibition of lipid oxidation in emulsion systems.
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CHAPTER FOUR
4 A N T IO X ID A N T  M E C H A N ISM S O F  PE PTID E  D ER IV E D  F R O M  A T L A N T IC  
M A C K E R E L  (SCOMBER SCOMBRUS) FISH  PR O TEIN .
4.1 IN T R O D U C T IO N
Oxidation of biological molecules especially lipids has been recognized as a process that 
is mediated through free radicals. This process is known to impact adversely on 
biological systems and food. In biological systems, damaging free radicals that are 
formed during the metabolism of oxygen are associated with the incidence of several 
disease conditions such as atherosclerosis, inflammation, Alzheimer’s disease and 
cancer (Frlich and Riederer, 1995). In food systems, lipid oxidation is of great concern 
because it leads to the development of undesirable off-flavours, odours and potentially 
toxic reaction products (Alghazeer and Howell, 2008).
The formation of free radicals and reactive oxygen species (ROS) in aerobic organisms 
during respiration is a process that cannot be avoided. These free radicals are very 
unstable and react rapidly with other biomolecules in the organism, leading to cell or 
tissue injury. However, in normal conditions, ROS are effectively eliminated by the 
antioxidant defense system, such as antioxidant enzymes, antioxidant compounds and 
non-enzymatic factors. On the other hand, in pathological conditions, the balance 
between the generation and the elimination of ROS is impaired and as a result, 
biomacromolecules, including DNA, membrane lipids and proteins, are damaged by
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ROS-mediated oxidative stress. Scientific evidence shows that this imbalanced oxidation 
is the trigger for the occurrence of numerous chronic diseases (Halliwell, 2001).
Lipid peroxidation in foods affects nutritive value and may cause disease conditions 
following consumption of potentially toxic reaction products (Alghazeer and Howell, 
2008). To overcome the effects of lipid peroxidation, synthetic antioxidants are widely 
used in the food industry. While these synthetic antioxidants show stronger antioxidant 
activity than that of natural antioxidants such as a-tocopherol and ascorbic acid, there is 
concern about their safety with regard to health (Yanishlieva-Maslarova, 2001). As a 
result, in the recent past, the research fields of human nutrition and biochemistry have 
focused on antioxidants sourced from food ingredients that could retard lipid 
peroxidation. Also the antioxidant properties of proteins and peptides derived from 
plant, animal and aquatic sources are documented in the literature (Mine and Shahidi, 
2006).
Since the antioxidant activity of the peptide derived from Atlantic mackerel (Scomber 
scombrus) has been established (LC1-Z), understanding of its antioxidant mechanisms 
may lead to the utilisation of the fish muscle as a source of potent natural antioxidants. 
Therefore, in this study we investigated the mechanisms of antioxidant activity of 
peptides prepared from Atlantic mackerel fish (Scomber scombrus) using 
gastrointestinal enzymes.
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4.2. M A T E R IA L S  A N D  M E TH O D S
4.2.1. Materials
Atlantic mackerel (Scomber scombrus) fillets were supplied by M & J Seafood, 
Farnham, UK and delivered in ice to the laboratory. l,l-diphenyl-2-picrylhydrazyl 
(DPPH), ascorbic acid, ferrous sulphate, a-deoxyribose, trichloroacetic acid, potassium 
ferricyanide, ferric chloride, ferrozine and trolox were obtained from Sigma-Aldrich, 
Dorset, UK. All other chemicals and solvents used were of Analytical grade and 
commercially available.
4.2.2. Methods
4.2.2.1. Isolation and purification
The peptide LC1-Z was isolated and purified as described in 3.2.2.1 to 3.2.2.3
4.2.2.2. The l,l-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging assay
The l,l-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity of the peptide 
was determined as described by Bersuder et al (1998). A volume of 500 pL of peptide 
LC1- Z (1 mg/ml) and standards BHT and ascorbic acid (0/01 %) were mixed with 500 
pL of 99.5 % ethanol and 125 pL of 0.02 % DPPH in 99.5 % ethanol. The mixture was
109
then kept at room temperature in the dark for 60 min, and the reduction of DPPH radical 
was measured at 517 nm using a UV-Visible spectrophotometer (UV Mini 1240, 
Shimadzu Europa, Milton Keynes, UK).
The DPPH radical-scavenging activity was calculated as follows:
[(Absorbance contlol -  Absorbance sam p ie ) / (  Absorbance c o n tro l) ]  \ 100%.
The control was conducted in the same manner, except that distilled water was used 
instead of peptide. A lower absorbance of the reaction mixture indicated a higher DPPH 
radical-scavenging activity. The test was carried out in triplicate.
4.2.2.3. Hydroxyl radical scavenging activity assay (HRSA)
The HRSA assay was performed as previously described by Chung et al (1997) with 
some modifications. The reaction mixture consisted of 0.1 ml of 10 mM FeS04 , 0.1 ml 
of 10 mM EDTA, 0.5 ml of 10 mM a-deoxyribose, 0.9 ml of sodium phosphate buffer 
(pH 7.4) and 0.2 ml of different concentrations of peptide (0.01, 0.05, 0.1, 0.15 and 0.2 
mg/ml) that were thoroughly mixed in a tube. Hydrogen peroxide (0.2 ml, 10 mM) was 
then added and the reaction mixture was incubated at 37 °C for 1 h. One milliliter of 2.8 
% trichloroacetic acid (TCA) and 1.0 ml of 1.0 % thiobarbituric acid (TBA) were added 
to the test tubes and boiled for 15 min. After cooling the mixture, the absorbance was 
measured at 532 nm using the spectrophotometer (UV Mini 1240, Shimadzu Europa,
1 1 0
Milton Keynes, UK). Sodium phosphate buffer (pH 7.4) instead of sample was used as 
blank. The HRSA was evaluated as the inhibition rate of a-deoxyribose oxidation by 
hydroxyl radical,
H R SA %  = (A0 - Ai)f A 0)) x 100
Where Ao was the absorbance of the blank and Ai was the absorbance in the presence of 
the test compound (LC1- Z). These values of HRSA were plotted against the 
concentration of peptide and the concentration to scavenge 50% of radical activity was 
defined as the IC50 value.
4.2.2.4. Reducing power assay
The ability of the hydrolysate to reduce iron (III) was determined according to the 
method of Yildirim et al (2001). An aliquot of 1 ml sample (LC1- Z) of each hydrolysate 
at different concentrations was mixed with 2.5 ml of 0.2 M phosphate buffer (pH 6 .6) 
and 2.5 ml of 1 % potassium ferricyanide (w/v). The mixture was incubated at 50 °C for 
30 min, followed by the addition of 2.5 ml of 10 % trichloroacetic acid (w/v). The 
mixture was then centrifuged at 1650 x g for 10 min. Finally, 2.5 ml of the supernatant 
solution were mixed with 2.5 ml of distilled water and 0.5 ml of 0.1% feme chloride 
(w/v). After 10 min reaction time, the absorbance of the resulting solution was measured 
at 700 nm using a spectrophotometer (UV Mini 1240, Shimadzu Europa, Milton Keynes,
1 1 1
UK). Increased absorbance of the reaction mixture indicates increased reducing power. 
The values are presented as the means of triplicate analyses.
4.2.2.5. Fe2+ chelating activity assay
The chelating activity of the peptide for ferrous ions Fe2+ was measured according to the 
method of Boyer and McCleary (1987) with slight modifications. To 0.5 ml of LC1- Z 
peptide (1 mg/ml), 1.6 ml of deionized water and 0.05 ml of FeCl2 (2 mM) was added. 
After 30 s, 0.1 ml ferrozine (5 mM) was added. Ferrozine reacted with the divalent iron 
to form stable magenta complex species that were very soluble in water. After 10 min at 
room temperature, the absorbance of the Fe2+-ferrozine complex was measured at 562 
nm on a spectrophotometer (UV Mini 1240, Shimadzu Europa, Milton Keynes, UK). 
The chelating activity of the peptide for Fe2+ was calculated as:
Chelating ability (% ) = ((Acontroi - A sample) / A controi)) x 100
Where ACOntroi was the absorbance of the control (without peptide) and Asampie was the 
absorbance in the presence of the LC1- Z peptide. The values are presented as the means 
of triplicate analyses.
1 1 2
3.2.3. Statistical analysis
Statistical analyses were performed with Minitab statistical software (13.1). 
Comparisons were made by one-way analysis of variance or Student’s t test as 
appropriate. P< 0.05 was considered statistically significant.
4.3. R E SU L T S AN D  D ISCU SSIO N
4.3.1. The l,l-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity
The l,l~diphenyl-2-picrylhydrazyl (DPPH) radical is a stable free radical that accepts an 
electron or hydrogen radical to become a stable diamagnetic molecule and shows 
maximum absorbance at 517 nm. When DPPH radicals encounter a proton-donating 
substrate such as an antioxidant, the radicals would be scavenged and the absorbance 
reduced. The reduction in absorbance is used as a measure of the radical-scavenging 
activity of the antioxidant under study. DPPH is often used as a substrate to evaluate 
antioxidant activity of potential antioxidants (Bersuder et al, 1998). Therefore, this 
DPPH based method was used in this study to investigate the radical scavenging activity 
of fish peptide with antioxidant activity, together with BHT and ascorbic acid as 
standards.
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The results showed that the peptide (LC1- Z) has radical scavenging activity just like 
BHT and ascorbic acid (figure 4.1). The radical scavenging activity of the peptide 
(1 mg/ml) of 5.34 % is comparable to that of the 0.01 % BHT (10.03 %) and 7 times 
more than ascorbic acid (35.2 %).
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Figure 4. 1 Radical scavenging activity of Atlantic mackerel peptide (LC1- Z) and 
standards BHT and ascorbic acid. Each value represents means ± % CV  (n=3).
During the oxidation of lipids, carbon-centered free radicals such as ROO* , RO* and R* 
are generated and peptides like antioxidants, are reported to interact with these 
compounds. Generally, the scavenging of free radicals by antioxidants is reported to be 
effected via the donation of hydrogen atoms. Amino acids histidine, leucine, methionine 
and tyrosine are known to enhance the radical-scavenging activities of antioxidant 
peptides (Park et al, 2001). Several peptides isolated from fish proteins containing these 
amino acids have been shown to exhibit radical scavenging activities (Je et al, 2005;
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Mendis et al, 2005; Rajapakse et al, 2005; Jung et al, 2007; Je et al, 2007). Histidine- 
containing peptides such as anserine, balenine and carnosine are reported to demonstrate 
high radical-scavenging activity. This activity is attributed to the proton-donation ability 
of the imidazole group of histidine (Park et al, 2001). A peptide His-Gly-Pro-Leu-Gly- 
Pro-Leu derived from gelatin prepared from hoki fish skin also displayed radical 
scavenging activity due to the presence of the N-terminal histidine as a strong proton 
donating residue in the sequence. In another study, the radical scavenging activity of 
peptides isolated from tuna fish with amino acids tyrosine and leucine exhibited radical 
scavenging activity (Je et al, 2007). The peptide isolated in this study contains the amino 
acids histidine and tyrosine and the observed radical scavenging activity may therefore 
be attributed to these amino acids.
Although the exact mechanism that underlies the scavenging of radicals by the isolated 
peptide is not well understood, the observed radical scavenging activity of the isolated 
peptide in this study can be attributed to the donation of hydrogen by amino acids such 
as histidine, leucine, methionine and tyrosine in the sequence of the peptide. As peptides 
can interact with free radicals and ROS, Figure 4.1 suggests that peptides may protect 
lipids from oxidation if they are oxidized preferentially to unsaturated fatty acids. 
Preferential oxidation of proteins and peptides can occur if available amino acids are 
more oxidatively labile than unsaturated fatty acids (Saeed et al, 2006), or if the physical 
location of a protein or peptide places it near the site of free radical or ROS generation 
where the protein or peptide would be able to rapidly scavenge the free radical prior to 
the migration of the radical to lipids (Elias et al, 2008). The isolated peptide under
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investigation is less than 2 kDa in size and is therefore stereochemically less bulky and 
will have its amino acids such as histidine, leucine, methionine and tyrosine exposed to 
exert antioxidant activities. These results agree with those of other studies in which 
peptides and hydrolysates from fish proteins (tuna, shell fish, smooth hound, Giant 
squid) hydrolysed with gastrointestinal enzymes exhibited radical scavenging activity 
(Rajapakse et al, 2005; Je et al, 2007; Bougatef et al, 2009; Jung et al, 2007).
4.3.2. The hydroxyl radical-scavenging activity
The hydroxyl radical is very reactive and can be generated in biological systems via the 
Fenton reaction. Hydroxyl radical is the most active free radical and attacks all 
biological molecules by setting off a free radical chain reaction, resulting in cell damage 
and hence human diseases (Halliwell, 2000). It interacts easily with biomolecules such 
as amino acids, proteins and DNA (Cacciuttolo et al, 1993). For this reason, its removal 
can perhaps be one of the most effective defenses of a living body against various 
diseases.
In the HRSA assay, the Fenton reactions proceed as Iron(II) (ferrous) is oxidized by 
hydrogen peroxide to iron(III) (ferric), a hydroxyl radical and a hydroxyl anion. Iron 
(III) is then reduced back to iron (II), a peroxide radical and a proton by the same 
hydrogen peroxide
(1) Fe2+ + H20 2 -> Fe3+ + OH- + OH“
(2) Fe3+ + H20 2 -> Fe2+ + OOH- + H+
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The resultant radical interacts with the antioxidant through a radical quenching 
mechanism and this is monitored spectrophotometrically. In this study, the peptide 
showed hydroxyl radical scavenging activity. As the concentration of a scavenging 
molecule is proportional to the radical scavenging activity, different concentrations of 
the peptide (LC1-Z) showed an increased scavenging activity (figure 4.2). The observed 
scavenging activity was linear with respect to peptide concentration and expressed 
through a linear relationship, y = 31.605x -  0.5408 (R2 = 0.9279) and accordingly an 
IC50 value of 1.60 mg/ml was obtained. The obtained results suggest that the peptide 
contains amino acids which are hydroxyl radical scavengers and could react with free 
radicals to convert them to more stable products and terminate the radical chain reaction.
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Figure 4.2. Hydroxyl radical scavenging activity (HRSA) of Atlantic mackerel 
peptide (LC1-Z). Each value represents means ± % CV (n=3).
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The potential scavenging abilities of phenolic substances is reported to be due to the 
active hydrogen donating ability through hydroxyl substitution. Also, high molecular 
weight and the proximity of many aromatic rings and hydroxyl groups are more 
important for the free radical scavenging by specific functional groups (Korycka-Dahl 
and Richardson, 1978). Similarly, it has been reported that amino acids cysteine, 
histidine and methionine are central to the hydroxyl radical scavenging activity of 
peptides. This activity is due to their characteristic special structure. In histidine, the 
imidazole group has the proton-donation ability (Tsuge et al, 1991). In methionine, the 
methionine sulfoxide is susceptible to oxidation and cysteine can donate the sulfur 
hydrogen (Hernandez-Ledesma et al, 2005). Tyrosine and phenyalanine have been 
shown to act positively as direct radical scavengers (Rajapalcse et al, 2005). The 
antioxidant activity of tyrosine is explained by the unique ability of its phenolic group to 
serve as a hydrogen donor, which is one mechanism of inhibiting radical-mediated 
oxidation chain reactions (Jung et al, 1995).
It therefore follows that the observed hydroxyl radical scavenging activity of the peptide 
is attributed to the characteristic amino acids such as histdine, tyrosine and phenyalanine 
present in the peptide. This observation concurs with similar studies that show that 
peptides containing such amino acids exhibit hydroxyl radical scavenging activity as 
seen in yellowfin sole (Jun et al, 2004), Alaska pollack (Je et al, 2005, giant squid 
(Rajapakse et al, 2005), chum salmon (Nagai et al, 2006), jumbo flying squid (Lin and 
Li 2006), shell fish (Jung et al, 2007), yellow stripe trevally (Klompong et al, 2007),
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walleye pollack (Nagai et al, 2007), tuna (Je et al, 2007), round scad (Thiansilakull et 
al, 2007) and grass carp (Ren et al, 2008).
4.3.3. The reducing power activity
Antioxidants can be explained as reductants, and inactivation of oxidants by reductants 
can be described as redox reactions in which one reaction species (oxidant) is reduced at 
the expense of the oxidation of another antioxidant. Therefore, the reducing power assay 
is often used to evaluate the ability of antioxidant to donate an electron. This assay 
measures the antioxidant effect of any substance in the reaction medium as reducing 
ability. Different studies have reported that there is a direct correlation between 
antioxidative activities and reducing power of certain bioactive compounds (Yildirim et 
al, 2000).
In this study, the ability of peptide (LC1-Z) to reduce Fe3+/ferrieyanide complex to the 
ferrous form was determined. Figure 4.3 shows that the reducing power of peptide 
increased with increasing concentrations (0 -  25 mg/ml) and the peptide exhibited 
reducing ability and was expressed linearly as y = 0.030lx + 0.0322 (R2 = 0.9943).
These results suggest the presence of amino acids in the peptide which functioned as 
electron donors and which may react with free radicals to form more stable products. 
These results concur with several studies in which fish derived peptides and protein 
hydrolysates isolated from Mackerel (Wu et al, 2003), Yellow stripe trevally (Klompong
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et al, 2007) and Round scad (Thiansilakul 1 et al, 2007) exhibited reducing power 
activity in a linear relationship.
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Figure 4.3. Reducing power of peptide ((LC1-Z)) isolated from Atlantic mackerel 
peptide. Each value represents means ± % CV (n=3).
4.3.4. Fe2+ chelating activity assay
Transition metal ions, such as Fe2+/3+, Cu2+, Co2+, in biological systems affect both the 
rate of autoxidation and breakdown of hydroperoxide to volatile compounds. Transition 
metal ions react very quickly with peroxides by acting as one-electron donors to form 
alkoxyl radicals (Gordon, 2001) as shown in the scheme below.
1 2 0
Metal'l+ + Lipid-OOH -* Metalf',+/;+ + OH“ + Lipid -  0<
Therefore, chelation of transition metal ions by antioxidant peptides would retard this 
oxidation reaction.
In this method used to determine the chelating activity of the peptide, the ferrozine 
makes complexes with ferrous ions. In the presence of chelating agents (peptide), the 
complex (red coloured) formation is interrupted and, as a result, the red colour of the 
complex is decreased. As a consequence, the chelating effect of the coexisting chelator 
can be determined by measuring the rate of colour reduction.
The isolated peptide demonstrated appreciable iron chelating activity of 5.72 % and was 
comparable to the potent antioxidants trolox (11.11 %) and ascorbic acid (12.67 %) as 
shown in figure 4.4. Similarly, peptides and hydrolysates with chelating activity have 
been reported from fish proteins from yellow stripe trevally (Klompong et al, 2007), 
round scad (Thiansilakull et al, 2007) and sole (Gimenze et al, 2009).
1 2 1
LC1-Z Trolox Ascorbic Acid
Figure 4.4. Ferrous ion chelating activity of Atlantic mackerel peptide 1 mg/ml 
(LC1-Z) and 0.01 % of standards trolox and ascorbic acid. Each value represents 
means ± % CV (n=3).
It has been reported that peptide chelators can inhibit lipid oxidation by changing the 
physical location of transition metals (e.g. partitioning metals away from oxidatively 
labile lipids or hydroperoxides), forming insoluble metal complexes, reducing the 
chemical reactivity of transition metals, and/or sterically hindering the interaction of 
metals and dispersed lipids (Diaz et al, 2003; Diaz and Decker, 2005).
Amino acids and peptides are typical metal chelating agents (Fujimoto et al, 1984). 
Chen et al (1995) has reported that the characteristic amino acid sequence of peptides is 
important for metal chelating activity of peptides. The antioxidant activity observed in
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histidine-containing peptides is thought to be related to their metal chelating ability, 
besides the lipid-radical trapping potential of the imidazole ring (Uchida and Kawakishi, 
1992; Murase et al, 1993). In carnosine and anserine (histidine-containing dipeptides), it 
has been shown that histidine is involved in metal chelation in addition to free radical 
scavenging and singlet oxygen activities it exhibits (Egorov et al, 1992). Therefore, the 
observed chelating activity of the peptide (LC1-Z) may be a result of the presence of the 
amino acid histidine in the peptide. Chelation of prooxidants such as iron and copper by 
the histidine containing peptide in biological systems will consequently lead to 
decreased lipid oxidation in biological and food systems.
Peptides, in general, can reduce lipid peroxidation through biologically designed 
mechanisms (e.g. iron-binding peptides) or by nonspecific mechanisms. Both of these 
types of peptides contribute to the endogenous antioxidant capacity of foods and could 
also be used as potential antioxidant additives. Overall, the antioxidant activity of 
peptides is due to complex interactions between their ability to inactivate reactive 
oxygen species, scavenge free radicals, chelate pro-oxidative transition metals, reduce 
hydroperoxides and alter the physical properties of food systems in a way that separates 
reactive species. Peptides therefore are somewhat distinctive in this way, compared to 
other food antioxidants as they can potentially act as multifunctional antioxidants that 
can inhibit several different lipid oxidation pathways (Elias et al, 2008).
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4.4. CONCLUSIONS
The results of the present study show that the peptide (LC1-Z) containing amino acids 
serine, histidine, tyrosine, phenylalanine and lysine, isolated from Atlantic mackerel 
exhibits the antioxidant activity through the scavenging of free radicals such as carbon 
centered radicals and hydroxyl radicals, reducing power activity and chelating activity; 
and the presence of amino acids such as histidine, tyrosine and phenylalanine is highly 
possible. Overall, the peptide is a potential natural antioxidant that can be important in 
food preservation, disease prevention and health preservation.
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CHAPTER FIVE
5. ANTIOXIDANT ACTIVITY OF PEPTIDES ISOLATED FROM ATLANTIC 
MACKEREL (SCOMBER SCOMBRUS) FISH PROTEIN IN CACO-2 AND Eh.Hy 
926 CELLS, AND ABSORPTION OF PEPTIDE IN A CACO-2 MONOLAYER 
MODEL
5.1. INTRODUCTION
In normal physiological conditions, cellular systems are constantly challenged by stress 
arising from both internal and external sources. In aerobic organisms, the potential 
sources of cell stress (oxidative stress) are the reduced derivatives of oxygen, also 
referred to as reactive oxygen species (ROS). ROS are produced in living cells as a 
result of normal cell metabolism, xenobiotic detoxication, UV- and X-ray irradiation. 
The effects of oxidative stress in mammalian cells range from rapid cell mortality to 
disturbance of many cell signaling processes (Klotz et al, 2003). As a result, ROS are 
implicated in the pathogenesis of many diseases that include cardiovascular diseases, 
certain cancers, rheumatoid arthritis, diabetes, Alzheimer’s disease, neurological 
disorders and the ageing process. On the other hand, aerobic organisms possess a 
protective system that limits their exposure to ROS. These protective components, also 
referred to as antioxidant defense system, include an array of enzymes and essential 
nutrients whose role is to prevent the generation of ROS and/or intercept the generation 
of ROS. Despite the presence of the anti oxidant defence system, the prooxidant- 
antioxidant balance favours the ROS and consequently creates oxidative stress with 
potential cell damage and onset of chronic diseases (Morrissey and O’Brien, 1998).
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The human colon carcinoma cell line (Caco-2) spontaneously exhibits structural and 
functional characteristics of mature small bowel enterocytes under standard culture 
conditions. Normal intestinal cell turnover can be disrupted by lipid hydroperoxides and 
this underscores the tumorigenic potential of oxidized lipids. Peroxidized lipids, as 
dietary oxidants, can initiate intestinal degenerative processes via generation of oxygen 
radicals (Parks et al, 1983). Subtoxic low levels of lipid hydroperoxide (1-5 pM) induce 
phase transition of intestinal cells from a quiescent to a proliferative state that is 
mediated by peroxide-induced disruption of cellular redox balance (Wang et al, 2002). 
Also, oxidized lipids have been shown to have a cytotoxic effect on caco-2 cells 
(Alghazeer et al, 2008). At lipid hydroperoxide concentrations that were a 100-fold 
higher than those that elicited proliferative responses (0.1 -  0.2 mM), caco-2 cells were 
significantly injured (Wang et al, 2002). The organic hydroperoxide, (e/t-butyl 
hydroperoxide (r-BHP), is a useful model compound to study mechanisms of oxidative 
cell injury. Exposure of mammalian cells to the membrane-permeable organic peroxide 
r-BHP induces an array of toxic events, such as depletion of reduced glutathione (GSH) 
and protein thiols, peroxidation of membrane lipids, DNA strand breakage, significant 
cellular ATP depletion, an alteration in intracellular calcium homeostasis and Ca2+‘ 
signalling and a loss of mitochondrial membrane potential. As a result of these events, 
cell necrosis is necessitated (Lapshina et al, 2005).
In addition, the caco-2 cell monolayer model has been used to study intestinal transport 
system. The model is widely used in intestinal transport studies of drugs and food
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compounds (Augustijns et al, 1998; Boisset et al, 2000; Rubio and Seiquer, 2002). This 
confluent caco-2 cell monolayer, has characteristics that closely resemble intestinal 
epithelial cells and displays several properties typical of differentiated intestinal 
epithelial cells (Wilson et al, 1990). Caco-2 cell monolayers are thought to be tighter 
than mammalian intestinal tissues (Boisset et al, 2000) and the brash border membrane- 
associated enzyme activities are generally thought to be lower (Bolte et al, 1998). Small 
peptides (primarily di- and tripeptides) and amino acids are both absorbed through 
various systems that include the energy-dependent transport linked with the co-transport 
of Na+ (Webb, 1990), specific peptide transport system PepTl (Yang et al, 1999) 
paracellular, passive diffusion, endocytosis and earlier mediated transport (Gardner, 
1998).
The human endothelial-like immortalised cell line Ea.hy926, derived from the fusion of 
HUVEC (human umbilical vein endothelia cells) with the lung carcinoma cell line 
A549, is a human endothelial cell line that shows characteristics of differentiated 
endothelial cells (Edgell et al, 1983). Endothelial cells (EC) express constitutively the 
NADPH oxidase enzyme system, which by generating reactive oxygen species (ROS) 
such as 02*’ and H20 2, are involved in the regulation of cellular redox-signalling. 
NADPH oxidase activation and increased ROS production are implicated in Angiotensin
II-dependent hypertension and the associated endothelial dysfunction (Wang et al,
2001).
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This study aims to investigate the antioxidant behavior of peptides in caco-2 cells 
exposed to proxidant t-BHP, scavenging of ROS in Ea.hy 926 exposed to angiotensin II, 
and absorption of peptides in a caco-2 cell monolayer.
5.2. MATERIALS AND METHODS
5.2.1. Materials
Human colorectal carcinoma (caco-2) cells lines were obtained from the European 
Collection of Cell Cultures (ECACC). The human endothelial-like immortalised cell line 
Ea.hy926 was a donation from the nutrition group, FHMS, University of Surrey, UK. 
Phosphate buffered saline (PBS) was obtained from Oxoid (Hampshire, UK); foetal 
bovine serum (FBS), trypsin EDTA solution, non-essential amino acids, Dulbecco’s 
Modified Eagle Media (DMEM), Hanks buffer saline solution (HBSS), glutamine, 
penicillin/streptomycin and non essential amino acids (NEAA) were obtained from 
Invitrogen (Paisley, UK). Tert-butyl hydroperoxide (tBHP), 2-Amino-7-dimethylamino- 
3-methylphenazine hydrochloride (MTT) dye, dimethyl sulphoxide (DMSO) were 
obtained from Sigma-Aldrich (Poole, UK). Caspase 3/7 reagent was obtained from 
Promega, Southampton, UK.
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5.2.2. Methods
The peptide (LC1-Z) was isolated as described in section 3.2
5.2.2.2. Antioxidant activity of peptide in caco-2 cells
5.2.2.2.I. Cell viability of caco-2 cells treated with peptide.
Caco-2 cells were cultured in Dulbecco’s Modified Eagle Media (DMEM) 
supplemented with 20 % heat-inactivated feotal bovine serum (FBS), 5 % glutamine, 5 
% penicillin/streptomycin and 5 % NEAA. The cells were grown in a 25-cm2 tissue- 
culture flask (Corning Co., Cambridge, MA) at concentrations 1 x 106 cells/mL and sub 
cultured every 48 hours, at 37 °C in 5 % C 02/95 % air in a humidified incubator. Cells 
were harvested from the tissue-culture flask by trypsinization (1ml trypsin/EDTA) after 
a 5 ml PBS wash, counted and seeded in a 96-well plate at 2 x 104 cells/well. After 24 
hours, 1.0 mg/ml peptide in DMEM without FBS was added to the wells. Plates were 
incubated for 24 hours at 37 °C in 5 % C 02/95 % air. Following removal of media from 
wells, cells were washed with PBS. MTT (5 pL of 10 mg/mL PBS) was added to each 
well. Following an additional 4 h of incubation at 37 °C, dimethyl sulfoxide (DMSO) 
reagent (150 pL) was added to dissolve the formazan crystals. The plates were shaken at
5.2.2.1 Isolation and purification of peptide
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37 °C for 20 min and the absorbance was read at 492 nm using a plate reader (Behring 
Co., Marburg, Germany). Standards of trolox, BHT and EGCG were also treated in the 
same way.
5.2.2.2.2. Treatment of caco-2 cells with peptides and tert-butyl hydroperoxide 
(tBHP).
From the cell suspension, caco-2 cells were counted, and seeded in a 96-well plate at 2 x 
104 cells/well. After 24 hours, 1.0 mg/ml peptide in DMEM without FBS was added to 
the wells. Plates were incubated for 24 hours at 37 °C in 5 % C 02/95 % air. Following 
removal of media from wells, cells were washed with PBS and then subjected to oxidant 
stress by incubation with 200 pL of 2.5 mM Ze/t-butyl hydroperoxide (f-BHP) for 150 
min.
To determine the effect of antioxidative peptides on Z-BHP-induced injury, MTT assay 
of cell viability was carried out as described by Sladowski et al. (1993). After 150 min 
of incubation with Z-BHP, cells in 96-well plates were rinsed with PBS. MTT (5 pL of 
10 mg/mL PBS) was added to each well. Following an additional 4 h of incubation at 37 
°C, dimethyl sulfoxide (DMSO) reagent (150 pL) was added to dissolve the formazan 
crystals. The plates were shaken at 37 °C for 20 min and the absorbance was read at 492 
nm using a plate reader (Boehring Co., Marburg, Germany). A control (without tBHP) 
and a standard with trolox were also treated in the same way.
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5.2.2.2.3. TBARS formation in caco-2 cells
The formation of TBARS (level of lipid peroxidation) in control and treated cell samples 
was measured according to the method of Ohkawa et al. (1979) with slight 
modifications. A caco-2 cell suspension was prepared as in 5.2.2.1.1 and seeded at 1 x 
106 cells in 25 cm2 cell culture flasks. After reaching confluence (80%), the mono-layer 
of caco-2 cells were treated with peptide (1 mg/ml) for 24 h. After incubation, DMEM 
was removed and cells were washed twice with PBS and then treated with 2.5 mM tBHT 
for 2.5 hours. After washing with PBS, the cells were scraped and lysed with 20 % 
trichloroacetic acid (TCA). Then, 2 ml of 0.7 % TBA were added and sample heated at 
100 °C for 1 hour. After cooling, the solutions were centrifuged at 1500 x g for 10 min. 
The absorbance of the pink supernatant was measured at 532 nm using a 
spectrophotometer (UV Mini 1240, Shimadzu Europa, Milton Keynes, UK). 
Malondialdehyde (MDA) concentration was calculated using 1,1,3,3- 
tetramethoxypropane as standard and was expressed as pmol of MDA.
5.2.2.4. The Caspase-Glo 3/7 Assay
Caco-2 cells were prepared according to section 5.2.2.2.I. After seeding in a 96 well 
plate with a white background, the cells were treated with 1 mg/ml peptide for 24 hours 
followed by 2 hours of tBHP. To the 100 pi tBHP treated cells in each well, 100 pi
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caspase 3/7 reagent was added and incubated for 30 minutes. Luminescence was 
measured using a luminometer (GloMax® 96 Luminometer, Promega, USA).
5.2.2.5. Morphological changes in caco-2 treated with peptide
A caco-2 cell suspension was prepared as in 5.2.2.1.1 and seeded at 1 x 106 cells in 25 
cm cell culture flasks. After reaching confluence (80%), the mono-layer of caco-2 cells 
were treated with peptide (1 mg/ml) for 24 h. After incubation, DMEM was removed 
and cells were washed twice with PBS and then treated with 2.5 mM tBHP for 2.5 hours. 
The cells were investigated for changes in morphology with a phase contrast microscope 
(Zeiss Telaval inverted microscopy) fitted with a camera (Nikon, Japan).
5.2.2.6. Reactive oxygen species (ROS) scavenging in Ea.hy926 cells treated with 
peptides
5.2.2.6.I. Cell culture preparation and cell viability of Ea.hy 926 ceils treated with 
peptides
Ea.hy 926 cells were cultured in glutamax Dulbecco’s Modified Eagle Media (Glu- 
DMEM) supplemented with 10 % heat-inactivated foetal bovine serum (FBS), 5 % 
glutamine, 5 % penicillin/streptomycin and 5 % NEAA. The cells were grown in a 25- 
cm2 tissue-culture flask (Corning Co, Cambridge, MA) at concentrations 1 x 106 
cells/mL and subcultured every 48 hours, at 37 °C in 5 % C 02/95 % air in a humidified
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incubator. Cells were harvested from tissue-culture flask by trypsinization (1ml 
trypsin/EDTA) after a 5 ml HBSS wash, counted, and seeded in 96-well flat bottomed 
plates at different cell concentrations (1 x 104 to 5 x 104 cells/well). After 24 hours, 1.0 
mg/ml peptide in Glu-DMEM without FBS was added to the wells. Plates were 
incubated for 17 h at 37 °C in 5% C 02/ 95 % air in a humidified incubator. Following 
removal of media from the wells, cells were washed with HBSS. The MTT assay of cell 
viability was earned out as described by Sladowski et al (1993). After 17 hours, 5 p.L 
MTT (10 mg/mL in PBS) was added to each well for 4 hours. The cells were washed 
with HBSS and 150 pL dimethyl sulfoxide (DMSO) reagent was added to dissolve the 
formazan crystals. The plates were shaken at and the absorbance was read at 492 nm 
using a plate reader (Behring Co, Marburg, Germany).
5.2.2.6.2. Lucigenin-enhanced chemiluminescent measurement of ROS
Specific superoxide (02*~) production was assessed by lucigenin chemiluminescence 
assay as described previously by Li et al (1998) with some modifications. Ea.hy 926 
cells where cultured in 25 cm2 tissue flask until confluent. The cells were treated with 
peptide (1 mg/ml) in FBS free media with and without 100 nM angiotensin II for 1 h, 
washed twice with HBSS and detached using trypsin. The cells were resuspended in 
FBS free medium followed by sonication. The cells were redistributed at 5 x 104 in 96 
well plates with a white background, and immediately 200 pM lucigenin added. Light
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emission was read using the luminometer (GloMax® 96 Luminometer, Promega) and 
expressed as chemiluminscence arbitrary light units.
S.2.2.6.3. ROS measurement by fluorescence method with dihydroethidium (DHE)
Ea.hy 926 cells were cultured in 25 cm2 tissue flask until confluent. FBS free DMEM 
was added to the flask a day before the treatments. Cells were then treated with peptide 
(1 mg/ml) in FBS free DMEM, and with and without lOOnM angiotensin II for 1 h. The 
cells were washed with HBSS, and 25 pM 2-hydroxyethidium was added and the cells 
were incubated for 20 min. The cells were then washed with HBSS and again incubated 
with HBSS for 1 h. The cells were then scraped with 500 pi cold methanol, 
homogenized and filtered on a 0.22 pm membrane filter. Ethidium and 2- 
hydroxyethidium (DHE) were detected with a fluorescence detector using an emission 
wavelength of 580 nm and an excitation of 480 nm using a fluorimeter (Varian, USA).
5.2.2.7. Peptide transport in a caco-2 monolayer model
5.2.2.7.1. Caco-2 monolayer preparation
Caco-2 cells were cultured in Dulbecco’s Modified Eagle Media (DMEM) 
supplemented with 20 % heat-inactivated foetal bovine serum (FBS), 5 % glutamine, 5 
% penicillin/streptomycin and 5 % NEAA. The cells were grown in a 25-cm2 tissue- 
culture flask (Corning Co., Cambridge, MA) at a concentration 1 x 106 cells/mL and
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subcultured every 48 h, at 37 °C in 5 % C 02/95 % air in a humidified incubator. Cells 
were harvested from the tissue-culture flask by trypsinization (lml trypsin/EDTA) after 
a 5 ml PBS wash. The suspended cells were seeded onto 0.3 pm pore, 1.2 cm diameter 
polycarbonate cell culture inserts with filters (Transwell, Costar) at l.OxlO6 cells/cm2 in
12-well plates. The cells on inserts were maintained in a humidified atmosphere of 5% 
C02-95% air at 37 °C and DMEM was changed every two days after seeding. Cell 
confluence was monitored by transepithelial electrical resistance (TEER) measurements 
using a TEER EVOM meter (World Precision Instrument, USA). The TEER value is an 
indication of the integrity of the alveolar epithelial cell monolayers. The cells became 
completely confluent on day 5 of cultivation and were used for transport experiments on 
day 7 with TEER values greaer than 200 O.
5.2.2.7.2. Peptide transport in caeo-2 monolayer model
Transport experiments were carried out using PBS as the transport medium. The cell 
monolayers were washed twice with PBS and the apical (A) and basolateral (B) 
compartments of the filter cups were filled with 0.75 ml of transport medium. The cells 
were equilibrated in a 5 % C 02/95 % air atmosphere at 37 °C for 1 h. Stock solutions of 
the peptide (1 mg/ml) were placed in either apical or basolateral reservoir and allowed to 
stand in a humidified atmosphere of 5 % C 02/95 % air at 37 °C for 180 min. The TEER 
across each monolayer was measured at the beginning and after 180 min.
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The apparent permeability coefficient (Papp, cm/s) for peptide was calculated using the 
following equation.
Papp = Vr x (dC/dZ) x (1/ACo)
Where Vr is the volume of the receiver chamber, dC/dz is the solute transfer rate, A is the 
surface area of the membrane (1.2 cm2; the normal surface area of the Trans well filter), 
and Co is the initial concentration of solute (peptide).
5.2.2.7.3. HPLC of absorbed peptide in caco-2 monolayer model
From both the apical and basal side of insert from each well, 300 pL was collected at 
180 min and put in vials. Each sample was then run on a reversed-phase high- 
performance liquid chromatograph (RP-HPLC) on a Phenomenex C18 (3.0 mm x 250 
mm) column with a linear gradient of acetonitrile (0-70 % in 50 min) containing 0.1 % 
trifiuoroacetic acid (TFA) and milliQ water containing 0.1 % TFA at a flow rate of 1 
inL/min. RP-HPLC analysis was performed on the HPLC system comprising a pump 
(Thermoseparation Products), autosampler (Spectra Physics AS 1000), detector 
(Thermoseparation Products UV6000LP) and integration software (Chromquest, 2004).
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5.2.3. Statistical analysis
Statistical analyses were performed with Minitab statistical software (13.1). 
Comparisons were made by one-way analysis of variance or Student’s t test where 
appropriate. P< 0.05 was considered statistically significant.
5.3. RESULTS AND DISCUSSION
5.3.1. Antioxidant activity of peptide in caco-2 cells
5.3.1.1 Cell viability of caco-2 cells treated with peptide
The MTT [3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolioum bromide] cell 
proliferation and viability assay is a safe, sensitive, in vitro assay for the measurement of 
cell proliferation or, when metabolic events lead to apoptosis or necrosis, a reduction in 
cell viability. Since proliferating cells are metabolically more active than non­
proliferating (resting) cells, the assay is suitable not only for the determination of cell 
viability and factor mediated cytotoxicity but also for the determination of cell activation 
and proliferation (Sladowski et al, 1993).
The principle of this assay is that the tetrazolium salt MTT is cleaved to formazan by the 
succinate-tetrazolium reductase which belongs to the mitochondrial respiratory chain
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and is active only in viable cells. MTT is reduced by metabolically active cells to 
insoluble purple formazan dye crystals which are solubilized and read 
spectrophometrically. The rate of tetrazolium reduction is proportional to the rate of cell 
proliferation. In this study, the proliferative status of caco-2 cells was assessed by the 
metabolic activity of viable cells using the MTT assay.
Figure 5.1 shows the viability of caco-2 cells treated with the peptide and standards. 
Caco-2 cells were prepared and treated with 1.0 mg/ml and 0.01 % of trolox, BHT and 
epigallocatechin gallate (EGCG). Cell viability is expressed as the percentage of the 
proliferating cells in respective treatments based on the control and values expressed as 
the mean ± % CV. At these concentrations, there was no difference observed between 
the control (100 %), peptide (96.6 %) and trolox (95.7 %) in the cell viabilities of the 
caco-2 cells (p<0.10). However, a significant difference (p<0.0004). was observed with 
BHT (81.9 %) and EGCG (80.4 %) where a marked reduction in the cell viability was 
observed in those treated with BHT and EGCG compared to those treated with trolox. 
This demonstrates that the peptide in this concentration range and under the study 
conditions are not toxic to caco-2 cells, and neither do they have a proxidant activity on 
caco-2 cells. Some phenolic based antioxidants are reported to have proxidant activity in 
higher concentrations and in these experiments BHT and EGCG may have had proxidant 
activity judging by the reduced cell viability (Alghazeer et al, 2008). Due to the 
observed effects of 1.0 mg/ml of peptide and 0.01 % trolox, these concentrations were 
chosen for antioxidant activity studies of the peptide in caco-2 cells.
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Figure 5.1. Cell viability of caco-2 cells treated with peptide (1.0 mg/ml) and 0.01% 
of trolox, BHT and EGCG. Each value represents means ± % CV (n=3).
5.3.I.2. Antioxidant activity in caco-2 cells treated with tert-butyl hydroperoxide 
(tBHP)
Peroxides including tBHP are known to have cytotoxic effects on several types of 
mammalian cells after penetration (Makino et al, 1995). With tBHP, the proposed 
mechanisms of induced toxicity include decomposition of organic peroxide by heme- 
containing proteins, membrane alterations, lipid-peroxidation, GSH depletion, and 
damages to cell proteins (protein-bound carbonyl formation and protein thiol oxidation), 
as well as arachidonic acid cascade mobilization and DNA damage (Lapshina et al, 
2005). In this study, tBHP induced cytotoxic effects in caco-2 cells are seen from the
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reduced cell viability (Figure 5.2). When caco-2 cells were treated with different 
concentrations of 0.5, 1.0, 5.0 and 10 mM tBHP, there was a marked reduced viability of 
88.64, 78.18, 60.34 and 52.50% respectively (Figure 5.2). There was a significant 
difference (p<0.0001) in the caco-2 cells viability when treated with the different tBHP 
concentrations in a dose dependent manner (y = -28.39 + 79.32, R2 = 0.9973). Therefore, 
2.0 pM tBHP concentration was required to effect 30% reduction in cell viability and 
this concentration was used in preceding experiments on antioxidant activity of the 
peptides.
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Figure 5.2. Proliferation of caco-2 cells incubated with t-BHP for 150 min at 
different concentrations. Each value represents means ± % CV (n=6).
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In experiments to see the effect of peptides on caco-2 cells in the presence of an oxidant 
(tBHP), caco-2 cells were prepared and incubated with 1.0 mg/ml of peptide for 24 h 
and then with 2.5 mM tBHP for 2.5 h. In cells treated with tBHP alone, the cell viability 
reduced significantly (79.3 %) but in the presence of the peptide and/or trolox no 
significant reduction was observed (94.7 % and 90.2 % respectively) (Figure 5.3). It is 
clear that the peptide provided some protective effects against the proxidant effects of 
tBHP and consequently the viability of the caco-2 cells. This shows that when cells are 
exposed to oxidants such as tBHP, cell death is induced, but in the presence of the 
peptide the cytotoxic effect of tBHP is reduced, due to the antioxidant behavior of the 
peptides. The cytotoxic effects of tBHP occur through the generated hydroperoxide 
radical. In the presence of the peptide, the radical is believed to be scavenged and hence 
its ability to oxidize cell components and membrane lipids is avoided. In this way the 
integrity of the cell is maintained and cells proliferate normally. Since peptides are 
absorbed across caco-2 cell membranes (Lapshina et al, 2005; Shimizu et al. 1997; 
Makino et al, 1995), and from our own studies (section 5.3.3), the antioxidant protection 
can be presumed to occur both inside and outside the cell, thus offering protection to cell 
constituents such as DNA and at the surface of the cell membrane. These results concur 
with those observed with peptides isolated from Alaska pollack (Kim et al, 2001), hold 
fish (Kim et al, 2007), and giant squid (Rajapakse et al, 2005).
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5.3.1.3. TBARS formation in caco-2 cells
In vivo studies of tBHP show that it is a membrane permeable oxidant and can be easily 
metabolized into free radical intermediates forming ROO* and RO* that initiates 
oxidation of membrane lipids and consequently forms TBARS (Barr and Mason, 1995). 
From figure 5.4, it can be seen that more TBARS (p<0.05) were formed in cells treated 
with tBHP (38.18 pg/ml) than in those treated with the peptide (33.18 pg/ml). As tBHP 
forms covalent bonds with cellular molecules and consequently oxidise membrane 
lipids, the cell integrity is compromised resulting in t-BHP-induced toxicity and cell 
death. Therefore the protective effect of the peptide from proxidant tBHP is presumed to 
be due to its ability to scavenge lipid-derived radicals that would otherwise oxidize 
PUFAs in cell membranes. This effect is considered to be similar to the action of a 
common lipid soluble antioxidant vitamin E to inhibit radical-mediated membrane lipid 
oxidation in human umbilical vein endothelial cells (HUVEC) (Shimpuku et al, 2000). 
On the other hand, Rajapakse et al (2005) attributed the antioxidant activity of a peptide 
derived from giant squid in human embryonic lung fibroblast to its size. The research 
showed that a lower molecular weight improves contact ability with membrane lipids 
and/or permeability. The peptide isolate in this study was fractionated on a less than 2 
kDa MWCO membrane and therefore fits with the theory that the observed antioxidant 
activity in caco-2 cells is an element of its size.
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Figure 5.3. Cell viability of caco-2 cells treated with 1 mg/ml peptide (LC1-Z) and 
0.01 % trolox, with/without tBHP (2.5mM). Each value represents means ± % CV 
(n=3).
Figure 5.4. TBARS as Malondialdehyde formed in caco-2 cells incubated with 
lmg/ml peptide (LC1-Z) and with/without tBHP.
5.3.I.4. Caspase activity in caco-2 cells treated with tBHP
Necrosis and apoptosis are two types of cell death distinguished in mammalian cells. 
Necrosis is characterized by cell swelling and disruption of cell membrane leading to the 
release of cellular components and consequently into an inflammatory response and 
reduction of intracellular glutathione content (Girottti, 2001; Saiato et al, 2005). 
Apoptosis is the process of programmed cell death that may occur in multicellular 
organisms and involves a series of biochemical events that lead to a variety of 
morphological changes, including blebbing, changes to the cell, cell shrinkage, nuclear 
fragmentation, chromatin condensation, and chromosomal DNA fragmentation. 
Apoptosis is triggered by a variety of stimuli, including cell surface receptors, 
mitochondrial response to stress, and cytotoxic T cells. Caspases are a class of cysteine 
proteases that includes several representatives involved in apoptosis. The caspases 
convey the apoptotic signal in a proteolytic cascade, with caspases cleaving and 
activating other caspases that then degrade other cellular targets that lead to cell death. 
The caspases at the upper end of the cascade include caspase-8 and caspase-9. Caspase- 
3, -6 and-7 are downstream caspases that are activated by the upstream proteases and act 
themselves to cleave cellular targets (Muzio, 1998). This caspase family plays a key 
effector role in apoptosis in mammalian cells (Garcio-Calvo et al 1999; Mooney, et al,
2002).
In this study, the Caspase-Glo 3/7 Assay, a homogeneous, luminescent assay that 
measures caspase 3 and 7 activities was used to measure apoptosis. The assay provides a
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luminogenic caspase-3/7 substrate, which contains the tetrapeptide sequence DEVD, in a 
reagent optimized for caspase activity, luciferase activity, and cell lysis. Adding a single 
Caspase-Glo 3/7 Reagent in an add-mix-measure format results in cell generation of a 
glow-type luminescent signal, produced by luciferase. The measured luminescence is 
proportional to the amount of caspase activity present.
Therefore, to verify apoptosis associated with caspase 3 and 7, we determined the 
activity in caco-2 cells. Table 5.1 shows that caspases 3 and 7 activity was 6 times more 
in the cells treated with tBHP only (157.5 + 7.99 %) compared to those treated with the 
peptide (25.7 ± 3.92 %). Wang et al (2000) have reported that redox perturbation, 
induced by subtoxic levels of lipid hydroperoxide, leads to activation of caspase 3, 
oxidative DNA damage, and enhanced apoptosis. Therefore, in this study, the observed 
caspase activity is as a result of peroxide tBHP induced apoptosis and is linked to DNA 
damage. As tBHP is membrane permeable, it is prone to attack by cellular* components 
that include DNA. DNA damage, and in particular apoptosis, was impaired by the 
peptide as can be seen by the caspases 3 and 7 activity observed in the cells treated with 
the peptide. Similar results are reported with polyphenol extracts and it is believed that 
phenolic substances with antioxidant activity have a protective effects from oxidants 
against DNA damage induced by H2O2 (Giovannelli et al, 2000). However, the 
mechanism of DNA protection is not clear (Wang et al, 2000).
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Table 5.1 Caspase activity in caco-2 cells treated with peptide (LC1-Z) in the 
presence of tBHP. Each value represents means ± % CV (n=3).
Treatment Caspase 3/7 activity
(%)
Peptide 38.5 + 6.83
Peptide + tBHP 25.7 + 3.92
tBHP 157.5 + 7.99
5.3.I.5. Morphological changes in caco-2 treated with peptide
The protective effects of the peptide from the oxidant activity of tBHP were investigated 
by microscopy. Figure 5.5 shows the morphological modification in the caco-2 cells 
treated with tBHP (D) where the cells are detached from the flask surface, indicating cell 
death due to the cytotoxic effect of tBHP. On the other hand, cells that were treated with 
the tBHP in the presence of peptide (Figure 5.5 C) appear healthy and were attached to 
the flask surface and compared well to the control (A) and to those cells treated with 
peptide only (B). This observation further confirms the protective effects of the peptides 
on cells subjected to oxidants like peroxides.
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BFigure 5.5. Caco-2 cells control (A), and those treated with peptide (B), peptide and 
tBHP (C) and tBHP only (2.5mM).
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5.3.2. Reactive oxygen species (ROS) scavenging in Ea.hy926 cells treated with 
peptide
Figure 5.6 shows the viability of Ea.hy 926 cells treated with the peptide and the control 
(no peptide). Ea.hy 926 cells were seeded at different concentrations in a 96 well plate 
and treated with 1.0 mg/ml. The cell viability is expressed as the absorbance of the 
proliferating cells at respective cell seeding concentrations and values are expressed as 
the mean ± SD. At these seeding concentrations, there were no differences observed in 
the cell viability of the peptide and control (p< 0.01). These results show that the peptide 
at this concentration was not cytotoxic to the Ea.hy 926 cells and therefore this peptide 
concentration was used further in ROS scavenging studies in Ea.hy 926 cells.
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Figure 5.6. The cell viability of Ea.hy 926 treated with peptide (LC1-Z) and control. 
Data points are means ± SD, n=3
One mechanistic pathway in which the intracellular reactive oxygen species (ROS) are 
produced is through the signal transduction of Angiotensin II-dependent cellular 
responses via activation of redox sensitive signalling cascades. In endothelial cells, this 
activation is through a phagocyte-type NADPH oxidase enzyme system that is relatively 
active but is stimulated acutely by agonists such as Angiotensin II and cytokines (Li and 
Shah, 2003). The ROS produced in this cascade are the electron-reduction product 
superoxide (02*~) and the electron-reduction product hydrogen peroxide (H2O2). These 
serve as progenitors for other ROS that consequently leads to oxidative stress. Numerous 
methods are utilised for ROS detection, each with potential pitfalls and advantages. All 
of these techniques can yield errors, and it is advisable to use at least 2 methods to avoid
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an erroneous conclusion (Dikalov et al, 2007). In this study, the lucigenin- 
chemilumniscence and fluorescence methods were utilized to measure ROS in 
endothelial cells, Ea.hy 926. In the lucigenin-chemilumniscence method, on exposure to 
superoxide (02*“), a chemiluminescent probe (lucigenin) releases a photon that is 
detected by a luminometer. Since most of these compounds are cell permeable, the 0 2*~ 
measured reflects the extracellular, as well as intracellular, 0 2*“ production. In the 
fluorescence method, the reaction of dihydroethidium with 0 2*~ yields a very specific 
product; 2-hydroxyethidium can then be used to estimate the intracellular production of
o2".
In this study, both methods showed that the treatment of Ea.hy 926 cells with 
angiotensin II resulted in increased ROS production (figure 5.7 and 5.8). When the 
Ea.hy 926 cells were stimulated with angiotensin II and later treated with the peptide, 
0 2*_ were reduced by 26 % and 39 % in the lucigenin-chemilumniscence and 
flourescence methods respectively. This study postulates that the reduction in 0 2*~ is due 
to a scavenging mechanism as several in vitro studies show that some peptides with 
particular amino acid sequences have superoxide radical scavenging activities 
(Rajapakse et al, 2005; Je et al, 2007; Bougatef et al, 2009; Jung et al, 2007). This 
shows the potential of the isolated peptide to impact positively on oxidative stress in 
endothelial cells through superoxide radical scavenging. However, the scope of this 
study has not shown the possible mechanism(s) in endothelial cells to explain the 
reduced 0 2*~ and this is worth exploring in further studies.
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Figure 5.7. ROS production in Ea.hy 926 cells in the presence of peptide (LC1-Z) 
and angiotensin II (Ang II) by the lucigenin-chemilumnescence method. Each value 
represents means ± SD (n=3)
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Figure 5.8. ROS production in Ea.hy 926 cells treated with peptide (Pep) and 
Angiotensin II (Ang II) by the DHE fluorescence method. Each value represents 
means ± SD (n=3)
1 5 1
5.3.3. Peptide transport in a caco-2 monolayer
Culturing of caco-2 cells on a semipermeable filter inserts for between 5 - 7  days 
resulted in the successful formation of a mono layer with transepithelial electrical 
resistance (TEER) values above 200 ohm (XT) x cm2. Therefore peptide transport studies 
were done in inserts that had a TEER value higher than 200 D. The peptide (1 mg/ml) 
was added to either side, apical and/or basolateral (donor side); transepithelial transport 
was expressed as apparent permeability and the ratio of the peak areas of the peptide 
from recipient and donor side (apical to basolateral and basolateral to apical) was 
determined. The basolateral to apical flux of 0.95+ 0.12 cm s"1 of the peptide was 
slightly higher (p< 0.01) than that of the apical to basolateral flux of 0.74 + 0.20 cm s' 1 
(Table 5.2).
Table 5.2. Apparent permeability of peptide in a caco-2 monolayer.
Movement of peptide Apparent permeability* %  Ratio of Peak areas*
(cm s'1)
Apical/basolateral 0.74 + 0.20 11.5
B asolateral/apical 0.95+ 0.12 12.2
* the ratio of the peak area of the peptide in the recipient side to that of the donor side 
(where peptide was added). $Data are mean + SD, n=3.
Figure 5.9 shows the chromatographic trace of the buffer taken from the apical and 
basolateral side respectively when the peptide was added to the apical side. However,
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the apical to basolateral flux and basolateral to apical flux of the peptide is not 
significantly different as the ratio of the peak areas (recipient/donor) is the same, i.e. 
11.5% for apical to basolateral and 12.2 % for basolateral to apical (Table 5.1). These 
results show that the transport of the peptide in the caco-2 monolayer model is not 
unidirectional.
Figure 5.9. Chromatogram of peptide added to apical side of insert. Black line 
represent the apical side, blue line represents the basolateral side.
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Three mechanisms for intestinal transport of oligopeptides are reported namely a) 
through the transporter (PepTl) - mediated transport for di and tripeptides b) 
transcytosis and c) paracellular transport through the intercellular junctions. These 
transport systems, together with their respective enzyme systems, are all present in caco- 
2 cells, making the caco-2 cell model an ideal one for transport studies (Hidalgo et al, 
1989). It has been demonstrated that Caco-2 cells express at least 8 aminopeptidases 
(Howell et al, 1992). Satake et al (2002) has reported that the paracellular route is the 
favoured for intestinal absorption for intact Val-Pro-Pro and that the transport is strongly 
dependent on their structure and properties.
The susceptibility to cellular peptidases is an important factor in determining the 
bioavailability of the peptide and hence a peptide which is highly susceptible to surface 
peptidases will have negligible transepithelial transport. Therefore, the digestion by 
cellular peptidases is the primary factor affecting intact peptide flux across the epithelial 
cell layer. In this study, we observed the presence of the intact peptide in the basolateral 
side when the peptide was added to the apical side as evidenced by the same retention 
times in the HPLC chromatograms (Figure 5.10). We therefore postulate that the peptide 
isolated in this study is probably transported intact across the caco-2 monolayer and to 
some degree survives the caco-2 endopeptidases. This study therefore infers that this 
peptide produced using gastrointestinal enzymes has the potential to impart its 
antioxidant bioactivity in vivo.
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5.4. CONCLUSIONS
This study showed that peptides from pepsin and pancreatin digestion of fish muscle in 
caco-2 cells possess antioxidant activity and in the presence of peroxides, offer 
protection to caco-2 cells against apoptosis and necrosis. This protection was observed 
by a significant proliferation of the caco-2 cells treated with peptides in the presence of 
oxidants tBHP. In Ea.hy 926 endothelial cells, the isolated peptide scavenged ROS after 
stimulation with angiotensin II. This study also showed that the isolated peptide can 
survive the endopeptidases of the caco-2 monolayer and be absorbed across the caco-2 
monolayer.
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6. GENERAL DISCUSSION AND CONCLUSIONS
6.1. Atlantic mackerel fish protein fractionation and peptide purification
The consumption of fish has been linked to a number of health benefits as a result of its 
unique content of proteins, omega-3 oils, vitamins and minerals. Atlantic mackerel is a 
particularly good source of lipids and proteins, and forms an important pail of people’s 
diets especially in the northern hemisphere countries near the Atlantic Ocean. The 
proximate composition of Atlantic mackerel muscle was 19.9 % protein, 3.7 % oil, and 
73.7 % water.
The aim of this study was to investigate the potential positive effects of Atlantic 
mackerel by investigating particularly the bioactivity of peptides derived from its muscle 
protein. Bioactive peptides are released from the protein by hydrolysis, and when 
absorbed, exert a biological function in the human body and impact on the health of the 
individual (Korhonen and Pihlanto, 2003, Yoshikawa et al, 2000). Many different 
enzyme combinations have been used to produce bioactive peptides from fish proteins 
(Howell and Kasase, 2009). In the present study, the muscle only (flesh) of Atlantic 
mackerel was hydrolysed with gastrointestinal enzymes, pepsin and pancreatine 
(mixture of trypsin and chymotrypsin). A  combination of these digestive enzymes has 
seldom been used to obtain peptides to investigate A C E  inhibition and antioxidant 
activity. The resultant hydrolysate was sequentially fractionated on 10, 5 and 2 kDa 
molecular weight cut off (MWCO) membrane ultrafilters and the A C E  inhibition and 
antioxidant activities were determined separately, as discussed below. For both
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activities, the fractions collected from the less than 2 kDa membrane filter exhibited the 
highest activities. This fraction was then purified by gel filtration, ion exchange and high 
perfonnance liquid chromatography to identify the peptide exhibiting highest A C E  
inhibition and antioxidant activity. The amino acid composition of the isolated peptide 
was then determined by HPLC.
6.2. Angiotensin converting enzyme inhibitory activity of peptide isolated from  
Atlantic mackerel
The A C E  inhibitory activity of fractionated ultrafiltration membrane fractions < 2 kDa 
(MFPH-V), 3-5 kDa (MFPH-III), 5-10 kDa (MFPH-II) and crude enzymatic hydrolysate 
(MFPH-I) were determined and found to be 95.0, 52.7, 33.3 and 26.6 % respectively. 
The < 2 kDa (MFPH-V) fraction showed the highest A C E  inhibitory activity and was 
consequently further purified by gel filtration chromatography with Sephadex G-25 
(Figure 2.1). The MFPH-V fraction showed 19 peptide fractions and when analysed for 
their A C E  inhibitory activity, (MFPH-V-J) showed the highest A C E  inhibitory activity 
of 36.09 % (Figure 2.2). This fraction (MFPH-V-J) was subjected to ion exchange 
chromatography and 16 fractions were identified and analysed for A C E  inhibitory 
activity (Figure 2.3). The fraction P MFPH-V-JP) showed the highest A C E  inhibitory 
activity of 86.1 %. This fraction was purified by liquid chromatography and 5 fractions 
that showed A C E  inhibitory activity were identified. The fraction with highest A CE  
inhibition with activity of 34.9 % was fraction denoted MFPH-V-JPA. This fraction was
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subjected to HPLC analysis for amino acid composition and contained the amino acids -  
histidine, proline, tyrosine, methionine, leucine, tryptophan and lysine
The inhibitory potential was quantified through the inhibitory concentration (IC50), i.e. 
the concentration required to inhibit 50 % of the enzyme. The (IC50) values of MFPH-V, 
MFPH-V-J, MFPH-V-JPA and MFPH-V-JPA2 were significantly different (p>0.0001) 
and were found to be 2.76, 0.43, 0.36 and 0.15 mg/ml respectively. This is the first time 
that a peptide with this IC50 has been obtained from Atlantic mackerel with 
gastrointestinal enzymes hydrolysis and is comparable to 2 peptides CW LPVY (0.019 
mg/ml, 22.2pM) and SKVPP (0.106 mg/ml, 74,22 pM) from tuna fish with trypsin, 
chymotrypsin, pronase and pepsin enzymatic hydrolysis(Astawan et al, 1995); 0.10 
mg/ml for an hydrolysate from mackerel (Itou and Akahane, 2004), 0.53 mg/ml for a 
seabream hydrolysate and 0.027 mg/ml for a salmon hydrolysate (Fahmi et al, 2004).
The inhibition of A C E  by peptides is strongly influenced by the amino acid sequence of 
the C-terminal tripeptide, hydrophobicity in the C-terminal tripeptide and size of the 
peptide. Cheung et al. (1980) suggested that the most favorable amino-terminal residues 
are branched amino acids such as Val and lie and that the most preferred C-terminal 
residues are among Tip, Tyr, Pro, or Phe. Peptides with hydrophobic amino acids in the 
C-terminal tripeptide are reported to be potent inhibitors (Wu et al, 2006a, Wu et al, 
2006b). The presence of a positive charge as in the guanidine group of the C-terminal 
tripeptide also contributes to the A CE inhibitory potency of several peptides. Therefore, 
the observed A C E  inhibitory activity of the isolated peptide (MFPH-V-JPA2) can be
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attributed partly to the presence of proline and tyrosine, hydrophobic amino acids in the 
C-terminal tripeptide. A  number of peptides from fish sources with proline in the C- 
terminal tripeptide have also been reported and show a range of IC50 values; FRVFTPN  
(0.01 mg/ml/9.59 pM), SKVPP (0.044 mg/ml/74.22 pM), YR PY (0.21 mg/ml/320 pM), 
FRVFTPN (0.01 mg/ml/9.59 pM) and M IFPGAGGPEL (0.029 mg/ml) Astawan et al, 
1995; Fugita et al, 2000; Matsumura et al, 1993; Jung, et al, 2006). It appeal's indeed 
that the position of the proline residue is just one factor that determines the A CE  
inhibitory activity of these peptides.
Obtaining peptides with A C E  inhibitory bioactivity and determination of the amino 
acids sequence can help to further understand the mechanisms through which the 
sequenced peptides exert the bioactivity. Peptides inhibit the A C E  either by binding to 
the active site (competitive inhibition) 01* to another site on the enzyme (non-competitive 
inhibition). In this study, the mechanism of A C E  inhibition by the isolated peptide was 
characterised through Lineweaver-Burk plots and the isolated peptide showed 
competitive inhibition. In the RAS, the inhibition of A C E  by peptides leads to the 
reduction in blood pressure. Hydrolysates from tuna and mackerel with IC50 values of 
0.029 mg/ml (Itou and Akahane, 2004) and 0.63 mg/ml (Astawan et al, 1995) 
respectively have been shown to reduce systolic blood pressure in SHR. The peptide 
isolated in this study with an IC50 value of 0.15 mg/ml may potentially reduce SBP in 
SHR.
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6.3. Antioxidant activity and mechanism of isolated peptide from Atlantic mackerel
When lipids are oxidized, peroxides and hydroperoxides are formed as primary products 
which are then transformed into carbonyl secondary products also referred to as 
thiobarbituric acid reactive substances (TBARS) that include Malondialdehyde (MDA). 
Therefore, peroxides/hydroperoxides and TBARS are considered as a biomarkers of 
lipid peroxidation (Liu et al, 1997; Orhan, et al, 2004). In this study, the inhibitory 
effects of the isolated peptide (LC1-Z) containing amino acids serine, histidine, tyrosine, 
phenylalanine, tiptophan and lysine, on oxidizing linoleic acid emulsion model system 
was investigated by monitoring peroxides using the ferric thiocyanate method and M DA  
by the TBARS method over 7 days. The isolated peptide showed a marked reduction in 
the formation of both primary and secondary oxidation products from linoleic acid. The 
formation of both peroxides and M D A  was markedly and effectively inhibited in the 
presence of the isolated peptide (LC1-Z). The trend in the inhibition of linoleic acid 
oxidation was similar to that of the antioxidant standards, 0.01 % butylated 
hydroxy toluene (BHT) and 0.01 % trolox. A  dose dependent inhibition of linoleic acid 
oxidation by the peptide was observed. From this dose dependent trend, an inhibitory 
concentration (IC50) of the peptide of 1.80 mg/ml assay volume (y = 8.254x + 35.239, R2 
= 0.85) was observed. However, at a peptide concentration of 8 mg/ml, the inhibition of 
linoleic acid oxidation inhibition is markedly more than (p<0.001) BHT and trolox (0.01 
%) at concentrations normally used in food systems, indicating the potential of using 
bioactive fish peptides as natural antioxidants.
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The lipid oxidation inhibitory ability and mechanism of inhibition of the peptide is 
attributed to the type of amino acids present in the peptide, sequence of amino acids and 
size of peptide. The presence of hydrophobic amino acids such as Gly, Leu, Phe, and Pro 
has been shown to exhibit higher antioxidative activities against lipid peroxidation 
(Saiga et al, 2003). The antioxidant activity of peptides containing histidine is attributed 
to hydrogen donating ability, lipid peroxyradical trapping, and/or the metal ion-chelating 
ability of the imidazole group (Chan and Decker, 1994). The observed higher 
antioxidative potency of the peptide in this study can therefore be attributed to the 
presence of hydrophobicity, which may lead to a higher interaction between the peptide 
and linoleic acid. In addition to hydrophobicity, the specific positioning of amino acid 
residues in the peptide sequence plays an important role in the antioxidative activity 
observed. In residue-activity relationships for synthetic antioxidative peptide mimics in 
linoleic acid peroxidation systems, a loss of the antioxidative activity was observed after 
deletion of terminal histidine residue (Chen et al, 1996; Chen et al, 1998).
The mechanism of antioxidant activity of the peptide in this study was investigated and 
observed to be through carbon centered radical scavenging, hydroxyl radical scavenging, 
metal chelating and reducing ability. In the carbon centered radical scavenging 
technique that was used, l,l-diphenyl-2-picrylhydrazyl (DPPH) is a stable free radical 
that accepts an electron or hydrogen radical to become a stable diamagnetic molecule. 
When DPPH radicals encounter a proton-donating substrate such as an antioxidant, the 
radicals are scavenged and the absorbance is reduced. The reduction in absorbance is 
used as a measure of the radical-scavenging activity of the antioxidant under study
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(Shimada et al, 1992). The peptide (LC1-Z) (1 mg/ml) exhibited radical scavenging 
activity of 5.34 % and was comparable to that of the 0.01 % BHT (10.03 %) and 7 times 
more than ascorbic acid (35.2 %). The scavenging of free radicals by antioxidants is 
reported to be effected via the donation of hydrogen atom. Amino acids histidine, 
leucine, methionine and tyrosine are known to enhance the radical-scavenging activities 
of antioxidant peptides (Park et al, 2001, Je et al, 2007). In this context, several peptides 
isolated from fish proteins, containing these amino acids, have exhibited radical 
scavenging activities (Je et al, 2005; Mendis et al, 2005; Rajapakse et al, 2005; Jung et 
al, 2007; Je et al, 2007). Therefore, the observations from this study suggest that the 
peptides interact with free radicals and protect lipids from oxidation by being 
preferentially oxidized rather than the lipids. This happens if the available amino acids 
of the peptide are more oxidatively labile than lipids, or if  the physical location of the 
peptide places itself near the site of free radical generation where the peptide is able to 
rapidly scavenge the free radical prior to the migration of the radical to lipids (Elias et 
al, 2008, Saeed et al, 2006).
The hydroxyl radical is very reactive and can be generated in biological systems via the 
Fenton reaction; it is one of the most active free radicals that attacks all biological 
molecules by setting off a free radical chain reaction, resulting in cell damage and hence 
human diseases (Halliwell, 2000). Hydroxyl radicals interact easily with biomolecules 
such as amino acids, proteins and D N A  (Cacciuttolo et al, 1993). In this study, we have 
shown that the isolated peptide has hydroxyl radical scavenging ability. As the 
concentration of a scavenging molecule is proportional to the radical scavenging
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activity, this scavenging activity of the peptide was linearly expressed (y = 31.605x -  
0.5408, R2 = 0.9279) and accordingly an IC50 value of 1.60 mg/ml was obtained. Amino 
acids cysteine, histidine, methionine, tyrosine and phenyalanine are key to the hydroxyl 
radical scavenging activity of peptides due to their characteristic structure. The 
imidazole group in histidine has the proton-donation ability (Tsuge et al, 1991), the 
sulfoxide group in methionine is susceptible to oxidation, and cysteine can donate the 
sulfur hydrogen (Hernandez-Ledesma et al, 2005). Tyrosine and phenyalanine act 
positively as direct radical scavengers by the unique ability of their phenolic groups that 
serve as hydrogen donors (Jung et al, 1995; Rajapakse et al, 2005, Saeed et al, 2006).
Antioxidants can be explained as reductants, and inactivation of oxidants by reductants 
can be described as redox reactions in which one reaction species (oxidant) is reduced at 
the expense of the oxidation of another antioxidant. Therefore, the reducing power assay 
is often used to evaluate the ability of antioxidants to donate electrons. In this study, the 
ability of the isolated fish peptide to reduce Fe3+/ferricyanide complex to the ferrous 
form was determined and showed that the reducing power of the peptide increased with 
increasing concentrations (0 -  25 mg/ml) and that the peptide exhibited reducing ability 
in a dose dependent manner (y = 0.0301x + 0.0322, R2 = 0.9943). The results propose 
that the peptide has amino acids that work as electron donors and react with free radicals 
to form more stable products.
Transition metal ions, such as Fe2+/3+, Cu3+, Co3+, in biological systems affect both the 
rate of autoxidation and breakdown of hydroperoxide to volatile compounds. Therefore,
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chelation of transition metal ions by antioxidant peptides would retard this oxidation 
reaction. The isolated peptide has demonstrated appreciable iron chelating activity of 
5.72 % and is comparable to potent antioxidants 0.01 % trolox (11.11 %) and 0.01 %  
ascorbic acid (12.67 %). It has been reported that peptide chelators can inhibit lipid 
oxidation by changing the physical location of transition metals (e.g. partitioning metals 
away from oxidatively labile lipids or hydroperoxides), forming insoluble metal 
complexes, reducing the chemical reactivity of transition metals, and/or sterically 
hindering the interaction of metals and dispersed lipids (Diaz et al, 2003; Diaz and 
Decker, 2005). Amino acids and peptides are typical metal chelating agents (Fujimoto et 
al, 1984) and the characteristic amino acid sequence of peptides is important for 
antioxidant activity (Chen et al, 1995). The antioxidant activity of histidine-containing 
peptides is related to their metal chelating ability, besides the lipid-radical trapping 
potential of the imidazole ring (Uchida and Kawakishi, 1992; Murase et al, 1993).
Overall, the observed antioxidant activity and consequent mechanism of antioxidant 
ability of peptides is generally explained by the peptide comprising amino acids such as 
histidine, tyrosine, and phenyalanine. The observed antioxidant activity of the peptide 
isolated from Atlantic mackerel has been reported from other fish sources such as 
Mackerel (Wu et al, 2003), yellow stripe trevally (Klompong et al, 2007) and round scad 
(Thiansilakull et al, 2007), yellowfin sole (Jun et al, 2004), Alaska pollack (Je et al, 
2005, giant squid (Rajapakse et al, 2005), chum salmon (Nagai et al, 2006), jumbo 
flying squid (Lin and Li 2006), shell fish (Jung et al, 2007), yellow stripe trevally
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(Klompong et al, 2007), walleye pollack (Nagai et al, 2007), tuna (Je et al, 2007), round 
scad (Thiansilakull et al, 2007) and grass caip (Ren et al, 2008).
6.4. Antioxidant activity of peptides isolated from Atlantic mackerel in epithelial 
and endothelial cells
Cell proliferation and viability was used to determine the safety and antioxidant activity 
in epithelial (caco-2 cell line) and endothelial cells (Ea.hy 926 cell line). When Caco-2 
cells were treated with either the peptide (LC1-Z) 1.0 mg/ml, 0.01 % trolox, 0.01 %  
BHT or 0.01 % epigallocatechin gallate (EGCG) there were no differences observed in 
cell viability between the control (100 %), peptide (96.6 %) and trolox (95.7 %) 
(p<0.10). However, there was a marked reduction with, a significant difference 
(p<0.0004), in the cells treated with BHT (81.9 %) and E G CG  (80.4 %). This 
observation indicates that the peptide at this concentration and under the study 
conditions is not toxic to caco-2 cells and do not have a proxidant effect in caco-2 cells. 
Some phenolic based antioxidants have been shown to exhibit proxidant activity at 
higher concentrations (Alghazeer et al, 2008) and in this study BHT and EG CG  
concentrations used exhibited lower cell viability and could imply that they acted as 
proxidants.
Peroxides including tBHP have cytotoxic effects on several types of mammalian cells 
after penetration (Makino et al, 1995). With respect to tBHP, its toxicity is due to its 
decomposition by heme-containing proteins, membrane alterations, lipid-peroxidation,
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GSH depletion, damage to cell proteins and D N A damage (Lapshina et al, 2005). In this 
study, tBHP induced cytotoxic effects in caco-2 cells when treated with different 
concentrations of tBHP (0.5, 1.0, 5.0 and 10 mM) resulting in reduced viability of 88.64, 
78.18, 60.34 and 52.50% respectively. To observe the effects of peptides on caco-2 cells 
in the presence of an oxidant (tBHP), caco-2 cells were treated with 1.0 mg/ml of 
peptide and 2.5 mM tBHP. Caco-2 cells treated with tBHP had cell viability reduced 
significantly (79.3 %) but in the presence of the peptide and trolox no significant 
reduction was observed (94.7 % and 90.2 % respectively). Our peptides were absorbed 
across caco-2 cell membranes and this was supported by other studies (Lapshina et al, 
2005; Shimizu et a l  1997; Makino et al, 1995). Therefore, the antioxidant activity is 
deduced to occur both inside and outside the cell, thus offering protection to cell 
constituents such as D N A  as well as at the surface of the cell membrane. These results 
agree with those observed with peptides isolated from Alaska Pollack (Kim et al, 2001), 
hold fish (Kim et al, 2007), and giant squid (Rajapakse et al, 2005).
In vivo studies of tBHP have shown that it is a membrane permeable oxidant and can be 
easily metabolized into free radical intermediates forming ROO* and RO* that initiates 
oxidation of membrane lipids and consequently forms TBARS (Barr and Mason, 1995). 
The formation of TBAR S was observed to be greater in cells that were treated with 
tBHP (38.18 pg/ml) than in those treated with the peptide (33.18 pg/ml).
Necrosis and apoptosis are two types of cell death distinguished in mammalian cells. 
Part of the apoptotic cell death process is due to a class of cysteine proteases, also called
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caspases that include caspase-3 and -7. The redox perturbation induced by subtoxic 
levels of lipid hydroperoxide leads to the activation of caspase 3, oxidative DNA  
damage, and enhances apoptosis (Wang et al 2000). Therefore, the activities of caspase- 
3 and -7 were determined in caco-2 cells as biomarkers of apoptosis; the activity was 
observed to be greater in cells treated with tBHP only (157.5 ± 7.99 %) compared with 
that in cells treated with the peptide (25.7 ± 3.92 %). Thus apoptosis and consequently 
D N A damage were reduced by the peptide. This result agrees with studies in which 
phenolic substances with antioxidant activity have exhibited protective effects from 
oxidants against D N A  damage induced by H2O2 (Giovannelli et al, 2000). In 
microscopy studies, the morphological modification in the caco-2 cells treated with 
tBHP was evident as the cells were detached from the flask surface as a result of the 
cytotoxic effect of tBHP. In the presence of the peptide, the cells appeared healthy and 
were attached to the flask surface. This observation further confirms the protective 
effects of the peptide from peroxides such as tBHP.
In endothelial cells, intracellular reactive oxygen species (ROS) are produced through 
the signal transduction of angiotensin II-dependent cellular responses via activation of 
redox sensitive signalling cascades (Li and Shah, 2003). The ROS produced in this 
cascade are the electron-reduction product superoxide (02*~) and the electron-reduction 
product hydrogen peroxide (H2O2); these serve as progenitors for other reactive oxygen 
species (ROS) that consequently lead to oxidative stress. In this study, production of 
ROS in the endothelial cell line, Ea.hy 926, was investigated after stimulation with 
angiotensin II in the presence of the peptide (LC1-Z). When the Ea.hy 926 cells were
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stimulated with angiotensin II and later treated with the peptide, ROS as ( V - were 
reduced by 26 % and 39 % in the lucigenin-chemilumniscence and flourescence method 
respectively. This study postulates that the reduction in O2*” is due to scavenging 
mechanism as several in vitro studies show that some peptides with particular amino 
acid sequences have superoxide radical scavenging activities (Rajapakse et al, 2005; Je 
et al, 2007; Bougatef et al, 2009; Jung et al, 2007). The present study shows the 
potential of the isolated peptide to impact positively on the oxidative stress in 
endothelial cells through superoxide radical scavenging.
The benefit of nutraceuticals depends on their ability to survive the gastrointestinal 
enzymes, lumen epithelial cells endopeptidases, and be absorbed into the lumen. 
Therefore, in this study we investigated the absoiption and survival of the antioxidant 
peptide in caco-2 cell monolayer model. A  monolayer of caco-2 cells was developed in a 
12 well cell culture plate with permeable filter inserts and 1 mg/ml of peptide was added 
to both the apical and basolateral side of the insert. Apparent permeability 
(transepithelial transport) was observed in both directions (apical to basolateral and 
basolateral to apical) with a basolateral to apical flux of 0.95 ± 0.12 cm s'1 and 0.74 ±
0.20 cm s'1. Chromatographic traces of the buffer solution taken from the apical and 
basolateral side showed the presence of the peptide on both sides i.e., 11.5 % for apical 
to basolateral and 12.2 % for basolateral to apical. This indicates that the peptide that 
can be transported across a caco-2 monolayer unidirectionally can survive the caco-2 
endopeptidases. This peptide produced from fish muscle using gastrointestinal enzymes 
has the potential to impart its antioxidant and antihypertensive bioactivity in vivo.
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6.5. General conclusions
■ The in vitro digestion of Atlantic mackerel (Scomber scombrus) fish protein with 
pepsin and pancreatin produced several useful peptide fractions with the most 
potent peptide containing amino acids histidine, proline, tyrosine, methionine, 
leucine, tryptophan and lysine and an A C E  inhibitory activity IC50 value of 0.15 
mg/ml.
■ The peptide with the amino acid composition histidine, proline, tyrosine, 
methionine, leucine, tryptophan and lysine is a competitive inhibitor for A C E  
and has inhibition constant (Ki) of 0.32 mg/ml.
■ The in vitro digestion of Atlantic mackerel (Scomber scombrus) fish protein with 
pepsin and pancreatin produced several useful peptide fractions and in particular 
the peptide (LC1-Z) containing the amino acids serine, histidine, tyrosine, 
phenylalanine and lysine had the highest antioxidant activity, comparable to 
trolox and BHT and higher than vitamin C.
■ The peptide (LC1-Z) exerted its antioxidant activity through carbon centered 
radical scavenging, hydroxyl radical scavenging, metal chelating and reducing 
ability.
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■ Peptide (LC1-Z), in the presence of peroxides, offered protection to caco-2 cells 
against apoptosis and necrosis.
■ In Ea.hy 926 endothelial cells, the peptide (LC1-Z) scavenged ROS after 
stimulation with angiotensin II.
■ The peptide (LC1-Z) survived the endopeptidases of the caco-2 cells and can be 
absorbed across the caco-2 monolayer and therefore exert its effect in the 
vascular system.
■ Peptides obtained from the muscle of Atlantic mackerel have the potential to 
lower hypertension and enhance antioxidant activity which may have major 
potential benefits for cardiovascular and other diseases as well as for food safety.
170
R E F E R E N C E S
7. REFERENCES
1. Afanasev I, Dorozhko A l, Brodskii A V, Kostyuk VA, Potapovich Al. 1989. 
Chelating and free radical scavenging mechanisms of inhibitory action of rutin 
and quercetin in lipid peroxidation. Biochem Pharmacol 38:1763-69.
2. Alghazeer R, Gao H, Howell NK. 2008. Cytotoxicity of oxidised lipids in 
cultured colonal human intestinal cancer cells (caco-2 cells). Toxicol Lett 
180:202-11.
3. Alghazeer R, Howell NK. 2008. Formation of 4-hydroxynonenal (4-HNE) in 
frozen mackerel (Scomber scombrus) in the presence and absence of green tea. J 
Sci Food Agric 88:1128-34.
4. Amarowicz R, Shahidi, F. 1997. Antioxidant activity of peptide fractions of 
capelin protein hydrolysates. Food Chem 58:355-9.
5. Araujo M C, Melo RI, Del-Nery E, Alves MF, Juliano M A, Casarini DE, Juliano 
L, Carmona AK. 1999. Internally quenched fluorogenic substrates for 
angiotensin I-converting enzyme. J Hypertension 17: 665-72.
6. Ariyoshi Y. 1993. Angiotensin-converting enzyme inhibitors derived from food 
proteins. Trends Food Sci Technol 4: 139-44.
7. Arnesen JA, Asbjorn G. 2002. Preparation and characterisation of gelatin from 
the skin of harp seal (phoca groendlandica). Bioresource Technol 82:191-4.
8. Aruoma 01, Halliwell B, Hoey BM, Butler J. 1988. The antioxidant action of 
taurine, hypotaurine and their metabolic precursors. J Biochem 256(25):l-255.
171
9. Aruoma OI, Laughton MI, Halliwell B.1989. Camosine, homocamosine and 
serine, could they act as antioxidants in vivo? J Biochem 264: 863-69.
10. Astawan M, Wahyuni M, Yasuhara T, Yamada K, Tadokoro T, Maekawa A. 
1995. Effects of angiotensin I-converting enzyme inhibitory substances derived 
from Indonesian dried-salted fish on blood pressure of rats, Biosci Biotechnol 
Biochem. 59(3):425-9.
11. Augustijns P, Annaert P, Heylen P, Van den Mooter G, Kinget R. 1998. Drug 
absorption studies of prodrug esters using the Caco-2 model: evaluation of ester 
hydrolysis and transepithelial transport. Int J Pharmaceutics 166:45-53.
12. Antonaccio M  J. 1982. Angiotensin converting enzyme (ACE) inhibitors. Ann 
Rev Pharmacol. Toxicol 22:5-87.
13. Baneijeea G, Guptaa N, Kapoorb A, Raman G. 2005. UV induced bystander 
signaling leading to apoptosis. Cancer Lett 223: 275-284.
14. Barr DP, Mason RP. 1995. Mechanism of radical production from the reaction of 
cytochrome c with organic hydroperoxides. J Biol Chem 270:12709- 16.
15. Becker GL. 1993. Preserving food and health: antioxidants make functional, 
nutritious preservatives. Food Process 12: 54 -  6.
16. Beldent V A , Michaud L, Wei MT, Chauvet PC. 1993. Proteolytic release of 
human angiotensin converting enzyme: localization of the cleavage site. J Biol 
Chem 268:26428-34.
17. Belitz HD , Grosch W, Schieberle P. 2009. Food Chemistry. 4th edition. Springer 
-  Verlag, Berlin, Germany.
172
18. Bersuder P, Hole M, Smith G. 1998. Antioxidants from a heated histidine- 
glucose model system. I. Investigation of the antioxidant role of histidine and 
isolation of antioxidants by high performance liquid chromatography. J AOCS  
75:181-87.
19. Beutner S, Bloedorn B, Frixel S, Herna'ndez Blanco I, Hoffmann T, Martin HD, 
Mayer B, Noack P, Ruck C, Schmidt M, Schu'lke I, Sell S, Ernst H, Haremza S, 
Seybold G, Sies H, Stahl W, Walsh R. 2001 Quantitative assessment of 
antioxidant properties of natural colorants and phytochemicals: carotenoids, 
flavonoids, phenols and indigoids. The role of p-carotene in antioxidant 
functions. J Agric Food Chem 81:559-68.
20. Boisset M, Botham RP, Haegele KD, Lenfant B, Pachot J I. 2000. Absoiption of 
angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop 
and in vivo:Importance of drug ionisation in the in vitro prediction of in vivo 
Absoiption. Eur J Pharmaceutical Sci 10:215-24.
21.Boltea G, Wolburgb H, Beuermanna K, Stocker S, Stem M. 1998. Specific 
interaction of food proteins with apical membranes of the human intestinal cell 
lines Caco-2 and T84. Clinica Chimica Acta 270:151-167
22. Bornstein P, Traus W. 1979. The chemistry and biology of collagen. In: Neurath 
H, Hill RL. Editors. The proteins. New Yorlc:Academie Press. p441-632.
23. Bougatef A, Hajji M, Balti R, Lassoued I, Triki-Ellouz Y, Nasri M. 2009. 
Antioxidant and free radical-scavenging activities of smooth hound (Mustelus 
mustelus) muscle protein hydrolysates obtained by gastrointestinal proteases. 
Food Chem 114:1198-1205.
173
24. Boyer RF, Mccleary CJ. 1987. Superoxide ion as a primary reductant in 
ascorbate-mediated ferritin iron release. Free Radical Biol. Med 3:389-95.
25. Burton GW, Ingold KU. 1984. p-Carotene: an unusual type of lipid antioxidant. 
Science 224:569-73.
26. Byun HG, Kim SK. 2001. Purification and characterization of angiotensin I 
converting enzyme (ACE) inhibitory peptides from Alaska pollack (Theragra 
chalcogramma) skin. Proc Biochem 36: 1155-62.
27. Byun HG, Kim SK. 2002. Structure and Activity of Angiotensin I Converting 
Enzyme Inhibitory Peptides Derived from Alaskan Pollack Skin. J Biochem Mol 
Biol 35: 239-43.
28. Cacciuttolo M A, Trinh L, Lumpkin JA, Rao G. 1993. Hyperoxia induces DNA  
damage in mammalian cells. Free Radical Biolo Med 14:267-76.
29. Caldwell PRB, Seegal BC, Hsu KC, Das M, Softer RL. 1976. Angiotensin- 
converting enzyme: vascular endothelial localization. Sci 191:1050-1.
30. Carlsen CU, Rasmussen KT, Kjeldsen KK, Westergaard P, Skibsted LH. 2003. 
Pro- and antioxidative activity of protein fractions from pork (Longissimus 
dorsi). Eur Food Res Technol 217:195-200.
31. Careri M  and Mangia A. 2003. Analysis of food proteins and peptides by 
chromatography and mass spectrometry. J Chromatography A, 1000: 609-35.
32. Chabance B, Marteau P, Rambaud JC, Migliore-Samour D, Boynard M, Perrotin 
P, Guillet R, Jollbs P, Fiat AM. 1998. Casein peptide release and passage to the 
blood in humans during digestion of ilk or yogurt. Biochmie 80:155-165.
174
33. Chan KM, Decker EA, Lee JB, Butterfield DA. 1994. EPR spin trapping studies 
of the hydroxyl radical scavenging ability of camosine and related dipeptides. J 
Agric Food Chem 42:1407-10.
34. Chen HM, Muramoto K, Yamauchi F, Fujimoto K, Nokihara K. 1998. 
Antioxidative properties of histidine-containing peptides designed from peptide 
fragments found in the digests of a soybean protein. J Agric Food Chem 46:49-
53.
35. Chen HM, Muramoto K, Yamauchi F, Nokihara K. 1996. Antioxidant activity of 
designed peptides based on the antioxidative peptide derived from digests of a 
soybean peptide. J Agric Food Chem 44: 2619-23.
36. Chen HM, Muramoto K, Yamauchi F. 1995. Structural analysis of antioxidative 
peptides from soybean conglycinin. J Agric Food Chem 43:574-8.
37. Chen KM, Decker EM. 1994. Endogenous skeletal muscle antioxidants. Crit Rev 
Food Sci Nutr 34:403-26.
38. Chen HM, Muramoto K, Yamauchi F, Nokihara K. 1996. Antioxidant activity of 
design peptides based on the antioxidative peptide isolated from digests of a 
soybean protein. J Agric Food Chem. 44 2619-23.
39. Chen X, Ahn DU. 1998. Antioxidant activities of six natural phenolics against 
lipid oxidation induced by Fe2+ or ultraviolet light. J A O CS 75:1717-21.
40. Cheng Z, Ren J, Li Y, Chang W, Chen Z. 2003. Establishment of a quantitative 
structure-activity relationship model for evaluating and predicting the protective 
potentials of phenolic antioxidants on lipid peroxidation. J Pharm Sci 92:475-84.
175
41. Cheung HS, Wang FL, Ondetti MA, Sabo EF, Cushman DW. 1980. Binding of 
Peptide Substrates and Inhibitor of Angiotensin-converting Enzyme: Importance 
of the COOH-Terminal Dipeptide Sequence. Biological Chem 255:401-5.
42. Chow JYC, Ma L, Cho CH. 1998. Effect of cigarette smoke on ethanol-induced 
gastric mucosal lesions: The role of nitric oxide and neutrophils 
Eur J Pharmacol 342:253-60.
43. Chung SK, Osawa T, Kawakishi S. 1997. Hydroxyl radical scavenging effects of 
species and scavengers from brown mustard (Brassica nigra). Biosci, Biotechnol 
Biochem 61:118-23.
44. Chuang WL, Pan BS, Tsai JS. 2000. Inhibition of Lipoxygenase and Blood 
Thinning Effects of Mackerel Protein Hydrolysate. J Food Biochem 24:333-43.
45. Collins A. 2005. Antioxidant intervention as a route to cancer prevention. Eur J 
Cancer 41:1923-30.
46. Coppen, 1983. The uses of antioxidants. In: Allen, J.C., Hamilton, R.J. (Eds.), 
Rancidity in Foods. Applied Science Publishers, London, pp. 67-87.
47. Criado S, Bertolotti SG, Soltermann A  T, Avila V, Garcia NA. 1995. Effect of 
fiavonoids on the photooxidation of fats -  a study on their activity as singlet 
molecular oxygen [02(lDg)] generators and quenchers. Fat Sci Technol 97:265- 
9.
48. Cushman DW and Cheung HS. 1971. Spectrophotometric assay and properties of 
the angiotensin converting enzyme of rabbit lung. Biochem. Pharmacol. 
20:1637-48.
176
49. Davalos A, Miguel M, Bartolome B, Lopez-Fandino R. 2004. Antioxidant 
activity of peptides derived from egg white proteins by enzymatic hydrolysis. J 
FoodProt 67:1939-44.
50. DAgostino PA, Hancock JR, Provost LR. 1997. Analysis of bioactive peptides 
by liquid chromatography-highresolution electrospray mass spectrometry. J 
Chromatography A, 767: 77-85
51. Decker EA, Crum AD, Calvert JT. 1992. Differences in the antioxidant 
mechanism of carnosine in the presence of copper and iron. J Agric Food Chem. 
40:756-59.
52. Diaz M, Decker, EA. 2005. Antioxidant mechanisms of caseinophosphopeptides 
and casein hydrolysates and their application in ground beef. J Agric Food Chem 
52:8208-13.
53. Diaz M, Dunn CM, McClements DJ, Decker EA. 2003. Use of 
caseinophosphopeptides as natural antioxidants in oil-in-water emulsions. J 
Agric Food Chem 51:2365-70.
54. Dikalov S, Griendling KK, Harrison DG. 2007. Measurement of Reactive 
Oxygen Species in Cardiovascular Studies. Hypertension 49:1-11.
55. Doig MT, Smiley JW. 1993. Direct Injection Assay of Angiotensin-Converting- 
Enzyme by High-Performance Liquid Chromatography Using a Shielded 
Hydrophobic Phase Column. J Chromatography 613:145.
56. Ducasse E, Giannakakis K, Chevalier J, Dasnoy D, Puppinck P, Speziale F, 
Fiorani P, Faraggiana T. 2005. Dysregulated Apoptosis in Primary Varicose
177
Eur J Vascular Endovascular Surgery 29: 316-23.
57. Eastoe JE, Leach A A . 1977. The chemical constitution of gelatin. In: Ward AG, 
Courts A, editors. The science and technology of gelatin, London, UK: 
Academic Press. 73-107.
58. Edgell CJ, McDonald CC, Graham, JB. 1983. Permanent cell line expressing 
human factor VUI-related antigen established by hybridisation. Proc Natl Acad 
Sci U SA  80: 3734-37.
59. Egorov SY, Kurella EG, Boldrynev A A  and Kasnovski AA. 1992. The 
quenching of singlet molecular oxygen by carnosine and anserine in aqueous 
solution. Bioorgan Khim 18:142-4.
60. Elias RJ, Kellerby SS, Decker EA. 2008. Antioxidant Activity of Proteins and 
Peptides. Crit Rev Food Sci Nutr 48:430-41.
61. Enari H, Takahashi Y, Kawarasaki M, Tada M, Tatsuta K. 2008. Identification of 
angiotensin I-converting enzyme inhibitory peptides derived from salmon muscle 
and their antihypertensive effect. Fisheries Sci 74:911-20.
62. Erickson M C. 1998. Lipid oxidation of muscle foods’ , in: Food Lipids, 
Chemistry, Nutrition and Biotechnology, Akoh C C and Min D B (eds), New 
York, Marcel Dekker, 297-32.
63. Fahmi A, Morimura S, Guob HC, Shigematsu T,Kida K, Uemurac Y. 2004. 
Production of angiotensin I converting enzyme inhibitory peptides from sea 
bream scales. Proc Biochem 39:1195-1200.
64. FAO, Discards in the world’s marine fisheries: an update; 2004.
Veins
178
65. Ferreira SH, Bartet DC, Greene LJ. 1970. Isolation of bradykinin-potentiating 
peptides from bothrops jararaca venom. Biochem 9:2583-93.
66. Fitzgerald RJ, Meisel H. 2000. Milk protein-derived peptide inhibitors of 
angiotensin-I-converting enzyme. Brit J Nutr 84:S33-S37.
67. Foote CS, Denny WR. 1968. Chemistry of singlet oxygen VII Quenching by b- 
carotene. J Amer Chem Soc 90:6233-5.
68. Fotherby MD, Panayiotou B. 1999. Antihypertensive therapy in the prevention 
of stroke: what, when, and for whom? Drugs 58: 663-74.
69. Frankel EN. 1998. Lipid Oxidation. Dundee, UK. The Oily Press.
70. Frankel EN. 1999. Food antioxidants and phytochemicals: present and future 
perspectives, Fett/Lipid 101(12):450.
71. Friedland J, Silverstein E. 1976. A  sensitive fluorimetric assay for serum 
angiotensin-converting enzyme. Am J Clinical Pathol 66: 416-26.
72. Friedland J, Silverstein E. 1977. Elevated serum and spleen angiotensin 
converting enzyme and serum lysozyme in Gaucher's disease. Am J Clinical 
Pathol 68, 225.
73. Friedman M. 1996. Nutritional value of proteins from different food sources. A  
review. J Agric Food Chem 44:6-29.
74. Frlich I, Riederer P. 1995. Free radical mechanisms in dementia of Alzheimer 
type and the potential for antioxidative treatment. Drug Res 45:443-449.
75. Fujimoto K, Neff WE, Frankel EN. 1984. The reaction of D N A  with lipid 
oxidation products, metals and reducing agents. Biochim Biophys Acta 795:100-
7.
179
76. Fujita H, Yamagami T, Ohshima K. 2001. Effects of an ace-inhibitory agent, 
lcatsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline 
and mildly hypertensive subjects. Nutr Res 21:1149-58.
77. Fujita H, Yokoyama K, Yoshikawa M. 2000. Classification and antihypertensive 
activity of angiotensin-I-converting enzyme inhibitory activity derived from food 
proteins. J Food Sci 65: 564-9.
78. Fujita H, Yoshikawa M. 1999. LKPNM: a prodrug-type A C E  inhibitory peptide 
derived from fish protein. Immunopharmacol 44:123-7.
79. Fukuzawa K, Inokami Y, Tokumura A, Terao J, Suzuki A. 1998. Rate constants 
for quenching singlet oxygen and activities for inhibiting lipid peroxidation of 
carotenoids and a-tocopherol in liposomes. Lipids 33:751-6.
80. Gardner MLG. 1988. Gastrointestinal absorption O f intact proteins. Ann Rev 
Nutr 8:329-50.
81. Gimenez B, Aleman A, Montero P, Gomez-Guillen MC. 2009. Antioxidant and 
functional properties of gelatin hydrolysates obtained from skin of sole and 
squid. Food Chem 114:976-83.
82. Giovannelli L, Testa G, De Filippo C, Cheynier V, Clifford MN, Dolara P. 2000. 
Effect of complex polyphenols and tannins from red wine on D N A  oxidative 
damage of rat colon mucosa in vivo. Eur J Nutr 39:207-212.
83. Girotti AW . 2001. Photosensitized oxidation of membrane lipids: reaction 
pathways, cytotoxic effects, and cytoprotective mechanisms 
J Photochem Photobiol B: Biol 63:103-13.
180
84. Golik A, Zaidenstein R, Dishi V, Blatt A, Cohen N, Cotter G, Berman S, 
Weissgarten J. 1998. Effects of Captopril and Enalapril on Zinc Metabolism in 
Hypertensive Patients. J Ame Col Nutr, 17:75-8.
85. Gordon MH. 1990. The mechanisms of antioxidant action in vitro. In: Hudson 
BJF editor. Food antioxidants. New York: Elsevier Applied Science, p 1-18.
86. Green D, Kroemer G. 1998. The central executioners of apoptosis: caspases or 
mitochondria? Trends Cell Biol 8: 267-271.
87. Haila K, Heinonen M. 1994. Action of b-carotene on purified rapeseed oil during 
light storage. Lebensm -  Wiss Technol 27: 573-7.
88. Haila KM, Lievonen SM, Heinonen IM. 1996. Effects of lutein, lycopene, 
annatto, and g-tocopherol on autoxidation of triglycerides. J Agric Food Chem 
44 2096-100.
89. Hall C. 2001. Sources of natural antioxidants: oilseeds, nuts, cereals, legumes, 
animal products and microbial sources. In: Pokorny J, Yanishlieva N, Gordon M, 
editors. Antioxidants in food: practical applications. Cambridge England: 
Woodhead Publishing Limited. P 159-209.
90. Halliwell B. 2000. Lipid peroxidation, antioxidants and cardiovascular disease: 
How should we move forward? Cardiovascular Res 47:410-18.
91. Halliwell B. 2001. Role of free radicals in the neurodegenerative diseases: 
Therapeutic implications for antioxidant treatment. Drugs Aging 18:479-84.
92. Halliwell B, Whiteman M. 2004. Measuring reactive species and oxidative 
damage in vivo and in cell culture: How should you do it and what do the results 
mean? Brit J Pharmacol 142:231-55.
181
93. Hattori M, Yamaji-Tsukamoto K, Kumagai H, Feng Y, Takahashi K. 1998. 
Antioxidative activity of soluble elastin peptides. J Agric Food Chem 46:2167-
70.
94. Hayakari M, Kondo Y, Izumi H. 1978. A  rapid and simple spectrophotometric 
assay of angiotensin-converting enzymeAnals Biochem. 84:361.
95. Hernandez-Ledesma B, Davalos A, Bartolom B, Amigo L. 2005. Preparation of 
antioxidant enzymatic hydrolysates from clactalbumin and a-lactoglobulin, 
identification of active peptides by HPLC-MS/MS. J Agric Food Chem 53:588-
93.
96. Heim KE, Tagliaferro AR, Bobilya DJ. 2002. Flavonoid antioxidants: chemistry, 
metabolism and structure-activity relationships. J Nutr Biochem 13: 572-84.
97. Hidalgo IJ, Raub TJ, Borchardt RT. 1989. Characterization of the human colon 
carcinoma cell line (caco-2) as a model system for intestinal epithelial 
permeability. Gastroenterology 96: 736 -  49.
98. Holmquist B, Bu nning P, Riordan JF. 1979. A  continuous spectrophotometric 
assay for the angiotensin converting enzyme. Anal Biochem 95:540-8.
99. Hopia Al, Huang SW, EN Frankel. 1996. Effect of a-tocopherol and trolox on 
the decomposition of methyl linoleate hydroperoxides. Lipids 31:357-65.
100. Howell NK, Kasase C. 2009. Bioactive peptides and proteins from fish 
muscle and collagen. In Biologically Active Food Proteins and Peptides in 
Health -  Fundamental and Clinical Aspects. Blackwell-Wiley Publ. London. In 
press
182
101. Howell NK, Saeed S. 1999. The effect of antioxidants on the production 
of lipid oxidation products and transfer of free radicals in oxidised lipid-protein 
systems. In: Basu TK, Temple NJ, Garg ML, editors. Antioxidants in Human 
Health and Disease. Oxford:CAB International. p43-54.
102. Howell S, Kenny AJ, Turner, A. J. 1992. A  survey of membrane 
peptidases in two human colonic cell lines, Caco-2 and HT-29. Biochem J. 
284:595-601.
103. Hultin HO. 1994. Oxidation of lipids in seafoods. In: Shahidi F, Botta JR, 
editors. Seafoods: Chemistry, Processing. Technology and Quality. London: 
Blackie Academic and Professional, p 49.
104. Hyun CK, Shin HK. 2000. Utilization of bovine blood plasma proteins 
for the production of angiotensin I converting enzyme inhibitory peptides. Pro 
Biochem 36:65.
105. Igic R, Belinda R. 2003. Properties and distribution of angiotensin I 
converting enzyme. Curr Pharm 9: 697-706.
106. Inagami T. 1992. The renin-angiotensin system. Essays Biochem 28: 
147-64.
107. Itou K, Akahane Y. 2004. Antihypertensive effect of heshiko, a 
fermented mackerel product, on spontaneously hypertensive rats. Fish Sci 
70:1121-29.
108. Iwami K, Hattori M, Ibuki F. 1987. Prominent antioxidant effect of wheat 
gliadine on linoleate peroxidation in powder model systems at high water 
activity. J Agric Food Chem 35:628-31.
183
109. Jao CL, Ko WC. 2002. l,l-Diphenyl-2-picrylhydrazyl (DPPH) radical 
scavenging by protein hydrolysates from tuna cooking juice. Fish Sci 68:430-5.
110. Je JY, Park PJ, Kim SK. 2005. Antioxidant activity of peptide isolated 
from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate. Food 
Res Int 38:45-50.
111. Je JY, Pyo J, Park PJ, Kwon JY, Kim SK. 2004. A  Novel Angiotensin I 
Converting Enzyme Inhibitory Peptide from Alaska Pollack (Theragra 
chalcogramma) Frame Protein Hydrolysate. J Agric Food Chem 52:7842-5.
112. Je JY, Qian ZJ, Byun HG, Kim SK. 2007. Purification and 
characterization of an antioxidant peptide obtained from tuna backbone protein 
by enzymatic hydrolysis. Proc Biochem 42 :840-6.
113. Je JY, Park PJ, Kim SK. 2005. Antioxidant activity of peptide isolated 
from Alaska pollack (Theragra chalcogramma) frame protein hydroiysate. Food 
Research Int 38:45-50.
114. Jorgensen K, Skibsted LH. 1993. Carotenoid scavenging of radicals. 
Effect of carotenoid structure and oxygen partial pressure on antioxidative 
activity. Z  Lebensm Unters Forsch 196:423-9.
115. Jun SY, Park PJ, Jung WK, Kim SK. 2004. Purification and 
characterization of an antioxidative peptide from enzymatic hydroiysate of 
yellowfin sole (Limanda aspera) frame protein. Eur Food Res Techol 219:20-6.
116. Jung M Y, Kim SK, Kim SY. 1995. Riboflavin-sensitized photooxidation 
of ascorbic acid: Kinetics and amino acid effects. Food Chem 53:397-403.
184
117. Jung WK, Mendis E, Je JY, Park PJ, Son BW, Kim HC, Choi YK, Kim 
SK .2006. Angiotensin I-converting enzyme inhibitory peptide from yellowfin 
sole (Limanda aspera) frame protein and its antihypertensive effect in 
spontaneously hypertensive rats. J Food Chem 94:26-32.
118. Jung WK, Qian ZJ, Lee SH, Choi SY, Sung NJ, Byun HG, Kim SK. 
2007. Free Radical Scavenging Activity of a Novel Antioxidative Peptide 
Isolated from In vitro Gastrointestinal Digests of Mytilus coruscus. J Med Food 
10:197-202.
119. Kamal-Eldin A, Appelqvist L-A  1996. The chemistry and antioxidant 
properties of tocopherols and tocotrienols. Lipids 31:671-701.
120. Kasase C, Ganeshalingam A, Howell N. 2008. Antioxidant activity of soy 
protein isolate enzymatic hydrolysate. In “Gums and stablizers for the food 
industry 14.” Ed Williams PA, Philips OG. RCS publishing, England.
121. Kawasaki T, Seki E, Osajima K, Yoshida M, Asada IC, Matsui T, 
Osajima Y. 2000. Antihypertensive effect of Valyl-Tyrosine, a short chain 
peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. 
J Hypertens 14:519-23.
122. Kawashima K, Itoh H, Miyoshi M, Chibata I. 1979. Antioxidant 
properties of branched-chain amino acid derivatives. Chem Pharmacol Bull 
27:1912-6.
123. Kelleher K. 2005. Discards in the world’ s marine fisheries An update. 
FAO Fisheries Technical Paper 470. Rome:Fishing Technology Service, FAO  
Fisheries Department, FAO.
185
124. Kim SK, Byun HG, Park PJ, Shahidi F. 2001. Angiotensin i converting 
enzyme inhibitory peptides purified from bovine skin gelatin hydrolysate. J 
Agric Food Chem 49, 2992-7.
125. Kim SK, Kim Y Y , Byun KS, Nam DSJ, Shahidi F. 2001. Isolation and 
characterization of antioxidative peptides from gelatin hydrolysate of Alaska 
pollack skin. J Agric Food Chem 49:1984-9.
126. Klompong V, Benjakul S, ICantachote D, Shahidi F. 2007. Antioxidative 
activity and functional properties of protein hydrolysate of yellow stripe trevally 
(Selaroides leptolepis) as influenced by the degree of hydrolysis and enzyme 
type. Food Chem 102:1317-27.
127. Klotz LO, Kroncke KD, Sies H. 2003. Singlet oxygen-induced signaling 
effects in mammalian cells. Photochem Photobiol Sci 2: 88-94.
128. Kohama Y, Matsumoto S, Oka H, Teramoto T, Okabe M, Mimura T. 
1988. Isolation of angiotensin-converting enzyme inhibitor from tuna muscle. 
Biochem Biophys Res Commn 155:332-7.
129. Kolakowska A. 2002. Lipid Oxidation in Food Systems. In Chemical and 
functional properties of food lipids. Eds Sikorski Z and Kolakowska A. London 
UK, CRC Press, ppl291.
130. Kong B and Xiong YL. 2006. Antioxidant Activity of Zein Hydrolysates 
in a Liposome System and the Possible Mode of Action. J Agric Food Chem 
54:6059-68.
131. Korhonen H, Pihlanto A. 2003. Food-derived bioactive peptides - 
Opportunities for designing future foods. Cur Pharm Design 9: 1297-308.
186
132. Korycka-Dahl M, Richardson M. 1978. Photogeneration of superoxide 
anion in serum of bovine milk and in model systems containing riboflavin and 
aminoacids. J Dairy Sci 61: 400-7.
133. Lapshina E A, Zavodnik B I, Labieniec M, Rekawiecka IC, Bryszewslcab 
M. 2005. Cytotoxic and genotoxic effects of tert-butyl hydroperoxide on Chinese 
hamster B 14 cells. Mutation Res 583:189-97.
134. Laurence DR, Bennett PN, Brown MJ. 1997. Clinical pharmacology 8th 
Ed. New York; Edinburgh : Churchill Livingstone, pp 430.
135. Lawrie RA. 1991. Meat Science, 5th ed. Oxford: Pergamon Press, pp 27-
29.
136. Lemanska K, Szymusiak H, Tyrakowska B, Zieliiski R, Soffers AEMF, 
Rietjens IMCM. 2001. The influence of pH on antioxidant properties and the 
mechanism of antioxidant action of hydroxyflavones 
Free Rad Biol Med 31(7): 869-81.
137. Leunga HWC, Wub CH, Line CH, Lee HZ. 2005. Luteolin induced D N A  
damage leading to human lung squamous carcinoma CH27 cell apoptosis Eur J 
Pharmacol 508:77- 83.
138. Li H, Van de Voort FR, Ismail AA. Cox R. 2000. Determination of 
peroxide value by Fourier transform near-infrared spectroscopy. J AOCS  
77(2): 137.
139. Li GH, Liu H, Shi YH, Le GW. 2005. Direct spectrophotometric 
measurement of angiotensin I-converting enzyme inhibitory activity for 
screening bioactive peptides. J Pharmaceutical Biomedical Analysis 37:219-24.
187
140. Lin L, Li BF. 2006. Radical scavenging properties of protein hydrolysates 
from Jumbo flying squid (Dosidicus eschrichitii Steenstrup) skin gelatin. J Sci 
Food Agric 86:2290-5.
141. Li Y, Zhu H, Kuppusamy P, Roubaud V, Zweier JL, Trush MA. 1998. 
Validation of lucigenin (Bis-N-methylacridinium) as a chemilumigenic probe for 
detecting superoxide anion radical production by enzymatic and cellular systems. 
J Biol Chem 273:2015-23.
142. Li JM, Shah AM . 2003. Mechanism of Endothelial Cell NADPH  
Oxidase Activation by Angiotensin II. J Biol Chem 278:12094-100.
143. Lo W M Y, Li-Chan CY. 2005. Angiotensin i converting enzyme 
inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein. J 
Agric Food Chem 53:3369-76.
144. Lovaas, E. 1992. A  sensitive spectrophotometric method for lipid 
hydroperoxide determination, J AOCS 69(8):777.
145. Makinen EM, Hopia Al. 2000. Effects of a-tocopherol and ascorbyl 
palmitate on the isomerization and decomposition of methyl linoleate 
hydroperoxides. Lipids 35:1215-23.
146. Makino N, Bannai S and Sugita Y. 1995. Kinetic studies on the removal 
of extracellular tert-butyl hydroperoxide by cultured fibroblasts. Biochem 
Biophys Acta 1243: 503-8.
147. Manger W M and Page IH. 1982. An overview of current concepts 
regarding the pathogenesis and pathophysiology of hypertension. In Arterial
188
Hypertension: Pathogenesis, Diagnosis, and Therapy; Rosenthal, J., Ed.; 
Springer-Verlag: New York, 1982; pp 1-40.
148. Marcuse R. 1960. Antioxidant effect of amino acids. Nature 186:886-7.
149. Marcuse R. 1962. The effect of some amino acids on oxidation of linoleic 
acid and its methyl esters. J A O CS 39:97-103.
150. Mason B. 2003. Marine survey sees net gain in number of fish species 
Nature 425, 889.
151. Matsufuji H, Matsui T, Ohshige S, Kawasaki T, Osajima K, Osajima Y. 
1995. Antihypertensive effects of angiotensin fragments in SHR. Biosci 
Biotechnol Biochem 59:1398-1401.
152. Matsufuji H, Matsui T, Seki E, Osajima IC, Nakashima M. Osajima Y. 
1994. Angiotensin I-converting enzyme inhibitory peptides in an alkaline 
protease hydrolyzate derived from sardine muscle. Biosci Biotechnol Biochem 
58:2244-5.
153. Matsui T, Matsufuji H, Seki E, Osajima K, Nakashima M, Osajima Y. 
1993. Inhibition of angiotensin I-converting enzyme by Bacillus licheniformis 
alkaline protease hydrolyzates derived from sardine muscle. Biosci Biotechnol 
Biochem 57:922-5.
154. Matsumura N, Fujii M, Takeda Y, Sugita K, Shimizu T. 1993. 
Angiotensin-I-converting enzyme inhibitory peptides derived from bonito bowels 
autolysate. Biosci Biotechnol Biochem 57:695-7.
155. Meisel H, Walsh D J, Murray B and FitzGerald R J. 2006. A C E  
inhibitory peptides. In: Nutraceutical Proteins and Peptides in Health and
189
Disease. Eds Mine Y  and Shahidi F. Taylor &  Francis Group, LLC. Boca Raton, 
FL. Pp 2 6 9 -3 1 8 .
156. Meisel H. 1997. Biochemical properties of bioactive peptides derived 
from milk proteins: Potential nutraceuticals for food and pharmaceutical 
applications. Livestock Prod Sci 50:125-38.
157. Mendis E, Rajapakse N, Kim SK. 2005. Antioxidant properties of a 
radical-scavenging peptide purified from enzymatically prepared fish skin gelatin 
hydroiysate. J Agric Food Chem 53:581-7.
158. Meng QC, Balcells E, DellTtalia L, Durand J, Oparil S. 1995. Sensitive 
method for quantitation of angiotensin-converting enzyme (ACE) activity in 
tissue. Biochemical Pharmacol 50: 1445.
159. Miller GJ, Quackenbush FW. 1957. A  comparison of alkylated phenols as 
antioxidants for lard. J AOCS 34:249-52.
160. Min DB. 1998. Lipid oxidation of edible oil, in Food Lipids, Chemistry, 
Nutrition and Biotechnology, Akoh, C.C. and Min, D.B., Eds., Marcel Dekker, 
New York, 283.
161. Mine Y  and Shahidi F. 2006. A C E  inhibitory peptides. In: Nutraceutical 
Proteins and Peptides in Health and Disease. Eds Mine Y  and Shahidi F. Taylor 
&  Francis Group, LLC. Boca Raton, FL. Pp 269 -  318.
162. Mooney LM, Al-Sakkaf KA, Brown BL, Dobson PRM. 2002. Apoptotic 
mechanisms in T47D and M CF-7 human breast cancer cells. Br J Cancer 87:909- 
17
190
163. Montero P, Gomez-Guillen MC. 2000. Extracting conditions for Megrim 
Lepidorhombus boscii) skin collagen affect functional properties of the resulting 
gelatin. Food Chem Toxicol 65:434-8.
164. Morel I, Lescoat G, Cogrel P, Sergent O, Pasdelpoup N, Brissot P, 
Cillard J. 1993. Antioxidant and iron-chelating activities of the flavonoids 
catechin, quercetin and diosmetin on iron-loaded hepatocyte cultures. Biochem 
Pharmacol 45:13-9.
165. Morrissey PA, O ’brien NM. 1998. Dietary antioxidants in health and 
Disease. Int Dairy J 8:463 -  72.
166. Mozaffarian D, Katan MB, Ascherio A, Stampfer M  J, Willett WC. 
2006. Trans Fatty Acids and Cardiovascular Disease. New J Eur Med 
354(15): 1601-13
167. Murase H, Nagao A, Terao J. 1993. Antioxidant and emulsifying activity 
of N-(long-chain-acyl) histidine and N-(long-chainacyl) carnosine. J Agric Food 
Chem 41 :1601-04.
168. Nagai T, Nagashima T, Abe A, Suzuki N. 2006. Antioxidative Activities 
and Angiotensin I-Converting Enzyme Inhibition of Extracts Prepared from 
Chum Salmon (Oncorhynchus Keta) Cartilage and Skin. Int J Food Properties 
9(4):813-22.
169. Nagai T, Suzuki N, Tanoue Y, Kai N, Nagashima T. 2007. Physical 
properties of kamaboko derived from walleye pollack (Theragra chalcogramma) 
surimi and functional properties of its enzymatic hydrolysates. J Food Agric Env 
5:76-81.
191
170. Nakajima K, Yoshie YS, Ogushi M. 2009.Comparison of A C E  inhibitory 
and DPPH radical scavenging activities of fish muscle hydrolysates. Food Chem 
114:844-51.
171. Nardini M, D ’Aquino M, Tomassi G, Gentili V, Felice M  D and Scaccini 
C. 1995. Inhibition of human low-density lipoprotein oxidation by caffeic acid 
and other hydroxycinnamic acid derivatives. Free Rad Biol Med 19:541-51.
172. Natesh R, Schwager SLU, Sturrock ED, Acharya R. 2003. Crystal 
structure of the human angiotensin-converting enzyme-lisinopril complex. 
Nature 421:551-4.
173. Neels HM, Scharpe SL, van Sande ME, Verkerlc RM, Van Acker KJ. 
1982. Improved micromethod for assay of serum angiotensin converting enzyme. 
Clin Chem 28: 1352-5.
174. Ng KKF, Vane JR. 1968. Some Properties of Angiotensin Converting 
Enzyme in the Lung in vivo. Nature 218:144-50.
175. Nomura A, Noda N, Maruyama S. 2002. Purification of angiotensin I-
converting enzyme inhibitors in pelagic thresher Alopias pelagicus muscle 
hydrolysate and viscera extracts. Fisheries Sci 68:954-6
176. Offer G, Knight P, Jeacocke R, Almond R, Elsey J, Parsons N, Sharp A,
Starr R, Purslow P. 1989. The structural basis of the water-holding, appearance 
and toughness of meat and meat-products. Food Microstruct 8(1): 151-70.
177. Ohkawa H, Ohishi N, Yagi, K. 1979. Assay for lipid peroxidation in
animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-8.
192
178. Oishi M, Onishi K, Nishijima M, Nakagomi K, Nakazawa H, Uchiyama 
S, Suzuki S. 1992. Rapid and simple coulometric measurements of peroxide 
value in edible oils and fats. J A O  A C  75:507.
179. Okamoto A, Hanagata H, Matsumuto E, Kawamura Y, Koizumi Y, 
Yanagida F. 1995. Angiotensin I converting enzyme inhibitory activities of 
various fermented foods. Biosci Biotechnol Biochem 59(6): 1147-49.
180. Ondetti M A, Cushman DW. 1982. Enzymes of the renin-angiotensin 
system and their inhibitors. Annu Rev Biochem 51: 283-308.
181. Ondetti M A, Rubin B, Cushman DW. 1977. Design of specific inhibitors 
of angiotensin-converting enzyme: new class of orally active antihypertensive 
agents. Science 196: 441-4.
182. Ondetti M A, Cushman DW. 1982. Enzymes of the renin-angiotensin 
system and their inhibitors. Annu Rev Biochem 51:283-308.
183. Ondetti M A, Williams NJ, Sabo EF, PluBc'ec J, Weaver ER, Kocy O. 
1971. Angiotensin-Converting Enzyme Inhibitors from the Venom of Buthrups 
jararaca. Isolation, Elucidation of Structure, and Synthesis. Biochem Nature 
19:22.
184. Ono S, Hosokawa M, Miyashita K, Takahashi IC. 2006. Inhibition 
properties of dipeptides from salmon muscle hydroiysate on angiotensin I- 
converting enzyme. Int J Food Sci Technol 41:383-6.
185. Ono S, Hosokawa M, Miyashita K, Takahashi IC.2003. Isolation of 
Peptides with Angiotensin I-converting Enzyme Inhibitory Effect Derived from 
Hydroiysate of Upstream Chum Salmon Muscle. J Food Sci 68(5): 1611-4.
193
186. Osawa T, Namiki M. 2001. Natural antioxidants isolated from eucalyptus 
leaf waxes. J Agric Food Chem 49:2992-7.
187. Park PJ, Jung WK, Nam KS. Shahidi F, Kim SK. 2001. Purification and 
characterization of antioxidative peptides from protein hydrolysate of lecithin- 
free egg yolk. J A O CS 78:651-656.
188. Parks DA, Bulkley GB, Granger DN. 1983. Role of oxygen-derived free 
radicals in digestive tract diseases. Surgery 94:415-22.
189. Pena-Ramos EA, Xiong YL. 2003. Whey and soy protein hydrolysates
inhibit lipid oxidation in cooked pork patties. Meat Sci 64:259-63.
190. Pearson AM , Young RB. 1989. Muscle and Meat Biochemistry. 
Academic Press, London, pp342-362.
191. Persson EB, Wilson. 1977. A  fluorogenic substrate for angiotensin-
converting enzyme, Anal Biochem 83:296.
192. Piez KA, Sherman MR. 1970. Characterization of product formed 
renaturation of alphal-CB2, a small peptide from collagen. Biochem 9:4129-34.
193. Pihlanto A. 2006. Antioxidative peptides derived from milk proteins. I 
Dairy J 16:1306-14.
194. Pokorny J. 1987. Major factors affecting the autoxidation of lipids’ , in: 
Autoxidation of Unsaturated Lipids, Chan H W S (ed.), London, Academic 
Press, pp 141-206.
195. Porter NA, Caldwell SEI, Kills I<A. 1995. Mechanism of free radical 
oxidation of unsaturated lipids. Lipids 30:277-90.
194
196. Rajapakse N, Mendis E, Byun HG, Kim SK. 2005. Purification and in 
vitro antioxidative effects of giant squid muscle peptides on free radical- 
mediated oxidative systems. J Nutr Biochem 16:562-9.
197. Ren J, Zhao M, Shi J, Wang J, Jiang Y, Cui C, Kakuda Y, Xue SJ. 2008. 
Purification and identification of antioxidant peptides from grass carp muscle 
hydrolysates by consecutive chromatography and electrospray ionization-mass 
spectrometry. Food Chem 108:727-36.
198. Revankar GD. 1974. Proline as an antioxidant in fish oil. J Food Sci 
Technol 11:1-11.
199. Rhee KS, Ziprin Y A , Rhee KC. 1979. Water-soluble antioxidant activity 
of oilseed protein derivatives in model lipid peroxidation systems of meat. J 
Food Sci 44:1132-35.
200. Riison T, Sims RJ, Fioriti JA. 1980. Effect of amino acids on the 
autoxidaton of safflower oil in emulsions. J A O CS 57:354-9.
201. Roberford M, Calderon PB. 1995. Free Radicals and Oxidation 
Phenomena in Biological Systems. New York: Dekker. Ch. 5.
202. Robertsa PR, Burneya JD, Blacka KW, Zalogab GP. 1999. Effect of 
Chain Length on Absorption of Biologically Active Peptides from the 
Gastrointestinal Tract. Int J Gastroenterology 60:4.
203. Rubio L A  and Seiquer I. 2002. Transport of Amino Acids from in vitro 
Digested Legume Proteins or Casein in Caco-2 Cell Cultures. J Agric Food 
Chem 50:5202-6.
195
204. Saeed S, Gillies D, Wagner G, Howell NIC. 2006. ESR and NMR  
spectroscopy studies on protein oxidation and formation of dityrosine in 
emulsions containing oxidised methyl linoleate. Food Chem Toxicol 44(8): 1385-
92.
205. Saiga A, Tanabe S, Nishimura T. 2003. Antioxidant activity of peptides 
obtained from porcine myofibrillar proteins by protease treatment. J Agric Food 
Chem 51:3661-7.
206. Sakanaka S, Tachibana Y, Ishihara N, Juneja LR. 2004. Antioxidant 
activity of egg-yolk protein hydrolysates in a linoleic acid oxidation system. 
Food Chem 86:99-103.
207. Samaranayaka AGP, Li CECY. 2008. Autolysis-assisted production of 
fish protein hydrolysates with antioxidant properties from Pacific hake 
(Merluccius productus). Food Chem 107:768-76.
208. Sathivel S, Bechtel PJ, Babbitt J, Smiley S, Crapo C, Reppond KD. 2003. 
Biochemical and functional properties of herring (Clupea harengus) byproduct 
hydrolysates. J Food Sci 68:2196-2200.
209. Satake M, Enjoh M, Nakamura Y, Takano T, Kawamura Y, Arai S, 
Shimizu M. 2002. transepithelial transport of the bioactive tripeptide, Val-Pro- 
Pro in human intestinal caco2 cell monolayer. Biosci Biotechnol Biochem 66(2): 
378 -  84.
210. Shahidi F, Amarowicz R. 1996. Antioxidant activity of protein 
hydrolyzates from aquatic species. J A O CS 73:1197-9.
196
211. Shimizu M, Tsunogai M, Arai S. 1997. Transepithelial transport of 
oligopeptides in the human intestinal cell, Caco-2. Peptides 18: 681-7.
212. Shimpuku H, Tachi Y, Shinohara M, Ohura K. 2000. Effect of vitamin E 
on the degradation of hydrogen peroxide in cultured human umbilical vein 
endothelial cells. Life Sci 68:353-9.
213. Sica DA. 2003. Angiotensin-converting enzyme inhibitors. In 
Hypertension Primer, 3rd ed.; Izzo, J. L., Black, H. R., Goodfriend, T. L., 
Sowers, J. R., Weder, A. B., Appel, L. J., Sheps, S. G., Sica, D. A., Vidt, D. G., 
Eds.; Lippincott Williams &  Wilkins: Baltimore, pp 426-429.
214. Sidhu KS. 2003. Health benefits and potential risks related to 
consumption of fish or fish oil. Regular Toxicol Pharm 38(3):336-44.
215. Sims RJ, Fioriti JA. 1977. Methional as an antioxidant for vegetable oils. 
J A O CS 54:4-7.
216. Sladowski D, Steer SJ, Clothier RH, Balls M. 1993. An improved M TT  
assay. J Immunol Metl57:203-7.
217. Spinelli J, Koury B, Miller R. 1972. Approaches to the utilization of fish 
for the preparation of protein isolates. Isolation and properties of myofibrillar 
and sarcoplasmic fish protein. J Food Sci 37:599.
218. St. Angelo AJ. 1996. Lipid oxidation in foods, Crit Rev Food Sci Nutr 
36(3):175.
219. Stahl W, Sies H, ‘Physical quenching of singlet oxygen in cis-trans 
isomerization of carotenoids’ , in: Carotenoids in Human Health, Canfield L  M,
197
Krinsky N I and Olson J A  (eds), New York, New York Academy of Sciences, 
1993, 10-19.
220. Suetsuna K, Osajima K. 1986. The inhibitory activities against 
angiotensin I converting enzyme of basic peptides originating from sardine and 
hair tail meat. Nippon Suisan Gakkaishi 52:1981-4.
221. Suetsuna K, Nakano T. 2000. Identification of an antihypertensive 
peptide from peptic digest of wakame (Undaria pinnatifida). J Nutr Biochem 
11:450-4.
222. Suetsuna K, Ukeda H, Ochi H. 2000. Isolation and characterization of 
free radical scavenging activities peptides derived from casein. J Nutr Biochem 
11:128-31.
223. Suetsuna K. 2000. Antioxidant peptides from the protease digest of 
prawn (Penaeus Japonicus) muscle. Marine Biotechnol 2:5-10.
224. te Nijenhuis K. 1977. Gelatin. Adv Polymer Sci 160-93.
225. Thiansilakull Y, Benjakull S, Shahidi F. 2007. Antioxidative Activity of 
Protein Hydrolysate from Round Scad Muscle Using Alcalase And Flavourzyme. 
J Food Biochem 31:266-87.
226. Thurman HV, Webber HH. 1984. MarineBiology. Charles E. Merrill 
Publishing C. A. Bell and Howell Co. Columbus, Ohio., 1984.
227. Tsuge N, Eikawa Y, Nomura Y, Yamamoto M, Sugisawa K. 1991. 
Antioxidative activity of peptides prepared by enzymatic hydrolysis of egg-white 
albumin. Nippon Nogei Kagaku Kaishi 65:1635-41.
198
228. Uchida K, Kawakishi S. 1992. Sequence-dependent reactivity of 
histidine-containing peptides with copper (II)/ascorbate. J Agric Biol Chem 
40:13-6.
229. Van der Greef J., Niessen W MA. 1992. Hyphenated methods in mass 
spectrometry. Int J Mass Spectrometry Ion Proc 118-119: 857-873.
230. Vanhoof G, Goossens F, De meester I, Hendricks D, Scharpe S. 1995. 
Proline motifs in peptides and their biological processing. The FASEB J 9: 736-
44.
231. Venugopal MG, Ramshaw JAM, Braswell E, Zhu D, Brodsky B. 1994. 
Electrostatic Interactions in Collagen-like Triple-Helical Peptides. Biochem 
33:7948.
232. Vermeirssen V, Van Camp J, Verstraete W. 2004. Bioavailability of 
angiotensin I converting enzyme inhibitory peptides. Brit J Nutr 92:357-66.
233. Vermeirssen V., Deplancke B., Tappenden K.A., Van Camp J., Gaskins 
H.R., Verstrete W. 2002. Intestinal transport of the lactokinin Ala-Leu-Pro-Met- 
His-Ile-Arg through a Caco-2-Bbe monolayer. J Peptide Sci 8: 95-100.
234. Wako Y, Ishikawa S, Muramoto K. 1996. Angiotensin I-converting 
enzyme inhibitors in autolysates of squid liver and mantle muscle. Biosci 
Biotechnol Biochem 60(8): 1353-5.
235. Wang JY, Fujimoto K, Miyazawa T, Endo Y. 1991. Antioxidative 
mechanism of maize zein in powder model systems against methyl linoleate: 
Effect of water activity and coexistence of antioxidants. J Agric Food Chem 
39:351-5.
199
236. Wang T G, Gotoh Y, Jennings M  H, Rhoads C A  and Aw T  Y. 2002. 
Lipid Hydroperoxide-Induced apoptosis in human colonic caco-2 cells is 
associated with an early loss of cellular redox balance. The FASEB J 14: 1567-
76.
237. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, Cohen RA. 
2001. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress 
response to angiotensin II in mice Circ Res 88:947-53.
238. Warner K, Frankel EN. 1987. Effects of (3-carotene on light stability of 
soybean oil. J A O CS 64:213-18.
239. Ward AG , Courts A. 1977. The Science and Technology of Gelatin. 
London: Academic Press, pp 508-9.
240. Webb KE, Matthews JC, DiRienzos D B. 1992. Peptide Absorption: A  
Review of Current Concepts and Future Perspectives. J Anim Sci 70:3248-57.
241. Webb KE. 1990. Intestinal absorption of protein hydrolysis products: a 
review. J Anim Sci 68:3011-22.
242. Wei L, Clauser E, Alhenc-Gelas F, Corvol P. 1992. The two homologous 
domains of human angiotensin I-converting enzyme interact differently with 
competitive inihibitors. J Biol Chem 267:13398-^105.
243. Willcox JK, Ash SL, Catignani G. 2004. Antioxidants and Prevention of 
Chronic Disease. Crit Rev Food Sci Nutr 44:275-95.
244. Wilson G, Hassan IF, Dix CJ, Williamson I, Shah R, Mackay M, 
Artursson P. 1990. Transport and permeability properties of human Caco-2 cells
200
—  an in vitro model of the intestinal epithelial-cell barrier. J Control Release 11: 
25-40.
245. W olff SP. 1994. Ferrous oxidation in presence of ferric ion indicator 
xylenol orange for measurement of hydroperoxides. Methods Enzymol 233:182.
246. Wu HC, Chen HM, Shiau CY. 2003. Free amino acids and peptides as 
related to antioxidant properties in protein hydrolysates of mackerel (Scomber 
austriasicus). Food Research International 36:949-57.
247. Wu J, Aluko RE, Muir AD. 2002. Improved method for direct high- 
performance liquid chromatography assay of angiotensin-converting enzyme- 
catalyzed reactions. J Chromatography A  950:125-30.
248. Wu J, Aluko RE, Nakai S. 2006a. Structural Requirements of 
Angiotensin I-Converting Enzyme Inhibitory Peptides: Quantitative Stracture- 
Activity Relationship Modeling of Peptides Containing 4-10 Amino Acid 
Residues. QSA R  Comb. Sci. 25, 873 -  880.
249. Wu J, Aluko R E, Nakai S. 2006b. Structural Requirements of 
Angiotensin I-Converting Enzyme Inhibitory Peptides: Quantitative Structure- 
Activity Relationship Study of Di- and Tripeptides. J Agric Food Chem 54:732- 
8.
250. www.genome.gov/page.cfm?pageID=10000552
251. Yamaguchi N, Naito S, Yokoo Y, Fujimaki, M. 1980. Application of 
protein hydrolyzate to biscuit as antioxidant. J Jpn Soc Food Sci Technol 27:56-
9.
201
252. Yamamoto Y, Kato E, Ando A. 1996. Increased antioxidative activity of 
ovalbumin by heat treating in an emulsion of linoleic acid. Biosci Biotechnol 
Biochem 60:1430-3.
253. Yanishlieva-Maslarova NV. 2001. Sources of natural antioxidants: 
vegetables, fruits, herbs, spices and teas, in Antioxidants in Food, Pokorny, J., 
Yanishlieva, N., and Gordon, M., Eds. CRC Press, Boca Raton, FL, Chapter 10.
254. Yang C Y, Dantzig AH, Pidgeon C. 1999. Intestinal Peptide Transport 
Systems and Oral Drug Availability. Pharmaceutical Res 16: 1331-43.
255. Yee JJ, Shipe WF, Kinsella JE. 1980. Anti oxidant effects of soy protein 
hydrolyzates on copper-catalyzed methyl linoleate oxidation. J Food Sci 45: 
1082-3.
256. Yildirim A, Mavi A, Kara AA. 2001. Determination of antioxidant and 
antimicrobial activities of Rumex crispus L. extracts. J Agric Food Chem 9: 
4083-9.
257. Yokoyama K, Chiba H, Yoshikawa M. 1992. Peptide inhibitors for 
angiotensin I-converting enzyme from thermolysin digest of dried bonito. Biosci 
Biotechnol Biochem 56: 1541-5.
258. Yoshikawa M, Fujita H, Matoba N, Takenaka Y, Yamamoto T, 
Yamauchi R, Tsuruki H, Tahahata IC. 2000. Bioactive peptides derived from 
food proteins preventing lifestyle related diseases. Biofactors 12:143-6.
259. Yoshinaka RK. Sato H, Anbe M. Sato, Shimizu Y. 1988. Distribution of 
collagen in body muscle of fishes with different swimming modes. Comparative 
Biochem Physiol 89B: 147-151.
202
260. Young RH, Brewer DR. 1978. The mechanism of quenching of singlet 
oxygen’ , in: Singlet Oxygen Reactions with Organic Compounds and Polymers, 
Ranby B and Rabek J F (eds), Chichester, John Wiley and Sons , pp 36-47.
261. Yu W, Zhao Y, Shu B. 2004. The radical scavenging activities of radix 
puerariae isoflavonoids: A  chemiluminescence study. Food Chem 86: 525-9.
262. Zhou S, Decker EA. 1999a. Ability of amino acids, dipeptides, 
polyamines, and sulfhydryls to quench hexanal, a saturated aldehydic lipid 
oxidation product. J Agric Food Chem 47:1932-6.
263. Zhou S, Decker EA. 1999b. Ability of carnosine and other skeletal 
muscle components to quench unsaturated aldehydic lipid oxidation products. J 
Agric Food Chem 47:51-5.
264. Ziv E, Bendayan MS. 2000. Intestinal absorption of peptides through the 
enterocytes. Microscopy Res Technique 49:346-52.
203
A P P E N D I C E S
Ab
so
rb
an
ce
APPENDICES
Appendix 1. Standard curve of BSA
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Appendix 2. Standard curve of DHE
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Appendix 3. Standard curves for hippuryl, histidyl leucine (HHL) and hippuric 
acid (HA)
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Appendix 4. Recovery of HA in reaction mixture.
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Recovery of hippuric acid in assay conditions spiked with a concentration of hippuric 
acid (0 -  l.OmM).
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Appendix 5. HPLC chromatogram of HHL and HA
Detector 1-228nm--  MixtureMlxturen.detAreaRetention Time
COCOo> «CO
CO pe £© *zr^. m+J* o
----- ^ ---------------------------, —rrr L ....; -.......   ■   I   I 1 1 1 1 I......... I ■ 1 1 ' I .............   I     Io 2 4 6 8 10 12 14 16
Minutes
Eluted with acetonitrile (v/v, containing 0.1% TFA) and milliQ water (v/v, containing 
0.1% TFA) on Phenomenex C18 (150 x 3.2 mm) column.
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Appendix 6. Standard curve of FeCh.
Concentration (FeC12) mg/ml
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A p p e n d ix  7 . S t a n d a r d  c u r v e  o f  M a lo n d ia ld e h y d e  (M D A )
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A p p e n d ix  8. T a b le  o f  A m in o  aeiSis
A A  Codes M W . Structure A A  Codes M W . Structure
Gly G 57.05 -NH-CH^ -CO- Asp D 115.1
0
CHj-cIi -OH 
-NH-CH-CO-
Ala A 71.08
c h 3
-NH-CH-CO- Gin Q 128.1
O
-NHt
-NH/H-CO-
Ser S 87.08 CHj-OH-NH-CH-CO- Lys IC 128.2
c h ?c h 4 c h ^c h 4n h 4
-NH-CH-CO-
Pro P 97.12 H4c CH* -N-CH-CO- Glu E 129.1
0
CHj-CH^-OH
-NH-CH-CO-
Val V 99.07
CH> CH4
' i k
-NH-CH-CO-
Met M 131.2 CHiCHiS-CHi-NH-CH-CO-
Thr T 101.1
OH CHi
¥-NH-CH-CO- His H 137.1
H
-NH-CH-CO-
Cys C 103.1 h 4c - s h-NH-CH-CO- Phe F 147.2
CH 4- ( p >  
-NH-CH-CO-
Leu L 113.2
CH,
C H . / h -C H *
-NH-dH-CO-
Ai'g R 156.2
n h 4
CH4CH j CH4NH-d 
-NH-CH-CO- NH
lie I 113.2
CH*
Hi-CI+CH,
-NH-CH-CO-
Tyr Y 163.2 c h 4-< o /  o hi 4 '_/-NH-CH-CO-
Asn N 114.1
O
GHj-^  -NH5 
-NH-CH-CO-
Tip W 186.2
H
ch/QJi
-NH-/H-CO-
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